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Mathematics is a place where you can do things
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SUMMARY
Mastitis, or intramammary infection (IMI), is one of the most
frequent diseases in dairy cattle. In addition to being painful for
the affected cow, especially in the case of a clinical mastitis, it
also has various other effects on production and herd routines.
Mastitis not only reduces the milk yield but also the milk quality.
It disrupts the herd routine by leading to increased culling rates.
Furthermore, clinical cases have to be treated. The milk loss
and the costs for necessary control and intervention lead to
considerable economic losses for the dairy farmer.
An important element of mastitis management is antimicrobial
treatment. In view of rising antimicrobial resistance, the use
of antibiotics in production animals has garnered the concern
of consumers and politicians. Mastitis prevention and control
strategies should therefore be multifaceted and only rely on
antibiotics when necessary.
The overall objective of this PhD project was to identify such
multifaceted and cost-effective intervention strategies. The pro-
ject itself was divided into two parts.
The first part of this PhD project focused on data analysis.
Register data from the Danish Cattle Database were analysed by
herd-wise logistic regressions for determinants for antimicrobial
treatment in relation to udder health. Principal component ana-
lysis and clustering were performed on the regression coefficients
to group herds according to their treatment patterns. Lactational
treatments and dry cow treatments were considered separately
throughout the whole data analysis.
The results showed that in both cases, herds grouped accord-
ing to the most prominent determinants. Treatment was de-
termined by milk production, age, or diagnostics for dry cow
treatments. For lactational treatments, the determinants were
milk production, age and diagnostics, or whether or not a cow
was subsequently culled.
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In the second part of the PhD project, a strain-, cow-, and
herd-specific bio-economic simulation model of intramammary
infections was developed and used to investigate and compare
different mastitis intervention strategies. The model incorporates
a previously existing model of a Danish dairy herd (iCull). It
additionally simulates the spread of several mastitis pathogens
within the herd, the effects of mastitis, and intervention measures
for clinical and subclinical cases.
The developed model simulates a Danish dairy herd with sev-
eral mastitis pathogens, and the transmission framework is strain-
and cow-specific: it specifically allows simulating different strains
of the same pathogen species, and it considers cow-specifics for
infection and cure. However, careful calibration to specific herd
conditions is paramount as the model is sensitive to changes in
the transmission parameters.
The modelled interventions included antibiotic treatment and
cow-specific reactive culling of infected animals for both clinical
and subclinical cases. Some intervention measures also partly
incorporate the findings of the first part of the project. The
investigated intervention strategies were divided into strategies
against clinical mastitis and strategies against both clinical and
subclinical mastitis.
The most effective strategy against clinical intramammary in-
fections was a “good hygiene”, represented by a low transmission
rate. However, specifics about the necessary measures to achieve
“good hygiene” and the costs associated with implementing such
measures are unknown. Cost-effectiveness, on the other hand,
could be improved by using more antibiotic treatments or by
culling. More specifically, a comparison of different intervention
strategies showed that cow-specific treatment or culling decisions
for clinical cases was most cost-effective. For these intervention
strategies, the number of antibiotic treatment days was reduced
at the cost of an increased number of culled cows.
When the intervention strategies against clinical mastitis were
supplemented by cow-specific treatment or culling of subclin-
ical cases, cost-efficiency could be further increased. Subclin-
ical cases were identified by two subsequent high somatic cell
counts (>200 000 cells/ml) and diagnostic testing for confirma-
tion. Depending on the main causative pathogen and among
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the investigated intervention strategies, the choice of the clinical
intervention measure varied. For Staphylococcus aureus, the choice
of the intervention measure against clinical cases affected cost-
effectiveness (more cost-effective interventions before addition of
measures against subclinical cases stayed more cost-effective after
addition of such a measure). For Streptococcus agalactiae, which
primarily causes subclinical mastitis, the intervention measure
against clinical cases was less relevant.
The preferred intervention strategy therefore depends on the
herd. It may also vary depending on the farmer’s preferences
regarding management measures such as treatment or culling.
Intervention strategies against mastitis should therefore be herd-
specific.
The limitations of a modelling approach, as it was taken in
this thesis, lie in the proper understanding of the transmission
dynamics and its parameterisation. If parameter estimates are
missing, for example in the case of hygienic measures, the re-
spective aspects cannot be properly investigated. Factors that
could not be included in the model, because of missing parameter
values or because they were unknown, may change the outcome
in a real life situation. Therefore, the model results should be
seen as recommendations for possible cost-effective intervention
strategies against mastitis until, ideally, they can be validated by
field studies.
In conclusion, the model presented in this thesis can be used
as a decision support tool in scientific research: it can identify
cost-effective intervention strategies against mastitis, while also
taking into account other related factors (e.g., antibiotic treatment
and culling). These findings may then be considered in the future
when planning new mastitis management strategies.

SAMMENDRAG
Yverbetændelse (mastitis), eller infektion i yveret, er en af de
hyppigste lidelser hos malkekvæg. Mastitis er smertefuldt for
dyrene, specielt ved klinisk mastitis, og påvirker mælkeydelsen,
mælkekvaliteten og rutinerne i besætningen. Rutinen i besætnin-
gen påvirkes ved at øge udsætningsraten og antallet af kliniske
behandlinger. Den reducerede mælkeydelse samt behovet for
øget kontrol med mastitis giver desuden et økonomisk tab. Et
vigtigt element i mastitis kontrol er behandling med antibiotika.
I lyset af stigende problemer med resistens, har anvendelsen af
antibiotika til produktionsdyr gjort forbrugerne og politikerne
bekymrede. Forebyggelses- og kontrolstrategier bør derfor være
alsidige og kun inkludere antibiotika når det er nødvendigt. Det
overordnede formål med dette ph.d.-projekt var at identificere
andre og omkostningseffektive interventionsstrategier. Projektet
blev opdelt i to dele.
Den første del af projektet fokuserer på dataanalyse. Register-
data fra kvægdatabasen blev analyseret med logistisk regression
for at afdække betydende faktorer for behandling med antibioti-
ka i forbindelse med yversundhed. Principal Component Analyse
og Clusteranalyse blev udført på regressionskoefficienterne for
forskellige besætningsgrupper ud fra deres behandlingsmønstre.
Laktationsbehandlinger og goldningsbehandlinger var domine-
rende i hele dataanalysen. Resultaterne viste for begge analyser
at besætningerne kunne grupperes i forhold til de mest domi-
nerende faktorer. For goldkøer blev behandlingerne bestemt af
køernes mælkeproduktion, alder eller diagnostik. For laktations-
behandlinger var de vigtigste faktorer mælkeproduktion, alder
og diagnostik, uanset om koen senere blev udsat.
I anden del af ph.d.-projektet blev en stamme-, ko- og be-
sætningsspecifik bio-økonomisk simuleringsmodel for mastitis
udviklet og brugt til at undersøge og sammenligne forskellige
mastitis interventionsstrategier. Modellen bygger på en eksiste-
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rende model af en dansk mælkekvægsbesætning (iCull). Mo-
dellen simulerer spredningen af adskillige mastitis patogener i
en besætning, virkningerne af mastitis samt management stra-
tegier til at forhindre kliniske og subkliniske tilfælde. Modellen
simulerer både specifikke stammer af mastitis patogener og er
desuden ko-specifik med hensyn til infektion og helbredelse. Det
er altafgørende at kalibrere modellen nøjagtigt til en specifik
besætning, da modellen er følsom overfor ændringer i spred-
ningsparametrene. De modellerede interventioner inkluderede
antibiotisk behandling og ko-specifik udsætning af inficerede
dyr af både kliniske og subkliniske tilfælde. Nogle kontrolfor-
anstaltninger benytter desuden nogle af resultaterne fra første
del af projektet. De modellerede interventionsstrategier var grup-
peret i strategier mod klinisk mastitis og strategier mod både
klinisk og subklinisk mastitis. Den mest effektive strategi mod
klinisk mastitis var “god hygiejne” repræsenteret ved en lav
spredningshastighed. Der mangler dog kendskab til de simulere-
de og nødvendige foranstaltninger for at opnå “god hygiejne”.
Desuden er omkostningerne af sådanne foranstaltninger ikke
kendt. Omkostningseffektiviteten kan forbedres ved at anvende
flere antibiotiske behandlinger eller udsætning. En sammenlig-
ning af forskellige interventionsstrategier viste at kospecifikke
behandlingsbeslutninger var de mest omkostningseffektive for
kliniske tilfælde. Her blev antallet af antibiotiske behandlingsda-
ge reduceret mens antallet af udsatte køer blev øget.
Når interventionsstrategierne mod klinisk mastitis blev sup-
pleret med kospecifik behandling eller udsætning af køer med
subklinisk mastitis, kunne omkostningseffektiviteten øges yder-
ligere. Subkliniske tilfælde blev identificeret ved to på hinan-
den efterfølgende høje målinger af SCC (Somatic Cell Count,
>200 000 celler/ml) som efterfølgende blev bekræftet diagno-
stisk. Valget af interventionsforanstaltningen mod kliniske tilfæl-
de blev påvirket af patogenet: Tiltag mod subkliniske tilfælde af
Staphylococcus aureus blev mere omkostningseffektive ved at
kombinere dem med andre tiltag; for Streptococcus agalactiae,
som primært forårsager subklinisk mastitis, var interventionsfor-
anstaltningen mod kliniske tilfælde mindre relevant. Den fore-
trukne interventionsstrategi afhænger derfor af besætningen og
dens situation. Den kan også variere afhængigt af landbrugerens
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præferencer med hensyn til forvaltningsforanstaltninger som be-
handling eller udsætning. Interventionsstrategier mod mastitis
bør derfor være besætningsspecifikke.
Begrænsningerne af en modelleringsmetode som beskrevet i
denne afhandling ligger i forståelsen af spredningsdynamikken
og dens parametrisering. Hvis der mangler parameter estimater,
f.eks. omkring hygiejniske forhold, kan dette ikke undersøges
korrekt. Faktorer som ikke kunne medtages i modellen på grund
af manglende parameterværdier eller fordi de var ukendte kan
ændre resultatet i en reel situation. Derfor bør modelresultaterne
ses som gode indikationer for mulige omkostningseffektive inter-
ventionsstrategier mod mastitis indtil de ideelt set kan valideres.
For at konkludere, kan modellen i denne afhandling anven-
des som et beslutnings støtteværktøj i videnskabelig forskning:
Den kan identificere omkostningseffektive interventionsstrate-
gier mod mastitis, samtidig med at der tages hensyn til andre
relaterede faktorer (f.eks. antibiotikabehandling og udslip). Dis-
se resultater kan inddrages i fremtidige overvejelser når man
planlægger nye mastitis managementstrategier.

ZUSAMMENFASSUNG
Masitits ist eine Entzündung der Milchdrüse, meist verursacht
durch Bakterien, und ist eine der am häufigsten auftretenden
Krankheiten bei Milchkühen. Sie verursacht Schmerzen, vor al-
lem in klinischen Fällen, und beeinträchtigt zusätzlich den land-
wirtschaftlichen Betrieb: Die Milchproduktion und Milchqualität
erkrankter Kühe ist reduziert, Schlachtungsraten sind vergleichs-
weise hoch und klinische Fälle müssen behandelt werden. Die
Milcheinbußen und zusätzlichen Kosten für notwendige Kontroll-
maßnahmen oder Interventionen führen zu großen wirtschaftli-
chen Nachteilen für den Bauern.
Ein wichtiges Element bei der Prävention und Kontrolle von
Mastitis ist die Behandlung mit Antibiotika. Die Verwendung
von Antibiotika in der Tierhaltung gerät in Anbetracht zuneh-
mender Antibiotikaresistenz jedoch verstärkt ins Bewusstsein
und in die Kritik von Verbrauchern und Politik. Strategien zur
Prävention und Kontrolle von Mastitis müssen daher heutzutage
verschiedene Herangehensweisen in Betracht ziehen und können
sich nicht nur auf Antibiotika beschränken.
Das Ziel dieses PhD-Projekts war es, kosteneffiziente Interven-
tionsstrategien zu finden, die sich nicht nur auf die Behandlung
mit Antibiotika konzentrieren.
Der erste Teil des PhD-Projekts beschreibt die Datenanalyse.
Registerdaten der dänischen Rinderdatenbank (kvægdatabasen)
wurden auf bestimmende Faktoren für Antibiotikabehandlun-
gen des Euters oder im Zusammenhang damit analysiert. Dabei
wurde zwischen Behandlungen während der Laktationsperiode
und bei der Trockenstellung unterschieden. Die Analyse wurde
für jede Behandlungsart einmal durchgeführt: Für jede Herde
wurde zunächst Antibiotikabehandlung durch eine logistische
Regression modelliert. Anschließend wurden eine Hauptkompo-
nentenanalyse und eine Clusteranalyse durchgeführt.
Die Ergebnisse zeigen, dass bei beiden Behandlungsarten die
Herden in drei Gruppen unterteilt werden können. In beiden
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Fällen war Milchproduktion einer der bestimmenden Faktoren.
Desweiteren wurde für Behandlungen bei der Trockenstellung
jeweils eine Gruppe durch Alter bzw. diagnostische Ergebnisse
charakterisiert. Während der Laktationsperiode waren diese bei-
den Faktoren gemeinsam für eine Gruppe bestimmend; in der
dritten Gruppe war mit entscheidend, ob die erkrankte Kuh im
Nachfolgenden geschlachtet wurde.
Im zweiten Teil des PhD-Projekts wurde ein biologisch-öko-
nomisches Simulationsmodell entwickelt, das durch Bakterien
verursachte Mastitis simuliert. Das Modell baut auf einem zuvor
beschriebenen Modell einer dänischen Milchkuhherde (iCull)
auf und simuliert darüberhinaus sowohl die Ausbreitung von
mehreren verschiedenen Mastitiserregern in der Herde als auch
die durch Mastitis hervorgerufenen Effekte und verschiedene
Maßnahmen gegen klinische und subklinische Mastitis.
Das entwickelte Modell lässt ausdrücklich verschiedene Stäm-
me einer Bakterienart zu, und sowohl Infektion als auch Heilung
sind von Besonderheiten der jeweiligen Kuh abhängig. Das Mo-
dell ist damit bakterienstamm-, tier- und herdenspezifisch. Dem-
nach muss es sorgfältig für die jeweilige Herde kalibriert werden,
da selbst kleine Änderungen in einigen der Modellparameter die
Ergebnisse beeinflussen können.
Schließlich wurde das Modell dafür verwendet, verschiedene
Interventionsstrategien zu untersuchen und zu vergleichen. Die
implementierten Strategien beinhalten sowohl die Behandlung
mit Antibiotika als auch die Schlachtung von infizierten Kühen
für klinische oder subklinische Mastitis. Einige der Interventi-
onsmaßnahmen ziehen außerdem Ergebnisse aus dem ersten
Teil des Projekts in Betracht. Die Interventionsstrategien wurden
unterteilt in klinische Strategien, die ausschließlich Maßnahmen
gegen klinische Mastitis enthielten, und kombinierte Strategi-
en, die darüber hinaus Maßnahmen gegen subklinische Mastitis
einbezogen.
Unter den untersuchten klinischen Strategien ist „gute Hy-
giene“, repräsentiert durch eine niedrige Infektionsrate, am ef-
fektivsten. Welche spezifischen Maßnahmen notwendig sind,
um eine gute Hygiene zu erreichen, und die damit verbunde-
nen Kosten sind jedoch nicht ausreichend untersucht, weshalb
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Kosteneffektivität nicht festgestellt werden konnte. Verbesserte
Kosteneffectivität konnte dafür durch den Mehrgebrauch von An-
tibiotika oder durch mehr Schlachtungen erreicht werden. In den
kosteneffektivsten Interventionsstrategien wurde fallspezifisch
zwischen einer Behandlung mit Antibiotika oder Schlachtung
entschieden. Dies reduzierte die Verwendung von Antibiotika,
erhöhte allerdings die Anzahl an geschlachteten Kühen.
Durch Ergänzung der klinischen Maßnahmen mit Maßnahmen
gegen subklinische Mastitis konnte die Kosteneffizienz in den
kombinierten Strategien weiter verbessert werden. Subklinische
Fälle wurden dabei durch zwei aufeinanderfolgende hohe Zellge-
halte in der Milch (>200 000Zellen/ml) identifiziert und durch
einen diagnostischen Test überprüft. Abhängig davon, welcher
Erreger hauptsächlich auftrat, spielte die jeweilige gewählte kli-
nische Maßnahme eine mehr oder weniger wichtige Rolle: Bei
Staphylococcus aureus führten kosteneffizientere klinische Maßnah-
men zu kosteneffizienteren kombinierten Strategien, während
bei Streptococcus agalactiae, welcher hauptsächlich subklinische
Mastitis verursacht, die klinische Maßnahme keine größere Rolle
spielt.
Die zu bevorzugende Interventionsstrategie hängt demnach
von der jeweiligen Herde ab. Sie wird aber auch von den Präfe-
renzen des Bauern abhängen, also davon, ob dieser lieber Anti-
biotika verwendet oder ob er bereit ist, mehr Kühe zu schlachten.
In jedem Fall sollten Interventionsstrategien gegen Mastitis herd-
spezifisch gewählt werden.
Die vorgestellte Herangehensweise durch Modellierung bie-
tet die Möglichkeit, verschiedene Interventionsmaßnahmen und
-strategien unter gleichen Bedingungen zu untersuchen und zu
vergleichen, ohne aufwändige und teuere Feldstudien durchfüh-
ren zu müssen. Sie hat jedoch auch gewisse Einschränkungen
und Grenzen: Zum einen ist zur Modellerstellung Wissen über
die Verbreitungsdynamik der Krankheitserreger notwendig und
zum anderen müssen die richtigen Parameterwerte bekannt sein.
Wenn Parameterwerte fehlen, wie zum Beispiel im Fall von gu-
ter Hygiene, können die betroffenen Aspekte nicht oder nicht
vollständig untersucht werden. Darüber hinaus können Wissens-
lücken dazu führen, dass relevante Faktoren nicht berücksichtigt
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werden. Fehlende Parameterwerte oder Faktoren können dazu
führen, dass sich in der Realität unerwartete Ergebnisse einstel-
len, die sich von den modellierten Ergebnissen unterscheiden.
Die hier gefundenen Ergebnisse sollten deshalb in erster Linie
als gute Leitindikatoren für mögliche kosteneffiziente Interventi-
onsstrategien gegen Mastitis gesehen werden, bis sie im späteren
Forschungsverlauf idealerweise bei Feldstudien bestätigt werden
können.
Das in dieser Dissertation vorgestellte Simulationsmodell
kann als Werkzeug zur Entscheidungshilfe in der wissenschaft-
lichen Forschung verwendet werden, da es kosteneffiziente In-
terventionsstrategien gegen Mastitis und damit verbundene Fak-
toren wie die Behandlung mit Antibiotika oder Schlachtungen
identifiziert. Die gefundenen Erkenntnisse können in Betracht ge-
zogen werden, wenn neue Präventions- und Kontrollmaßnahmen
gegen Mastitis geplant werden.
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1 PURPOSE AND OUTL INE
The purpose of this PhD study was to improve mastitis con-
trol through identification of cost-efficient intervention strategies
against mastitis in dairy cows, i.e., intervention strategies that
can reduce the occurence of mastitis in a dairy herd without
lowering the net income. The plan was to achieve this by devel-
oping a strain-, cow-, and herd-specific bio-economic simulation
model that is able to simulate population and infection dynamics
in a dairy herd. The model should then be used to investigate
costs and efficacy of different pathogen-, cow- and herd-specific
intervention strategies, showing that it can be used as a decision
support tool in scientific research.
The PhD thesis itself is based on four manuscripts and has the
following structure:
the introduction in Chapter 2 gives an overview over mast-
itis and modelling. In Section 2.3, the objectives of the PhD
project and related research questions are presented.
chapter 3 includes Manuscript I, in which data from the Dan-
ish Cattle Database are analysed for predictors of antimicrobial
treatment in relation to udder health.
chapter 4 presents the model (Manuscript II), and interven-
tion strategies against clinical mastitis (Manuscript III), as well
as combined intervention strategies against both clinical and
subclinical mastitis (Manuscript IV).
an overall discussion of these manuscripts follows in
Chapter 5.
the conclusions in Chapter 6 answer the research questions
presented in Section 2.3.
chapter 7 presents future perspectives.
1
2 purpose and outline
Objective 1: Investigate if data from the Danish Cattle
Database can be used to characterise different farmers’
mastitis management
RQ1A, RQ1B
Manuscript I:
Determinants of antimicrobial treatment for udder health
in Danish dairy cattle herds
Objective 2: Develop and test a strain-, cow-, and herd-
specific simulation model of IMI
RQ2
Manuscript II:
A strain-, cow-, and herd-specific bio-economic simula-
tion model of intramammary infections in dairy cattle
herds
Objective 3: Investigate costs and efficacy of various
intervention strategies against IMI
RQ3, RQ4, RQ5
Manuscript III:
Economic and epidemiolo-
gical impact of different in-
tervention strategies against
clinical mastitis and sub-
clinical
Manuscript IV:
Economic and epidemi-
ological impact of differ-
ent intervention strategies
against subclinical and clin-
ical mastitis
Figure 1: Overview over the objectives, the manuscripts included in
the thesis, and the related research questions (RQ, see Section
2.3).
2 INTRODUCT ION
2.1 mastitis
Literally, mastitis means “related to the breast”, coming from
Ancient Greek mastós (breast) and -îtis (pertaining to), though
the suffix -itis is now commonly used to indicate a disease or
an inflammation. The word mastitis consequently describes
an inflammation of the breast or the mammary gland and can,
theoretically, occur in all mammals.
In this thesis, however, I will restrict all considerations to
mastitis in dairy cattle, where it has an important economic
impact (Halasa et al., 2007).
2.1.1 Biology
In dairy cattle, mastitis is also commonly called intramammary
infection (IMI). While both terms are often used interchangeably,
they are not exactly the same: IMI is an infection and mastitis is
an inflammation of the mammary gland (Lopez-Benavides et al.,
2012).
Intramammary infections are caused by infecting microorgan-
isms, most often bacteria, e.g., Staphylococcus aureus, Streptococ-
cus uberis, Streptococcus agalactiae, or Escherichia coli. Therefore,
IMI can usually be diagnosed by a suitable bacterial culture
(Lopez-Benavides et al., 2012) or polymerase chain reaction
(PCR) (Taponen et al., 2009). Typically, bacterial culture is the
preferred method (Lopez-Benavides et al., 2012), as it detects live
microorganisms, while PCR detects DNA of bacteria that are not
necessarily viable.
An inflammation, on the other hand, describes foremost an
immunological response, which is most often caused by infect-
ing agents (Harmon, 2001; Lopez-Benavides et al., 2012). This
response leads to an influx of leukocytes into the tissue of the
3
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mammary gland, from where they can then infiltrate the milk
(Harmon, 2001). Hence, mastitis is usually accompanied by a
high somatic cell count (SCC). Clinical mastitis cases show visible
signs in the milk (e.g., flakes or clots) or udder (e.g., swelling,
heat, or pain). If there are no visible symptoms of inflammation,
the mastitis is called subclinical and usually diagnosed by SCC
or the California Mastitis Test (Lopez-Benavides et al., 2012).
In the following, when I talk about mastitis, it will assumed to
be caused by an infection. I will also use the terms subclinical
and clinical for IMI in the same way as they would be used for
mastitis.
Occurrence
For a long time, Streptococcus agalactiae was considered to be one
of the primary mastitis pathogens (Dodd et al., 1969; Murphy,
1956; Smith et al., 1985), with Staphylococcus aureus, Streptococcus
uberis, Streptococcus dysgalactiae, Escherichia coli, and some Klebsi-
ella species (Harmon, 1994; Smith et al., 1985; Zadoks et al., 2011)
as other common major mastitis pathogens.
However, over the years, the relative impact of different mast-
itis pathogens has changed, probably due to the introduction
of control programs and subsequent changes in prevalences
(Pitkälä et al., 2004; Wilson et al., 1997). This led, for example, to
common occurrence of coagulase-negative staphylococci (CNS)
and Corynebacterium bovis (Pitkälä et al., 2004; Wilson et al.,
1997), though these are considered minor pathogens, as their
impact seems to be lower than that of the major pathogens
(Schukken et al., 2009; Taponen and Pyörälä, 2009).
Among all these mastitis causing pathogens S. aureus may be
the most studied (Zadoks et al., 2011). Although this could also
be connected to its importance as a human pathogen (Zadoks
et al., 2011), S. aureus appeared as the most prevalent isolate, e.g.,
in a study conducted by Østerås et al. (2006). Still, it is important
to remember that there can be large variations in prevalence
between different herds (Piepers et al., 2007). To my knowledge
there are, however, no recent studies about the distribution of
different mastitis pathogens on cow level in Denmark.
For S. agalactiae in particular, this change over time resulted in
decreased within-herd prevalences in the 1990s (Keefe, 1997). In
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Figure 2: Transmission routes of mastitis pathogens.
Denmark, herd level prevalence of S. agalactiae decreased from
over 30% in the 1950s to about 2% in 1992 (Mweu et al., 2012)
until, starting in 2000, the number of infected herds began to
increase again (Mweu et al., 2012). In 2017, approximately 5.5%
of the herds were tested positive (Farre, 2017). A similar develop-
ment could be seen in other Scandinavian countries (Jørgensen
et al., 2016). On top of that, formerly efficient control of S. agalac-
tiae was shown to no longer be as effective, indicating a change
in transmission behaviour (Jørgensen et al., 2016).
Transmission
There are two major reservoirs for mastitis pathogens in a dairy
herd: the infected udder and the herd environment, e.g., bedding
or manure (Harmon, 1994; Smith et al., 1985).
Bacteria from an infected udder can spread during the milking
process (Harmon, 1994) by remaining on or in parts of the milking
equipment, from where they can be transferred to other quarters.
For instance, fluctuations in the milking vacuum might cause a re-
flux of milk from a contaminated milking claw to the teats (Besier
et al., 2016). This transmission route is contingent on the udder as
a reservoir and, therefore, depends upon the number of infected
quarters. In contrast, new infections with bacteria from the herd
environment seem to occur primarily between milkings (Harmon,
1994) and are thought to be independent of the incidence (Zadoks
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et al., 2001a). These two transmission routes are commonly called
contagious and environmental transmission, respectively.
Historically, every mastitis pathogen was categorized as either
contagious or environmental: S. aureus and S. agalactiae were
considered contagious, while other pathogens were seen as
environmental (Harmon, 1994; Smith et al., 1985). However,
in more recent times, this strict distinction has been disputed.
Zadoks et al. (2001a) found that a model describing contagious
transmission seemed to fit their data better than one for envir-
onmental spread, even though S. uberis was thought to be an
environmental pathogen. Moreover, molecular studies of various
pathogens suggest that contagious or environmental behaviour
may not be inherent to a species but rather differ between strains
(Zadoks et al., 2011): if several cows in a herd are infected by a
single strain, one would assume cow-to-cow spread. Contrarily,
strain heterogeneity for one pathogen species in a herd suggests
environmental transmission. Furthermore, Jørgensen et al. (2016)
found that S. agalactiae, which was formerly considered a strictly
contagious pathogen (Murphy, 1956), exhibited parallel conta-
gious and environmental transmission cycles: in addition to
contagious transmission through the milking machine, S. agalac-
tiae could be found in the barn environment, in bovine faeces,
and in the drinking water, i.e. in typical environmental samples
(see Figure 2).
Consequently, mastitis pathogens should not be classified
into contagious and environmental based on their species but
rather depending on the specific strains present in a dairy herd
(Schukken et al., 2012). Additionally, a third transmission type
combining the basic contagious and environmental transmission
routes may be considered.
Risk factors
Transmission does not only depend on the causative pathogen.
Various other factors have been investigated for facilitating estab-
lishment of IMI. Zadoks et al. (2001b) found, among other factors,
that age, lactation stage, a previous IMI, and a high SCC were
cow or quarter level risk factors for mastitis. Steeneveld et al.
(2008) also identified lactation stage, previous IMI, and SCC, as
well as season as risk factors for clinical mastitis.
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Other studies linked a high herd milk yield to an increased
clinical mastitis incidence (Schukken et al., 1990; Syväjärvi et al.,
1986) or found an unfavourable genetic correlation between clin-
ical mastitis and milk yield (Koeck et al., 2014; Syväjärvi et al.,
1986). Yet, actually estimating the extent to which milk produc-
tion influences mastitis is more difficult (Seegers et al., 2003).
Furthermore, milk flow (or milking speed) has been considered
as a risk factor for IMI. In this case, however, the evidence seems
to be contradictory. Jensen et al. (1985) reported a positive ge-
netic correlation between milk flow and clinical mastitis, whereas
Miller et al. (1978) could not find evidence for an association
between faster milking and increased mastitis risk. Besier et al.
(2016) suggested that it could be a combination of several milk-
ing parameters that are responsible for an increase in mastitis
occurence.
Biological effects on production
While a high herd milk yield seems to be a risk factor for mastitis,
mastitis in return reduces the milk production of the individual
cow.
Several studies have shown that clinical mastitis reduces the
milk yield of the affected cow until the end of the lactation (e.g.,
110kg to 552kg over the entire lactation, Rajala-Schultz et al.,
1999). Houben et al. (1993) even found that this effect could carry
over into the next lactation, if a cow had three or more cases of
clinical mastitis. The amount of milk lost seems to depend on
the causative pathogen (Gröhn et al., 2004; Hertl et al., 2014b)
and the number of previous clinical mastitis cases of a cow in a
lactation (Hertl et al., 2014b).
Similarly, subclinical mastitis can be associated with a reduced
milk production: mastitis is generally accompanied by a high
SCC, as described above, and elevated SCC levels lead to a re-
duced milk yield (Hagnestam-Nielsen et al., 2009; Halasa et
al., 2009a; Hortet et al., 1999). In this case, too, the causative
pathogen influences the milk loss; studies have shown that dif-
ferent pathogens generally differ in how much they affect SCC
(Schukken et al., 2009; Wilson et al., 1997).
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Other studies have suggested that clinical mastitis could also
alter a cow’s heat cycle (Moore et al., 1991) or reduce the probab-
ility of conception (Barker et al., 1998; Hertl et al., 2014a).
2.1.2 Interventions
In 1969, Dodd et al. wrote that they
. . . cannot conceive of any system of completely pre-
venting all udder disease; therefore, the object of a
control must be to reduce udder infection to a low
level.
They proposed three possibilities for reducing IMI: increasing
cure rates, replacing infected cows, or reducing infection rates.
This is still the case today.
Lactational treatment
Increasing the cure rates should naturally decrease the preval-
ence, as fewer cows will remain infected. In the case of contagious
pathogen strains, it can also be expected that fewer new infec-
tions will occur as a consequence (Steeneveld et al., 2011), which
would further contribute to reducing infection.
To increase cure rates for IMI, infected quarters (intramammary
treatment) or cows (systemic treatment) can be treated. Lacta-
tional treatment is most commonly antimicrobial intramammary
treatment (Barkema et al., 2006), although systemic adminis-
tration of antibiotics may be beneficial for S. aureus mastitis
and is recommended for severe E. coli cases (Pyörälä, 2009). In
addition, it can be supplemented by the use of non-steroidal
anti-inflammatory drugs (NSAIDs), mostly for pain relief (Breen,
2017). Different treatment strategies may have different cure rates
also depending on cow characteristics (Steeneveld et al., 2011).
Cure probabilities may also differ between two different strains
of the same species (van den Borne et al., 2010b). In any case,
milk from animals receiving antibiotic treatment must not be
sold until the risk of finding antibiotic residue in the milk is low
(Edmondson, 2014). This withdrawal period may be around 6 to
7 days, but it depends on the antibiotic used and the method of
administration.
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In Denmark, clinical IMI are typically treated with antibiotics
or, in some cases, the cow is culled. Treatment is usually ad-
ministered intramammarily. Subclinical IMI do not commonly
receive lactational treatment.
Dry cow treatment
Another type of treatment is dry cow therapy (DCT). DCT con-
sists of antibiotic treatment of cows at dry off, i.e., after the last
milking in the lactation. It is aimed at increasing the cure rates as
well as reducing the infection rate in the dry period by preventing
new infections (Dodd et al., 1969).
There are two forms of DCT, blanket DCT (all cows are
treated) and selective DCT (only some cows are treated). Se-
lective DCT and blanket DCT are both similarly effective in
curing infections, however, treating all cows is generally better
for preventing new infections (Rindsig et al., 1978).
Selective DCT originated from economical considerations
(Morris et al., 1978), but today, concern about antimicrobial res-
istance is another factor in favour of selecting cows for selective
DCT (Halasa et al., 2009c). In Denmark, blanket DCT is not
allowed and cows need to have a positive diagnostic result (often
using PCR) not older than 42 days to receive DCT. Another pos-
sibility to determine infection status of cows for DCT was used
by Scherpenzeel et al. (2016), who used different thresholds for
high SCC as indicators for infection.
Culling
Similar to the increased cure rates described above, replacing
infected animals with uninfected ones will decrease prevalence
immediately, and subsequently it should lead to less new infec-
tions with contagious pathogen strains.
Replacement of infected animals implies that the farmer has to
dispose of them in some way. As these cows are diseased, this
will usually happen by culling the cows in question. For instance,
Milian-Suazo et al. (1988) concluded that there were three ma-
jor reasons for culling dairy cows: low milk production, poor
reproductive performance, and udder problems, all of which
can be related to mastitis (see Section 2.1.1). Others have found
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that mastitis increased the culling risk for affected cows (Gröhn
et al., 1998; Piepers et al., 2009). These findings suggest that
farmers may actually use culling as a control measure. However,
in scientific literature, culling is seldom considered as an inter-
vention but rather as a side effect of IMI (Halasa and Hogeveen,
2018). Most studies of culling strategies in connection with mast-
itis investigate premature culling in the more general scope of
optimal replacement strategies (Cha et al., 2014; Heikkilä et al.,
2012), while only two studies included culling as an intervention
measure (van den Borne et al., 2010a; Halasa, 2012).
Hygiene
Reduction in infection rates can be expected to lead to a lower
prevalence — perhaps not immediately, but in the long term and
with a lasting effect. Lowering the infection rate can therefore be
considered more of a prevention than an intervention measure.
A high level of biosecurity can avoid introduction of new
mastitis pathogens or pathogen strains into a herd (Barkema et al.,
2009). Furthermore, mastitis pathogens depend on direct contact
with contaminated material during milking or in the environment
for transmission (see Section 2.1.1). For this reason, transmission
of these pathogens is subject to the conditions, i.e. equipment
and management, in each herd. Neave et al. (1966) found that
following a simple hygiene routine at milking could reduce the
number of new infections. In other studies, inadequate milking
machine calibration and the associated irregular fluctuations in
the milking vacuum could lead to increased mastitis prevalence
(Besier et al., 2016; Nyhan and Cowhig, 1967).
Hygiene, proper milking machine maintenance, and biosecur-
ity can therefore be expected to lead to reduced transmission or
infection rates, and these measures are included in the ten point
recommended mastitis control plan (NMC, n.d.).
There are, however, only few studies investigating the actual
effect of hygienic measures on mastitis (Huijps et al., 2010; Lam
et al., 1996; Neave et al., 1969).
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2.1.3 Economics
As mentioned above, bovine mastitis, or IMI, is one of the most
costly diseases in dairy cattle and it has a great economic impact
on herd economics (Halasa et al., 2007). Costs arise from both
interventions (see Section 2.1.2) and the described production
effects (see Section 2.1.1):
If an IMI is treated with antimicrobials, it leads to additional
costs for drugs, veterinary services, diagnostic testing, additional
labour, and for discarded milk. Culled cows have to be replaced
either by buying replacement stock or by raising new animals. In
this case, further indirect costs could arise if the new cow has a
lower milk yield than the culled cow (Halasa et al., 2007). On the
other hand, milk production in cows with subclinical or clinical
mastitis also leads to substantially less income for the farmer
(Halasa et al., 2007).
Costs for mastitis are usually underestimated by the farmer
(Huijps et al., 2008), and estimates can vary substantially. Halasa
et al. (2009b), e.g., found costs between €101 and €328 per clinical
case or between €0 and €310 per subclinical case of mastitis.
In general, costs vary from one herd to another depending on
various factors, for example causative pathogen (Halasa et al.,
2009b), mastitis incidence, or management (Halasa et al., 2007).
Therefore, an economically beneficial strategy in one herd might
not be economically beneficial in another.
Within a herd, costs differ between cows depending for ex-
ample on milk yield potential, age, or pregnancy status (Cha
et al., 2014). Furthermore, as described in Section 2.1.1, risk
factors (previous IMI, Hertl et al., 2014b) or the causative patho-
gen may also affect the impact on production and thus influence
the costs. Hence, differences between cows are also taken into
consideration when replacement strategies are evaluated: what
is the benefit of keeping a cow versus replacing it? This is called
retention payoff (RPO) (Cha et al., 2014).
As there are differences in costs between both herds and cows,
economic decisions should take pathogen-, cow-, and herd-specifics
into account. It should also be kept in mind that farmers may be
equally motivated by economic factors and other perceived bene-
fits, e.g., healthy animals (Valeeva et al., 2007). Jansen and Lam
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(2012) suggested that there were two importanct factors determin-
ing mastitis management in a herd: the farmer had to believe that
there was a mastitis problem and that a management strategy
would be effective. Hence, in addition to economic benefits, ef-
fectiveness of intervention strategies should be communicated to
farmers.
Yet, while cost-effectiveness has been studied for intervention
strategies comprising treatment or culling (van den Borne et al.,
2010a; Halasa, 2012), or single hygienic measures (Huijps et al.,
2010), little is known about cost-effectiveness of comprehensive
hygiene or biosecurity strategies.
One way to investigate and compare different intervention
strategies is through a modelling approach, which leads to the
second part of this chapter.
2.2 modelling
The first known mathematical model in epidemiology was pub-
lished in 1766 by Daniel Bernoulli, showing the advantages of
smallpox inoculation (Bernoulli and Blower, 2004). Since then,
epidemiological models have developed and grown more com-
plex. Today, we differentiate between different types of models,
the most common being compartmental models, network mod-
els, and agent- or individual-based models (Lanzas and Chen,
2015). The modelled population is divided into groups or com-
partments, depending on their infection status, e.g., susceptible,
infectious, and recovered.
In compartmental models, the individuals, or rather the units
of interest, are not considered separately. Instead, a certain
contact structure is assumed for the infection process. Then,
transitions between the compartments are modelled and the com-
partment sizes are tracked. Network models are focused on more
realistic contact structures. Agent-based models, on the other
hand, explicitly model each individual and their characteristics
(Lanzas and Chen, 2015). But what can these models be used
for?
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2.2.1 Models as decision support tools
Reality is complex. Pathogen transmission, e.g., can be influ-
enced by a multitude of possibly interrelated factors (Lanzas and
Chen, 2015), as described in Section 2.1. Models can be aimed at
understanding this complexity by modelling assumed structures
and interdependencies and investigating how they influence the
model dynamics (Keeling and Rohani, 2008). A possibly more ob-
vious use of models is for prediction (Keeling and Rohani, 2008).
A predictive model that can be used to forecast the outcome of
different decisions is, in a way, a decision support tool.
Predicitive models have to be as accurate as possible to be
able to guide decision making (Keeling and Rohani, 2008). For
that, they have to address the complexity, lest they guide de-
cision making in the wrong direction (Lanzas and Chen, 2015).
Hence, modellers usually have to defend why simplifications
or assumptions in their model will still allow studying the re-
spective research question. However, complexity can also lead
to unforeseen results that may or may not match reality, so Basu
and Andrews (2013) suggested that modellers should also be
able to defend when a more complex model was needed, e.g.,
because of a strong a priori belief about a factor’s influence.
The underlying structure of a model should be a good repres-
ention of reality, as “structural uncertainty” can have a bigger
impact on model outcome than uncertainty in the parameter
values (Basu and Andrews, 2013). Fitting a model to data, i.e.
finding the “right” parameter values, is called model calibration.
Basu and Andrews (2013) suggested that calibration could be
used to filter out models or model structures that are not suit-
able, because they cannot be adequately fitted to data. Actual
model validation is a difficult problem, considering that no two
outbreaks are ever exactly the same, even if they were caused by
the same pathogen (Heesterbeek et al., 2015). It is usually done
by looking at the aggregate outcome of a model and comparing
it to data or expectations until sufficient confidence in its validity
is gained (Sargent, 2003). For this reason, it is particularly im-
portant, that models are well documented (Keeling and Rohani,
2008).
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In summary, a good model should be built to be suitable for
its purpose, incorporating just as much complexity as needed,
and it should be able to be fitted to data (Keeling and Rohani,
2008). Still, no matter how complex or good the model is, it is
important to remember that a model can never be expected to
predict the future completely accurately (Keeling and Rohani,
2008).
Now, what are the requirements for a model as a decision
support tool? The modeller has to understand the underlying
structure of the problem, so they can program the model, and
they need the data to parameterize it. The model has to be well
described, so it can be understood and so that results are reprodu-
cible (for transparency); it has to be accurate, so as not to mislead
decision making (accuracy); and it has to be flexible enough to be
able to incorporate future changes or new information (flexibility)
(Keeling and Rohani, 2008).
2.2.2 Modelling mastitis
It is a misnomer to talk about modelling mastitis, as it is not
really mastitis but the underlying infection that is modelled. So,
what is needed to model IMI in dairy herds? The first question
should be the purpose of the model. In this work, I am interested
in a decision support tool for prevention and control of IMI, as
described in Chapter 1.
For that, I have to model a dairy herd including its main in-
come, milk production, and IMI occurence and dynamics in the
herd. Pathogen transmission should be included, because interre-
lations between transmission and interventions can be expected,
at least for contagious pathogens (Section 2.1.2). As different
pathogens can have different effects on the milk production, and
two strains of one pathogen species may have different transmis-
sion behaviour (Section 2.1.1), the model should be strain-specific.
It should also be cow-specific, to account for risk factors for IMI
(Section 2.1.1) and differences in cure rates following treatment
depending on cow characteristics (Section 2.1.2). To be able to
investigate and compare different intervention strategies, op-
tions for treatment, culling, and DCT have to be included in the
model. Furthermore, parameters like transmission rate depend
2.2 modelling 15
Dairy herd (herd-specific)
Dairy cow
4 quarters
Milk yield
SCC
Culling, feeding, etc.
Economics
IMI transmission
Clinical
Subclinical
Cow-specific
Risk factors
Cure after treatment
Pathogen-specific
Strain-specific
IMI interventions
Dry cow treatment
Antimicrobial treatment
Reactive culling
Production effects
Figure 3: Overview over the requirements for a model used as decision
support tool for prevention and control of IMI.
on conditions (hygiene, biosecurity) in a herd (Section 2.1.2) and
farmers have different preferences regarding mastitis manage-
ment (Huijps et al., 2009). Thus, herd-specifics should be taken into
account. Including these elements (see Figure 3 for an overview)
will allow investigation of costs and effectiveness of control and
prevention strategies for mastitis considering realistic situations.
One of the first models for IMI was described by Dodd et al.
(1969) with the aim to describe the dynamics of IMI in dairy
herds. However, in the same study, Dodd et al. (1969) already
suggested that mathematical models could be used in the future
to investigate the effects of control strategies on mastitis. In later
years, various models were developed to evaluate IMI control
measures. Most of these models are stochastic and individual-
based in the sense that individual cows and their disease states
are explicitly modelled, though individual behaviour is not
modelled and contact structures are simple.
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In the following, I will introduce some of these bio-economic
models, all of which include IMI transmission, as a comprehens-
ive review of all models would need a chapter on its own.
simmast Allore et al. (1998) developed a discrete-event simu-
lation model, including contagious and environmental transmis-
sion. Infection depends on cow-specific parameters. Milk yield
is modelled daily for every cow, and adjusted according to IMI
status and pathogen. The model includes a treatment option for
clinical cases, and a culling strategy for mastitis. This model was
validated against data.
simherd iv Østergaard et al. (2005) used SimHerd to model a
typical Danish dairy herd in weekly time steps including, among
other things, milk yield and SCC for every cow. IMI transmission
is modelled through a baseline risk function, depending on the
pathogen, lactation stage, and adjusted for cow risk factors. Dur-
ing the dry period, the baseline risk for clinical IMI is reduced.
IMI cases are divided into different categories (subclinical, and
mild, moderate, severe, or permanent effect clinical). This cat-
egory determines, together with the pathogen, the effect on milk
yield, SCC, feed intake, and body weight. Treatment of clinical
cases leads to milk withdrawal for a number of days. There is a
low probability that a new clinical case will be culled, otherwise
IMI can indirectly lead to culling due to a reduced milk yield.
bovine imi model Halasa et al. (2009b) modelled contagious
and environmental IMI in a Dutch dairy herd with a two week
time step. Somatic cell scores are modelled for every cow and
adjusted for IMI, a high bulk tank SCC leads to a penalty. Milk
yield is also modelled for every cow and adjusted for production
losses due to pathogen-specific clinical IMI or high SCC. Clin-
ical cases are treated, and their milk is discarded for six days.
Cows can be culled with a low probability due to clinical IMI,
or, related to subclinical IMI, due to reduced milk production
or conception failure. Replacement heifers are only introduced
in case of a cumulative (milk) quota deficiency. Feeding costs
are also adjusted for IMI. An extension of this model (Halasa
et al., 2010) further includes IMI in the dry period. Transmission
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during the dry period is based on separate parameters and al-
ways environmental; clinical cases can only occur in the first or
last two weeks. In this extension, different options for DCT are
included. A second extension (van den Borne et al., 2010a) adds
treatment options for subclinical contagious IMI, and a third one
introduces different treatment options for clinical IMI (Halasa,
2012).
While these models all have their strengths, they are also
missing certain factors:
All three models simulate transmission on cow-level. Yet,
infection and important interventions (e.g., treatment) happen on
quarter-level. Modelling on quarter-level would allow up to four
pathogens per cow and additional measures, e.g., drying off of
single quarters. Furthermore, none of the models is strain-specific
or includes cow-specific cure rates.
SIMMAST and the bovine IMI model only allow one patho-
gen per cow. The SIMMAST model is additionally missing IMI
during the dry period and DCT. SimHerd, on the other hand,
does not directly include contagious transmission, nor is DCT
mentioned. It also does not consider culling as an intervention
strategy against IMI. The bovine IMI model has no cow-specific
infection and does not take pathogen-specific effects for subclin-
ical IMI into account.
Hence, none of these models truly allow strain-, cow-, and
herd-specific evaluation of prevention or intervention strategies
against IMI for cost-effectiveness.
2.3 objectives and research questions
The general objective of this PhD study was to develop a strain-,
cow-, and herd-specific model that could be used in scientific
research to investigate costs and efficacy of different interventions
against IMI (see Chapter 1), covering all points mentioned in
Section 2.2.2.
To that end, it would help to understand how herds can differ
in regards to mastitis management, i.e., how different farmers
are dealing with mastitis in their herd. In Denmark, all cattle
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related data is collected in the Danish Cattle Database. The first
objective was therefore to investigate, whether data from the Danish
Cattle Database can be used to characterise different farmers’ mastitis
management, specifically antibiotic treatment.
The second objective was to develop and test a cow-, strain-, and
herd-specific simulation model of IMI. For that, an existing herd
model (Kirkeby et al., 2016) was extended by adding a transmis-
sion framework for IMI, using literature values to parameterise
the model. However, studies with parameter estimates are scarce
and conditions are changing (see Chapter 4), so parameterization
can be quite a challenge. Therefore, it is especially important to
understand how the parameters influence the model.
Finally, the last objective was to investigate costs and efficacy
of various intervention strategies against IMI. This objective was
divided into two parts, intervention strategies against clinical IMI
and intervention strategies against both clinical and subclinical IMI.
Figure 1 shows an overview over the objectives, how the cor-
responding manuscripts are connected, and where the following
related research questions (RQ) fit.
rq1a Can already available data be used to determine and distin-
guish between treatment practices for mastitis in different herds?
rq1b If so, what characterises the different groups/treatment prac-
tices?
rq2 Which parameters are most influential in modelling spread of
mastitis pathogens?
rq3 Which intervention strategies against clinical IMI can reduce
IMI incidence compared to a default three day intramammary antibiotic
treatment and can an economic benefit be expected?
rq4 Which intervention strategies combining interventions against
both clinical and subclinical IMI can reduce IMI incidence compared to
using only the clinical strategy? What are the economic effects?
rq5 Is there a “best” intervention strategy against IMI?
3 DETERM INANTS FORTREATMENT
While the purpose of this PhD was to improve mastitis control
through identification of cost-efficient intervention strategies by
a modelling approach, it is also important to understand current
practices in mastitis management.
Different approaches are conceivable to determine how farmers
manage mastitis in their herd, e.g. interviews with farmers and
veterinarians or farm visits. For this PhD project, another strategy
was chosen: register data from the Danish Cattle Database were
analysed for their value in relation to mastitis control. This
approach, if successful, would have a notable advantage in that
it could be easily repeated for updated data found in the Danish
Cattle Database.
An important element in mastitis management is antimicrobial
treatment, mostly of clinical cases or at dry off, as described in
Section 2.1.2. In fact, mastitis is one of the main reasons for the
use of antibiotics in Danish (DANMAP, 2016) and other European
dairy herds (EMA and EFSA, 2017). However, consumer aware-
ness regarding the use of antibiotics in the dairy industry is
rising, asking for justifiable and responsible treatment strategies
(Ruegg, 2003).
If data from the Danish Cattle Database could be used to
characterise different farmers’ mastitis management or, more
specifically, antibiotic treatment strategies, this knowledge could
be integrated into the second part of the PhD project (Chapter 4)
to optimise antimicrobial usage in intervention strategies. Fur-
thermore, understanding factors that determine whether a cow
receives antibiotic treatment or not in a specific herd can aid in
tailoring new management programs to the farmer’s preferences.
This first part of the PhD project is presented in the first ma-
nuscript in Section 3.2 after a short presentation of the used
methods.
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3.1 materials and methods
Data from the Danish Cattle Database (Section 3.1.1) were used
as input in herd-wise logistic regressions (Section 3.1.2) to predict
antibiotic treatment in the herds. Then, each herd, represented
by a set of regression coefficients, was considered as a point in
a sample space for principal component analysis (PCA, Section
3.1.3). The PCA transformed points were clustered to identify
similar herds (Section 3.1.4). The overall predictive capabilities
of the logistic regressions were evaluated by the area under the
curve (AUC, Section 3.1.5).
3.1.1 Danish Cattle Database
The Danish Cattle Database is maintained by the Danish Ag-
riculture & Food Council (RYK, 2016). It accumulates various
cattle data, e.g., milk recordings, animal movements (entry and
departure of animals), calvings, dry off, as well as animal health
and treatment data. Entries into the database are made by farm-
ers, advisory services, technicians, dairies, or slaughterhouses.
Mandatory information is passed on to the Central Husbandry
Register (CHR).
3.1.2 Logistic regression
Data from the Danish Cattle Database were used in mixed ef-
fects logistic regressions to predict antibiotic treatment for udder
health reasons. A traditional approach might have used the
possible predictors and herd as fixed effects, adding cow as a
random effect, to assess probability for treatment under given
circumstances. In this study (Section 3.2), we removed herd as
an effect and ran one logistic regression for each herd instead.
This allowed us to predict treatment for individual herds and
compare between the different herds.
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3.1.3 Principal component analysis
PCA is in essence a transformation (by rotation or reflection) of a
sample space. If we assume that we have n variables and more
observations than variables, then PCA can be seen as simply
providing a new coordinate system. That is, the principal com-
ponents are new coordinate axes for the sample space.
The principal components are chosen such that the first com-
ponent accounts for the highest possible variation in point co-
ordinates. The other components are added subsequently, catch-
ing as much variation in coordinates as possible under the con-
straint that they must be perpendicular to the prior principal
components. This procedure ensures that there is more vari-
ation in the earlier principal components than in the later, while
maintaining a cartesian coordinate system.
PCA is often used to reduce the dimension of data. The less
variation there is in the last principal components, the better
dimensionality reduction works. For example, if all observations
are nearly the same in the last principal component coordinate,
this coordinate could be ignored. PCA is not useful, on the other
hand, if the observations are uniformly distributed in space.
3.1.4 Clustering
Clustering is the grouping of objects, so that obervations in one
group are more similar to each other than to observations in
other groups. There are a variety of clustering algorithms used
in many different fields. In this study, we used a clustering
algorithm devised by Ward (1963).
In Ward’s algorithm, observations are grouped hierarchically,
using the sum of the group error sum of squares as an objective
function, where the error sum of squares of a group (ESSgroup)
with k elements is the sum of the squared differences between
each observation xi in the group and their mean value x¯.
ESSgroup =
k∑
i=1
(xi − x¯)
2
The algorithm starts with n groups, one for each observation.
The number of groups is then subsequently reduced by testing
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all possible unions of two groups with respect to minimising the
objective function until only one group including all observations
is left.
3.1.5 Area under the curve
The diagnostic capability of any binary classifier or test that
depends on a cutoff can be described by the receiver operating
characteristics (ROC) curve. The ROC curve shows the relation
between test sensitivity (true positive ratio) and test specificity
(false positive ratio) and is therefore bounded by the unit square.
It is plotted by varying the cutoff from its minimum to its max-
imum value and plotting sensitivity of the corresponding test
over 1−specificity. A perfect test would then position in the up-
per left corner (0, 1), while the diagonal would describe random
guessing. Therefore, tests should not have a ROC curve falling
below the diagonal, as the diagnosis could be simply reversed
to achieve a better result. A cutoff is usually chosen to minimise
distance to (0, 1).
The area under the ROC curve (AUC) is the integral over the
ROC curve, i.e. the area between the ROC curve and the x-axis.
It can be seen as a measure of how well the test performs over
all possible cutoffs, although it does not specify for which range
of cutoff values the test performs best. Generally, the AUC has a
value between 0 (“always wrong”) and 1 (“perfect test”), but, as
described above, values below 0.5 can be avoided by reversing
diagnoses for certain cutoff ranges.
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abstract
Societal pressure to limit the use of antibiotics in livestock pro-
duction systems, including dairy cattle systems, is consistently
increasing. To motivate farmers to reduce antibiotic usage, it is
important to understand the factors that determine whether a
cow will be treated with antibiotics or not. If farmers’ usual prac-
tices regarding antibiotic treatments are taken into account, they
may be motivated to adopt control measures that can facilitate
prudent use of antibiotics and are at the same time cost-effective.
In this study, we analyzed database recordings of milk yield
and somatic cell count from the routine milk recording scheme,
clinical registrations of mastitis and PCR results, and cow factors
such as days in milk and parity in relation to antibiotic treatments
for 518 dairy herds in Denmark. Farm-wise logistic regressions
were used to predict antimicrobial treatment based on these
factors. The resulting regression coefficients of 422 herds were
further analyzed by principal component analysis and clustering
to determine the driving predictors for treatment in different
groups of farms. The results showed that determinants that were
most important for predicting antibiotic treatments vary from
one farm to another. Health indicators such as PCR or somatic
cell count were most indicative for treatment on some farms,
whereas other groups seemed to depend more on production
factors (milk yield) or later culling of the cows. This shows that
farmers behave differently and differences can be identified in
register data. This information can be considered when devel-
oping costeffective herd-specific control measures of mastitis to
promote prudent use of antibiotics in Danish dairy cattle farms.
key words: dairy cattle, antibiotic treatment, mastitis, cluster
analysis
introduction
Mastitis is one of the most frequent and costly diseases in dairy
cattle (e.g., Halasa et al., 2007). Besides impairing animal welfare
(Broom, 1991; von Keyserlingk et al., 2009), it is also a major
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reason for economic losses and prescription of antibiotics in
dairy cattle herds (DANMAP, 2014, p. 34; EMA and EFSA,
2017, p. 29). The use of antibiotics in food animals has been a
growing concern over the last decades, with increasing consumer
awareness regarding this point and its effect on antimicrobial
resistance (Ruegg, 2003).
Antimicrobial treatment is an important element in the man-
agement of mastitis in dairy herds. It is applied for treatment of
clinical mastitis (Halasa, 2012; Steeneveld et al., 2011) and sub-
clinical mastitis (van den Borne et al., 2010), and at dry-off to cure
or prevent mastitis cases (Halasa et al., 2009a,b). However, its use
must be prudent (i.e., limited to cases in which treatment with
antibiotics is necessary while choosing a suitable antibiotic) to
reduce the risk of antimicrobial resistance. To optimize antimicro-
bial usage, it is important to understand antimicrobial treatment
patterns for udder health in dairy cattle herds and investigate
factors that influence or enhance the treatments. However, it
can be challenging to identify what farmers actually do, or why,
as such information is not normally registered. Nevertheless,
observable factors may give indications and thus may be useful
as proxies for behaviors explaining antimicrobial treatment on a
farm. Once influential factors are identified for a specific farm,
veterinarians and udder health advisors can guide farmers to
a prudent and cost-effective selection strategy of cows for treat-
ment, while also taking the farmer’s usual selection criteria or
management practice into account. This might ease motivating
farmers to adopt proposed management programs to improve
udder health, thus aiding the prudent use of antimicrobials. As
blanket dry cow therapy is prohibited in Denmark, an appro-
priate selection of cows for antibiotic treatment, both during
lactation and at dry-off, is expected to have a positive effect on
udder health and animal welfare while facilitating prudent use
of antibiotics (Scherpenzeel et al., 2016). In Denmark, antimi-
crobials are prescribed by the herd veterinarian and exclusively
distributed through pharmacies. In addition, treatments are nor-
mally carried out by veterinarians, but a farmer can have a herd
health contract with a consulting veterinarian, allowing him to
treat clinical cases of mastitis himself.
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The proposed strategies can be developed and examined us-
ing, for instance, simulation models adjusted to the herd-specific
parameters and with focus on cost effectively optimizing an-
timicrobial usage. These models can also consider other factors,
such as spread of pathogens (e.g., van den Borne et al., 2010;
Halasa et al., 2010), and thereby provide a more comprehen-
sive understanding of management and treatment regimens and
their expected outcomes, depending on given farm and cow pa-
rameters. This knowledge could additionally be used by policy
makers when considering new regulations on a national scale.
In Denmark, herd and cow level registrations are collected in
the Danish cattle database. They include, in addition to cow
ID, for instance, milk yield and SCC from samples obtained
through the routine milk recording scheme (6 or 11 times per
year), and other recordings as part of a herd health scheme. The
data also include recordings about diseases and treatments for
individual cows and are being used for, among other purposes,
the development of herd health and breeding programs. Its
potential for development of herd-specific health management
programs can, however, be further exploited.
We investigated whether data from the Danish cattle database
could be used to predict antimicrobial treatment in relation to
udder health management on different farms, and we identified
differences between farms regarding treatment and determined
which factors were most important for treatment on different
farms. This information can be used to develop herd-specific
strategies to improve udder health, considering prudent use of
antimicrobials and the apparent selection strategy of cows for
treatment.
materials and methods
Data
Anonymized data from 1,500 randomly chosen conventional
cattle farms with any milk yield recordings in Denmark, where
at least 90% of the animals are Danish Holstein cows, were
retrieved from the Danish cattle database between February 27
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and March 1, 2016. At this time, the total number of dairy farms
in Denmark was 3,232. Data included information on milk yield,
SCC, animal movements, reproduction and calving, dry-off dates,
PCR results (from cow-milk samples), clinical registrations, and
treatments. Clinical registrations are usually carried out by the
veterinarian, but some farmers may also add to the registrations.
These registrations include mainly the results of the California
mastitis test, but also acute mastitis cases. Only data from Danish
Holstein cows were considered in the analyses.
As a first step, data irrelevant for udder health management
were removed: clinical registrations and treatment recordings
in the database are related to various diseases, but only clinical
registrations pertaining to the udder or the mammary gland,
registered as the Danish equivalents of “udder” or “mammary
gland,” or results from the California mastitis test were kept.
Treatments were considered relevant if they were registered as
dry-cow treatment, pertaining to the udder or for diagnosed
pathogens causing IMI.
As we were interested in treatment patterns in relation to ud-
der health management, in the second step, we split the data
set into 3 parts. The first part included 518 herds with available
mastitis PCR results, clinical registrations, and treatment record-
ings in relation to udder health; the second part included 370
herds without PCR but with available clinical registrations and
treatment recordings, and the third part consisted of 424 herds
with only treatment recordings available.
From the milk recordings of these farms, average milk yields
per parity were calculated for every cow and SCC values were
log-transformed. Milk yields recorded as 0 or not available (NA),
where SCC was also NA, were discarded because they were con-
sidered to be automated recordings for cows that were not actu-
ally milked (e.g., cows that were just dried off). Log-transformed
SCC values that were given as negative infinity were regarded as
NA because a SCC of 0 should not be possible. Parity and DIM
were calculated according to the given calving dates. Parity was
categorized as 1, 2, or > 3, and DIM were categorized as lactation
stages in early (0–30 DIM), mid (31–250), late (251–450), and very
late (> 450 DIM) lactation. Observations in the last lactation of
a cow were marked according to animal movements showing
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death of the cow, with NA signaling that neither death nor a
following lactation could be identified. Treatment registrations
within 14 d of a previous registration were considered part of
the same treatment (Barkema et al., 1998), except if a subsequent
treatment was registered as dry-off treatment, which was always
kept. The PCR was recorded for each tested pathogen (Staphy-
lococcus aureus, other staphylococci including CNS, enterococci,
Corynebacterium bovis, Escherichia coli, Streptococcus dysgalactiae,
Streptococcus agalactiae, Streptococcus uberis, Klebsiella spp., Ser-
ratia marcescens, Arcanobacterium pyogenes and Peptostreptococcus
indolicus, Mycoplasma bovis, Mycoplasma spp., Prototheca spp., β-
lactamase, yeast), but reduced to 1 observation in the data set
with the minimum cycle threshold (CT) value. A PCR result
with a CT value below 37 was considered positive, as this is the
usual cut-off value used in Denmark for antibiotic treatments.
Multiple clinical registrations made for 1 animal on the same day
with the same result were considered as only 1 recording. As
PCR recordings based on milk from the Danish milk recording
scheme started in 2009, only data from 2009 onward were taken
into account.
Finally, the 3 parts of the data set were transformed in 2 ways
to account for possible differences between lactational and dry-
off treatments. For lactational treatments, each recorded treat-
ment led to one treatment observation and no-treatment obser-
vations were taken for each lactation stage (early, mid, late, very
late) without a lactational treatment following in the same lacta-
tion/parity. For instance, a cow without treatment would lead to
around 3 to 4 no-treatment observations per lactation (depending
on when it was dried off), whereas a cow treated in mid lacta-
tion would have a treatment observation in mid lactation and
may have a no-treatment observation later in lactation. Dry-off
treatments were not considered in the data set for lactational
treatments, though it was noted if a dry-off treatment occurred
at the end of a lactation. For dry-off treatments, there was one
observation per parity. In both cases, treatment and no-treatment
observations were linked with the corresponding farm and cow,
and to the following factors: lactation stage, parity, last average
milk yield, and last log-transformed SCC before the observation,
as well as information about prior PCR testing (positive PCR or
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negative/no PCR), clinical registrations (yes/no), and whether
or not the observation was in the cow’s last parity (yes/no/NA).
This is to account for whether the cow was culled or not. Ob-
servations in the dry-off treatment data set were additionally
linked to information about lactational treatments in the same
lactation (yes/no). Observations where parity was unknown
were removed.
This led to 1 data set for lactational treatments and 1 for dry-off
treatments, each with 3 parts (with PCR and clinical registrations,
without PCR, without PCR or clinical registrations).
Statistical Analysis
For the statistical analyses, the data sets were subdivided into
smaller data sets, each representing one farm and only including
observations of that farm. All computations were done in the
statistical computing software R version 3.3.1 “Bug in Your Hair”
(R Core Team, 2016), using the additional packages data.table
(Dowle et al., 2015), zoo (Zeileis and Grothendieck, 2005), lme4
(Bates et al., 2015), and ROCR (Sing et al., 2005). Figures were
made using the packages ggplot2 (Wickham, 2009), ggbiplot (Vu,
2011), and dendextend (Galili, 2015).
logistic regression analysis. To investigate whether av-
erage milk yield, log-transformed SCC, PCR, and clinical regis-
tration can predict treatment, we performed farm-wise logistic
regression. Adding parity, lactation stage, and information about
whether or not the cow was in her last lactation as categorical co-
variates in a multivariable logistic regression to predict lactational
treatments in a combined model leads to
logit [P (TREATi)] = βi0 +βi1AVGMYi +βi2 logSCCi
+βi3PCRi +βi4CLINi +βi5PARi +βi6LACi +βi7LASTi
+COWi.
As observations for dry-off treatments were always taken at the
end of a parity, lactation stage was removed in this case, and
instead information about whether there was a treatment dur-
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ing the same lactation was added to predict dry-off treatments,
leading to
logit [P (DCTi)] = βi0 +βi1AVGMYi +βi2 logSCCi
+βi3PCRi +βi4CLINi +βi5PARi +βi6LTREATi
+βi7LASTi +COWi.
The left-hand sides of the equations, P (TREATi) and P (DCTi),
are the probabilities of lactational and dryoff treatment, respec-
tively. AVGMY (last average milk yield), logSCC (last log-
transformed SCC), PCR, CLIN (clinical registration), PAR (par-
ity), LAC (lactation stage), LTREAT (treatment during lactation),
and LAST (cow’s last lactation) are the above-mentioned predic-
tors, and COW ∼ N (0,σcow) is a random effect of cow. As our
analyses were all farm-wise, i = 1, . . . 1312 was a farm index. For
farms without PCR or clinical registrations, the corresponding
variables (PCR, CLIN, or both) were removed.
To evaluate how well the multivariable logistic regression
models predicted treatment, models were also additionally fitted
on subsets of data, where 10% of the cows at each farm were
randomly excluded when fitting the model and then used for
testing model predictions. When predicting treatment for new
cows, the model used the average population-level values for
the random cow factor. The area under the receiver operating
characteristic curve (AUC) was then calculated to evaluate the
predictive capability of the models.
principal component analysis. We used the coefficients
of the variables obtained by logistic regression in principal com-
ponent analyses (PCA) to investigate similarities or differences
between the farms regarding treatment and treatment determi-
nants. For numerical stabilization, farms with extreme coefficient
values were excluded from the PCA. Because not all coefficients
were significant, we decided to take the range of the significant
coefficients of farms in the same data set and with the same
type of registrations (available PCR recordings or clinical reg-
istrations) as a scale and considered values as extreme if they
were outside of that range. Farms where the logistic regression
did not converge were also excluded, leading to 422 farms (325
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farms without PCR, 334 without PCR or clinical registrations)
included in the PCA on lactational treatment coefficients and
381 farms (274 farms without PCR, 213 farms without PCR or
clinical registrations) included in the PCA on dry-off treatment
coefficients. The variables were centered (to 0) and scaled (to
unit variance) before PCA was performed.
The rotated regression coefficients where clustered, using
Ward’s clustering criterion (Ward, 1963) with a cut-off value
of 3 clusters. The number of clusters was chosen by a visual
inspection of the corresponding dendrograms.
results
The number of observations per farm differed greatly among
farms. In the data set for lactational treatments, numbers ranged
from 639 (for farms with PCR recordings; 421 for farms with only
clinical registrations; 129 for farms without clinical registrations
or PCR) to 15,610 (11,980; 7,795) observations with 79 (34; 2) to
4,969 (3,053; 1,354) cases (treatments) and 424 (310; 70) to 13,090
(8,924; 7,732) controls (nontreatments) across a mean number
of 42 (25; 9) to 1,317 (844; 547) cows per farm per year. The
corresponding numbers for dry-off treatments were 285 (147; 64)
to 10,640 (6,523; 3,775) observations with 1 to 2,348 (2,162; 903)
cases and 249 (142; 53) to 9,487 (4,361; 3,770) controls. Fourteen
(38; 91) farms had no registered dry-off treatments. Distributions
of observations are given in Table I.1.
The multivariable logistic regression for lactational treatments,
for herds with both PCR and clinical registrations, showed simi-
lar significance for all factors on the majority of the farms, though
slightly less for parity (Figure I.1). The coefficients themselves
showed a higher probability of treatment with a higher SCC,
higher milk yield or later in lactation (Figure I.2). Clinical reg-
istration coefficients suggested higher probability for treatment
with a clinical registration, whereas PCR coefficients indicated
a lower probability for treatment with a positive PCR. Similarly,
cows in their last lactation (before culling) mostly had a lower
probability for treatment (Figure I.2). Parity coefficients were
more centered around 0 with a small shift to the left, indicating
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Figure I.1: Histogram of P-values in multivariable logistic regressions
of lactational treatments for farms with PCR and clinical
registrations.
slightly lower treatment probability for higher parities. This was
especially observable in the significant coefficients (Figure I.3).
For most farms, only some of the coefficients were significant,
but for 124 farms (39 farms with PCR and clinical registrations,
47 farms without PCR, 38 farms without PCR or clinical registra-
tions), all coefficients were significant.
Multivariable logistic regression results for dry-off treatments
for herds with PCR and clinical registrations were comparable
to those for lactational treatments (Figures I.4 and I.5), though
there were more extreme values in the regression coefficients
(results not shown). Notable differences could be seen for PCR,
where coefficients suggested a higher probability for dry-off
treatment given a positive PCR result. A higher probability for
treatment was also indicated by coefficients for preceding lacta-
tional treatments (Figure I.5). On 86 farms (37 farms including
PCR, 27 farms without PCR, 22 farms without PCR or clinical
registrations), all coefficients were significant.
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Figure I.2: Histogram of coefficients in multivariable logistic regres-
sions of lactational treatments for farms with PCR and
clinical registrations. Farms with extreme coefficients (see
Figure I.3) are removed from further analysis.
Model validation by fitting the regressions on 90% of the cows
in each model showed very good model fit for the remaining 10%
with the mean AUC at 76% for lactational treatments and 85%
for dry-off treatments, and the median AUC at 76.3% (lactational)
and 85.8% (dry cow, Figure I.6).
The PCA results showed that for both types of treatments
the first 2 principal components explain more than 50% of the
variance (Figures I.7 and I.8). These 2 components included all
used predictors, although to varying degrees.
Clustering by Ward’s clustering criterion on all principal com-
ponents for lactational treatments showed 3 clusters (Figure I.9),
one of which was aligned with parity, clinical registrations, and
PCR. The second cluster was aligned around average milk yield
and lactation stage, and the third cluster was aligned around
a cow’s last lactation. The SCC seemed to be between this last
and the first cluster (Figure I.7). For dry-off treatments, farms
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Figure I.3: Histogram of significant coefficients in multivariable logistic
regressions of lactational treatments for farms with PCR and
clinical registrations. The depicted ranges were taken as
standard for the coefficient ranges in Figure I.2.
seemed to cluster mainly around average milk yield and between
parity and a cow’s last lactation, with a smaller third cluster
aligned with clinical registrations, PCR, SCC, and lactational
treatments in the same lactation (Figures I.8 and I.10). For farms
without PCR, clustering for dry-off treatments added several
small clusters before more than one big cluster appeared (results
not shown).
The included figures show results for farms with PCR and
clinical registrations. Specific results of the logistic regression,
clustering and PCA for herds without PCR, and herds without
PCR or clinical registrations are not shown nor further discussed
separately, as they displayed similar trends for both lactational
and dry-off treatments.
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Figure I.4: Histogram of P-values in multivariable logistic regressions
of dry-off treatments for farms with PCR and clinical regis-
trations.
discussion
Milk yield recording data, including SCC, are collected regularly
on most farms for all cows, leading to near-complete informa-
tion, whereas PCR has to be transferred and clinical registrations
have to be entered into the database manually by the veterinar-
ian or the farmer, who might forget to register this information,
sometimes leading to incomplete data or registration errors. Nev-
ertheless, Wolff et al. (2012) investigated the completeness and
quality of the national database registers in Denmark, Finland,
Norway, and Sweden. The authors found that the Danish register
regarding clinical mastitis had the highest quality and around
90% completeness, which increases our confidence in the out-
comes of the current study. Still, registration errors do occur, and
during data management, we encountered some of those such
as recordings of dry-off treatments during early lactation, which
are most likely treatments for clinical mastitis.
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Figure I.5: Histogram of significant coefficients in multivariable logistic
regressions of dry-off treatments for farms with PCR and
clinical registrations. Values outside of the depicted ranges
were removed as extreme values.
In this study, we conducted untraditional farm-wise logistic
regressions because we were interested in both individual farms
and in differences between the farms, and not in generic or aver-
age estimates corrected for the farm effect. By estimating logistic
regression parameters for each farm, we obtained information
about individual farms (farm-specific), which could then be used
to investigate differences between the farms. We also distin-
guished between lactational and dry-off treatments, where those
were recorded.
Our logistic regression analyses showed that, on many farms,
a high SCC and high milk yield are associated with a higher
probability of treatment, both for lactational and for dry-off treat-
ments, as is a clinical registration. Cows that were treated during
lactation also had a higher probability for dry-off treatment. It
could be that farmers treat cows at dry-off that had a treatment
(a mastitis problem) during the lactation, whether they need
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Figure I.6: Histogram of area under the receiver operating characteris-
tics curve (AUC) for all farms without extreme coefficients
for (a) lactational treatments and (b) dry-off treatments.
Model performance was tested on 10% of the cows, which
were not included in model fitting.
or do not need the treatment. Earlier studies (e.g., Steeneveld
et al., 2008; Waage et al., 1998; Zadoks et al., 2001) have on the
other hand shown that high milk production and SCC, as well as
previous IMI, are risk factors for clinical mastitis that may lead
to antibiotic treatment. These factors may therefore just indicate
that there was an IMI (likely to be chronic) that had to be treated.
However, it is also expected that farmers would like to keep cows
that are performing better than the average cow; therefore, they
may rather treat such cows in case of a potential udder health
complication to ensure optimal performance of the cows (accord-
ing to the farmer’s belief). Also, because blanket dry cow therapy
is not allowed in Denmark, SCC is one of the main indicators
used for selecting cows for testing (using bacterial culture or
PCR), subsequently allowing dry-off treatment with antibiotics
if the cow is tested positive. If, on top of that, farmers decide to
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Figure I.7: Principal component analysis (PCA) biplot with Ward’s
clustering criterion for lactational treatments on farms with
PCR and clinical registrations. PC1 = principal component
1; PC2 = principal component 2; var. = variance. Color
version available online.
select cows for testing based on whether or not they already had
mastitis and mastitis treatment, the associations between dry-off
treatments and SCC or preceding lactational treatments could be
further explained.
A positive PCR was also associated with a higher probability of
dry-off treatment, which can be explained by the fact that Danish
legislation allows farmers to use dry cow therapy on PCR-positive
cows (Figure I.5). On the other hand, a positive PCR seemed to
lower the probability for a treatment during lactation (Figures
I.2 and I.3). To find a satisfactory explanation for this, a more
thorough understanding of when and why farmers decide to use
PCR, specifically in relation to lactational treatments, is needed.
For both types of treatment, the regression coefficients showed
that cows were rarely treated in their last lactation. This is likely
explained by the farmer choosing to cull instead of treating a
cow.
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Figure I.8: Principal component analysis (PCA) biplot with Ward’s
clustering criterion for dry-off treatments on farms with
PCR and clinical registrations. One observation (principal
component 1 (PC1) = 2.8 and principal component 2 (PC2)
= −13.2) in group 3 is not shown in the plot. Var. = variance.
Color version available online.
The multivariable logistic regression showed different farmer
behavior toward treatment when it comes to the parity of the
cows (Figures I.2, I.3, and I.5). There seem to be farmers that
tend to treat younger cows rather than older ones, as well as
farmers that treat the older ones rather than the younger cows.
As younger cows are considered the future potential of the farm,
the decision to treat instead of cull in case of an udder health
complication may not be surprising. On the other hand, a farmer
may decide to keep only higher producing cows and treat those,
even if they are older, or hope that younger cows can clear an
infection more easily without treatment.
Our results from the PCA and clustering indicated 3 big clus-
ters for lactational treatments (Figure I.9) and 2 big and 1 smaller
cluster for dry-off treatments (Figure I.10). In both cases, 1 clus-
ter covered farms where farmers mostly concentrated on health
indicators such as positive PCR, clinical registrations, and SCC.
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Figure I.9: Dendrogram of Ward’s clustering criterion (lactational treat-
ments on farms with PCR and clinical registrations). The
clustering height (y-axis) is given in variance units accord-
ing to Ward’s clustering criterion. Color version available
online.
For dry-off treatments, treatments in the same lactation were
included in these health indicators, and this cluster was the
smallest. Another cluster covered farmers whose decision to
treat was based mostly on production factors like average milk
yield, and in the case of lactational treatments, DIM, keeping the
“more profitable” (high producing) cows. The third cluster for
lactational treatments seemed to be centered around a cow’s last
lactation, also partly including SCC. For dry-off treatments, the
third cluster seemed mostly influenced by parity and a cow’s
last lactation. This may indicate that the farmers’ decision to cull
instead of treating cows during the lactation is affected by the
SCC of the cow, whereas the decision for dry-off treatments may
be more affected by the age of the cow.
The decision for treatment may also be influenced by the con-
sulting veterinarian. As we do not account for the veterinarian in
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Figure I.10: Dendrogram of Ward’s clustering criterion (dry-off treat-
ments on farms with PCR and clinical registrations). The
clustering height (y-axis) is given in variance units accord-
ing to Ward’s clustering criterion. Color version available
online.
our analyses, it is possible that the clustering may be influenced
by the herd veterinarian. Further studies could investigate the
veterinarian’s influence by including the veterinarian as an effect
in the model. The farmer himself may also have biased our re-
sults by his perception of which cases should receive treatment,
because some farmers may add to the clinical registrations. Still,
we expect this bias to be minor because the majority of the cases
are registered by the veterinarian.
Cows with clinical mastitis that were not treated but were for
instance culled or slaughtered were not considered separately,
as culling determinants on different farms were out of the scope
of this study. Nevertheless, we tried to adjust for culling by
including a binary variable indicating if a cow was in the last
lactation. As expected, cows in their last lactation were rarely
treated. Further studies focusing on understanding determinants
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for culling of dairy cows or the more specific relation between
treatments and culling may use the methods presented in this
study.
We chose a cut-off at a CT value of 37 to define a positive or
negative PCR result and we did not consider other cut-off values,
nor the pathogen that the PCR reacted to. The cut-off value
of 37 is the value that permits treating cows with antibiotics in
Denmark, which farmers generally use. Farmers are allowed to
treat cows with antibiotics based purely on a positive PCR result,
regardless of the pathogen the PCR reacted to. If they only test
cows that they think should be treated, any positive PCR might
result in treatment.
Our results clearly show that farmers behave differently. For
instance, the results show that health indicators are most in-
dicative for some farms, whereas others use production-related
factors (Figures I.7 and I.8). In addition, variations in the extent
of the determinants’ effects are clear between farms (Figures
I.2, I.3, and I.5). This indicates that a herd-specific approach
for udder health improvement with a focus on optimizing the
use of antibiotics may be useful. Simulation models could be
used to examine and gradually adjust farm-specific udder health
management programs under different circumstances (e.g., the
level of the mastitis problem in the herd, the causative agent
of mastitis, the farmer’s way of selecting cows for treatments
with antimicrobials, and with different assumptions about the
current treatment regimen). This will allow for cost-effective
changes of control programs, without having to adopt a totally
different strategy. Thereafter, the information can be communi-
cated by the veterinarian or the milk quality advisors (or both)
to provide farm-specific advice not only based on the farmer’s
statement about his udder health management, but also aug-
mented with available data. Herd-specific control programs that
consider a farmer’s behavior toward selection of cows for antimi-
crobial treatments may motivate the farmer to adopt new mastitis
control programs resulting in not only improving udder health
cost-effectively, but also enhancing prudent use of antibiotics.
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conclusions
Danish cattle database recordings can be used to find determi-
nants for antibiotic treatment in relation to udder health. De-
terminants that were most important for predicting antibiotic
treatments vary from one farm to another. Health indicators such
as PCR or SCC were most indicative for treatment on some farms,
whereas other groups seemed to depend more on production
factors (milk yield) or later culling of the cows. This shows that
farmers behave differently and differences can be identified in
register data. Hence, a data-assisted farm-specific approach to
improve udder health, which considers how the farmer selects
animals for antibiotic treatments, may prove useful in motivating
the farmer to adopt the proposed approach. This would improve
udder health and encourage prudent use of antibiotics.
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4 MODELL ING IM I ANDINTERVENT IONS
The main part of the PhD project was related to simulation
modelling, or more specifically, modelling prevention and con-
trol of mastitis in dairy herds. Modelling different intervention
strategies against IMI allows their comparison regarding cost-
effectiveness, and is thus an important step in improving mastitis
control.
However, as described in Section 2.2.2, already existing models
were missing certain factors. Therefore, a new model address-
ing these gaps and fulfilling all requirements (see Section 2.2.2
and Figure 3) was needed. In short, the model should simu-
late a dairy herd with milk production, pathogen transmission,
and intervention measures. The here proposed model uses a
recently described dairy herd model (Kirkeby et al., 2016), with
a newly added transmission framework for IMI (Manuscript II),
and intervention measures against clinical and subclinical IMI
(Manuscripts III and IV).
In this chapter, the model and intervention strategies are
presented in Sections 4.3, 4.4, and 4.5, after a short summary
of the model, highlighting the requirements mentioned in Sec-
tion 2.2.2. Furthermore, additional one pathogen scenarios not
presented in Manuscript II are shown in Section 4.2.
4.1 materials and methods
In the following, a short description of the model is given. A more
thorough description of the transmission framework, IMI effects
on production, and voluntary culling can be found in Section
4.3. Selected interventions against clinical and subclinical IMI are
described and investigated in Sections 4.4 and 4.5, respectively.
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4.1.1 Herd model
The base herd model was taken from the iCull model (Kirkeby et
al., 2016), that was originally used to investigate paratuberculosis
control actions.
In the model, the herd is initiated by drawing a number of
animals in every category (calves, heifers, inseminated heifers,
pregnant heifers, lactating cows, inseminated lactating cows,
pregnant lactating cows, and dry cows), depending on a target
count (default value 200 cows) and a demographic distribution.
Then, a closed dairy cattle herd is modelled with daily time steps.
Upon entering a category, the number of days the animal will
stay there is drawn from a distribution, before it moves on to the
next category, again. As an example, a pregnant lactating cow
could be dried off, stay a dry cow for 56 days, calve, and return
to being a lactating cow for a number of days.
The base iCull also models daily milk yield (originally energy
corrected milk) and SCC for every lactating cow, including pro-
tein and fat percentages, which are used to calculate the income
from milk. Milk yield recordings are simulated once a month.
Feeding costs for lactating cows depend on the modelled milk
yield, for other animals, feeding costs are fixed.
Culling is divided into involuntary and voluntary culling.
Once a week, animals are evaluated for voluntary culling, if
the target count (see above) is exceeded. Milk production, repro-
duction status, SCC, and parity are weighted and cows with the
highest weight are culled.
Furthermore, the base model includes the option to estimate
the future average milk production (FAP) of a cow, depending on,
among other things, its milk yield and recorded SCC (Græsbøll
et al., 2017).
4.1.2 IMI transmission framework
IMI transmission is similar to the bovine IMI model (Halasa
et al., 2009b), but modelled at quarter level. Furthermore, in-
fection (risk factors, Zadoks et al., 2001a) and cure after treat-
ment (Steeneveld et al., 2011) are cow-specific. To demonstrate
differences between strains, two S. uberis strains are included,
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together with three other pathogens (S. aureus, S. agalactiae, and
E. coli). Each pathogen strain has an assigned transmission
mode, three of which are available (contagious, environmental,
and opportunistic—a mixture of contagious and environmental,
see Section 2.1.1 and Figure 2). The model is therefore strain-
specific.
For dry cows, IMI transmission is independent of the number
of infected quarters, and clinical cases can only occur in the first
and last week of the dry period (Halasa et al., 2010). For cows
that received DCT, transmission rates are lower, and quarters
with subclinical IMI cannot flare up.
Transmission rates in general can be easily adjusted to account
for different herd situations.
4.1.3 Effects on production
The effects of IMI on milk production are modelled for both
clinical and subclinical IMI. For subclinical IMI, the SCC is in-
creased, depending on the causative pathogen (Schepers et al.,
1997; Wilson et al., 1997); and milk yield is lowered (Hortet et al.,
1999). For clinical IMI, milk yield is reduced until the end of
lactation, also depending on the pathogen (Gröhn et al., 2004).
This part was coded by Carsten Kirkeby.
4.1.4 Interventions
Voluntary Culling
As described above, SCC, which can be seen as an indicator for
subclinical IMI (see Section 2.1.1), was already considered in
voluntary culling decisions. In the MiCull model, previous cases
of clinical IMI were added as an additional weight for voluntary
culling (Bar et al., 2008a).
Dry Cow Treatment
If a cow gets a clinical IMI in the first week of the dry period, it
will be treated with DCT. On top of that, cows are selected for
testing, if they had a clinical IMI during the lactation, or if they
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had a high SCC at a milk recording within the last three months.
Testing is done by PCR, and if the test returns a positive result,
DCT will be administered.
Clinical Interventions
The default intervention against clinical IMI is a three day in-
tramammary treatment of all clinical cases. Other intervention
options include longer treatment or reactive culling. Not re-
covered cows can be culled after treatment or cows can be culled
instead of treated, for example if they had repeated cases of
clinical IMI or after diagnostic testing of clinical quarters to de-
termine the causative pathogen. Based on the test result, an
expected recovery probability is estimated and cows below a
certain threshold (0.5 or 0.75) are culled instead of treated. The
culling threshold can be adjusted for primiparous cows. Clinical
intervention strategies are investigated in Manuscript III (Section
4.4).
Subclinical Interventions
By default, there are no intervention measures against subclinical
IMI. In all options for subclinical interventions, cows with two
subsequent high SCC are tested for IMI and test positive cows
are treated. The test can be repeated a month later, and cows that
are still tested positive are culled. There are also cow-specific
intervention options. Interventions against subclinical IMI in
combination with different clinical intervention measures are
investigated in Manuscript IV (Section 4.5).
Furthermore, for clinical IMI that persisted as subclinical IMI
after treatment, the cure probability after treatment for subclinical
IMI is reduced to the minimum of the cure probabilities for
treatment of clinical and subclinical IMI. This option can be used
or ignored in the model.
4.2 results not presented in the papers
In addition to the one pathogen scenarios presented in Manu-
script II, eight one pathogen scenarios (for S. aureus, S. agalactiae,
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contagious S. uberis, or environmental S. uberis) are presented
in Table 1 and Figure 4. The results show that the per case
costs, particularly for subclinical cases, increased with decreasing
transmission rate, i.e. with decreasing number of cases.
This phenomenon can be explained by culling dynamics and
costs caused by milk loss. In a closed herd, the farmer can only
cull a certain number of animals, as replacement heifers have
to be available. In general culling decisions, involuntary culling
and culling for acute IMI have the highest priorities. Clinical
cases have a fixed low probability to become acute, so higher
prevalences will also lead to more acute cases. Consequently,
less cows with subclinical IMI will be culled with a high SCC.
These animals will stay in the herd and the additional lost milk
increases the per case costs.
Figure 4: Daily cow level prevalences in the one pathogen scenarios
described in Table 1. Every scenario shows 500 iterations
over five years with an additional five year burn-in period.
One random iteration is shown in gray, the mean is displayed
in black. The top row shows scenarios with unadjusted trans-
mission rates. Scenarios 7, 9, 14, and 21 are also presented in
Manuscript II.
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Scenario Pathogen
Transmission rate
scaling factor Transmission rate
Transmission rate
(dry cows)
culled with
high SCC
Per case cost,
subclinical
Per case cost,
clinical
1 S. aureus 1 0.0179 0.0179 60 (52, 67) 28 (27, 29) 337 (320, 354)
7 S. aureus 0.2 0.0036 0.0036 22 (18, 26) 86 (78, 94) 267 (197, 356)
9 S. aureus 0.1 0.0018 0.0018 13 (10, 16) 100 (86, 114) 226 (173, 315)
10 S. agalactiae 1 0.0068 0.0011 66 (59, 73) 118 (111, 125) 95 (80, 117)
14 S. agalactiae 0.55 0.0037 0.0006 24 (19, 29) 369 (309, 442) 121 (88, 185)
17 S. agalactiae 0.25 0.0017 0.0003 10 (8, 13) 569 (462, 711) 154 (76, 348)
18 S. uberis (c) 1 0.0155 0.0011 51 (45, 56) 37 (34, 41) 114 (86, 156)
21 S. uberis (c) 0.8 0.0124 0.0009 15 (10, 20) 80 (69, 91) 175 (116, 281)
24 S. uberis (c) 0.5 0.0078 0.0006 6 (4, 9) 106 (89, 127) 191 (144, 259)
26 S. uberis (e) 1 0.0155 0.0011 58 (52, 66) 28 (27, 29) 267 (259, 276)
27 S. uberis (e) 0.1 0.0016 0.0001 31 (27, 35) 67 (63, 71) 306 (274, 344)
33 S. uberis (e) 0.01 0.0002 0.000 01 6 (4, 9) 109 (92, 130) 172 (144, 211)
Table 1: Median per case costs (with 5% and 95% percentiles) for subclinical and clinical IMI in € per year (mean over 5 years)
in one pathogen scenarios. Scenarios marked in gray are also presented in Manuscript II. Numbers are rounded.
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abstract
Intramammary infections (IMI) in dairy cattle lead to economic
losses for farmers, both through reduced milk production and
disease control measures. We present the first strain-, cow- and
herd-specific bio-economic simulation model of intramammary
infections in a dairy cattle herd. The model can be used to inves-
tigate the cost-effectiveness of different prevention and control
strategies against IMI. The objective of this study was to de-
scribe a transmission framework, which simulates spread of IMI
causing pathogens through different transmission modes. These
include the traditional contagious and environmental spread
and a new opportunistic transmission mode. In addition, the
within-herd transmission dynamics of IMI causing pathogens
were studied. Sensitivity analysis was conducted to investigate
the influence of input parameters on model predictions. The re-
sults show that the model is able to represent various within-herd
levels of IMI prevalence, depending on the simulated pathogens
and their parameter settings. The parameters can be adjusted
to include different combinations of IMI causing pathogens at
different prevalence levels, representing herd-specific situations.
The model is most sensitive to varying the transmission rate
parameters and the strain-specific recovery rates from IMI. It can
be used for investigating both short term operational and long
term strategic decisions for the prevention and control of IMI in
dairy cattle herds.
key words: mastitis, mathematical model, cow-specific,
pathogen-specific
ii.1 introduction
Mastitis or intramammary infection (IMI) is one of the most fre-
quent and costly diseases in dairy herds, where costs arise from
both milk loss and control measures (Halasa et al., 2007; Seegers
et al., 2003). They can be caused by many different pathogens,
traditionally differentiated into environmental and contagious.
Contagious pathogens are thought to be transmitted during the
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milking process (Harmon, 1994). They can cause outbreaks, in-
fecting many animals in a short period of time resulting in high
incidence rates (Zadoks et al., 2001a). In contrast, environmental
pathogens are considered to be transmitted, among other things,
through reservoirs in the stable and to have an endemic nature,
associated with low incidence rates (Blowey and Edmondson,
2010; Zadoks et al., 2001a).
Traditionally, Staphylococcus aureus and Streptococcus agalactiae
are examples for contagious pathogens, while Escherichia coli and
Streptococcus uberis are considered as environmental. However,
Zadoks et al. (2001a) described how S. uberis caused an outbreak
like situation, suggesting that this particular pathogen strain
was transmitted contagiously, indicating that differentstrains can
have different properties. Consequently, control strategies should
take the differences (in spread and recovery following treatment)
between strains of the same pathogen species into account to be
effective. Moreover, some pathogen strains may create reservoirs
in the environment and yet express contagious transmission be-
tween cows, reflecting an “opportunistic” behavior that combines
both contagious and environmental characteristics (Jørgensen et
al., 2016). In order to capture this more differentiated behavior,
we introduce a new transmission mode with both contagious and
environmental characteristics at the same time, in contrast to a
purely contagious or purely environmental transmission. In the
model S. agalactiae is used as an example for the opportunistic
nature of IMI causing pathogens.
Simulation models of IMI have previously been used to inves-
tigate the impact of different management strategies against IMI
(e.g. Allore et al., 1998; van den Borne et al., 2010a; Hagnestam-
Nielsen and Østergaard, 2009; Halasa et al., 2010; Østergaard
et al., 2005; Steeneveld et al., 2011). Some of these models have
been pathogen-specific, taking traditional transmission modes be-
tween pathogens into account (Halasa et al., 2009a, 2010). Others
were cow-specific, taking risk factors for infection into account
(Allore et al., 1998), or focusing on characteristics of the single
cow (Steeneveld et al., 2011); or herd-specific, looking into differ-
ences between herds such as herds having different pathogens
(Østergaard et al., 2005). However, to our knowledge, no previous
models have been simultaneously strain-, cow- and herd-specific.
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The model we propose considers the spread dynamics not only
on species level, but also specifically distinguishes between dif-
ferent strains of the same species, for instance allowing future
economic assessment of strain-specific diagnostics, perhaps on
farm level. It includes the characteristics of the single cow for
infection, recovery following potential treatment, and its future
production potential, allowing a comparison of a cow to its herd
mates, while modelling IMI transmission on quarter level. This al-
lows investigating cost-effectiveness of control actions on quarter
level, such as blinding (drying off) chronically infected quarters.
In addition, the model includes differences between herds such
as size, production and management. It is thus strain-, cow- and
herd-specific and can be used as a tool to examine both short
and long term decisions to prevent and control IMI for individ-
ual cows in individual herds, which is to our knowledge not
available in previous bio-economic models.
The objective of this study is to describe a new transmission
framework of IMI causing pathogens, including a new oppor-
tunistic transmission mode.
ii.2 materials and methods
ii.2.1 Model framework
This study was conducted with the MiCull model (Mastitis-iCull),
version 1.0. The model framework was created by combining
an extension of the transmission framework for IMI created by
Halasa et al. (2009a) with the iCull simulation model of a dairy
herd described by Kirkeby et al. (2016), using R version 3.2.2 –
“Fire Safety” (R Core Team, 2016).
The base iCull model is a stochastic mechanistic bio-economic
model that simulates a dairy herd using single-day time steps
to allow for both operational and strategic decision making
(Kirkeby et al., 2016). In brief, the model simulates a dairy cattle
herd in five different physical herd compartments: calves, heifers,
lactating cows, dry cows and calving area. Each cow spends a
random (drawn from a given distribution) predefined number
of days in each compartment before moving on to the next, with
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the exception of possible removal from the herd by culling or
slaughter decisions (see II.2.3). Lactation curves and somatic cell
count (SCC) curves are modelled for every cow and depend on
cow-specific parameters, indicating the individual level relative
to the mean in the herd (Græsbøll et al., 2016). Feeding is depen-
dent on the life stage of each animal, and for lactating cows it is
modelled based on the amount of milk produced (Kirkeby et al.,
2016).
In the present MiCull model, lactation and SCC curves, as well
as farmer decisions, were adjusted to include IMI related factors
as described below. The transmission framework for IMI includes
environmental (constant infection probability), contagious (in-
fection probability depends on the number of infected quarters),
and opportunistic (infection probability depends on the number
of infected quarters or the presence of bacteria in the environ-
ment) transmission on quarter level, cow-specific infection and
recovery, and different strains of the same pathogen.
ii.2.2 Pathogen transmission
Pathogen transmission occurs on quarter level, i.e. between the
quarters of dairy cows in a herd, independent of whether two
quarters belong to the same or different cows. Each quarter can
be in one of three infection states, susceptible (S), subclinically
infected (Is), and clinically infected (Ic), or it can be blinded
(NA). At the moment, the model includes 5 different pathogen
strains for demonstration purposes (Table II.1). Other pathogens
or updated pathogen parameters can be easily added. New
infections with IMI causing pathogens are handled differently
for milking cows, dry cows and heifers as described below.
Susceptibility
The MiCull model is cow-specific, including in the infection
process in lactating cows. Risk factors, such as parity and pre-
vious cases of clinical IMI (quarter-level), are used to adjust the
susceptibility for IMI of a cow (Zadoks et al., 2001b). Cows in
their first parity and quarters without prior IMI are taken as
reference, and the risk ratios for cows in the second and third or
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Figure II.1: Diagram of the transmission framework used in the simu-
lation model.
higher parity (RR(parity)), as well as for quarters with prior in-
fections (RR(prior)) are calculated (mean of S. aureus and S. uberis,
Zadoks et al., 2001b). The product of all risk ratios pertaining to
a quarter q is then used to adjust the susceptibility Suscq of the
quarter for new IMI, Suscq = RR
(parity)
q · RR(prior)q . In equation
(1), the susceptibility leads to an adjustment of the transmission
rate, depending on cow parameters, thus leading to cow-specific
infection.
Lactating cows
For lactating cows, all transitions between the three infection
states are modelled (Figure II.1). The probability of infection for
each quarter includes the susceptibility and is thus cow-specific.
In the model, all pathogen strains are identified by a unique
strain ID (strain), and active pathogens are marked as such. Infec-
tions can occur for all active strains, and the respective infection
probabilities p(strain)q are calculated for all quarters q every
day/time step, depending on the transmission mode, see equa-
tion (1). In the equation, all parameters except the susceptibility
factor Suscq (see II.2.2) and the total number of quarters N de-
pend on the pathogen strain, which is not specifically notated in
(1) for easier readability, it will however be noted in the text (e.g.,
β(strain) instead of β).
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p
(strain)
q =

1− exp(−β ·Suscq) (environmental),
1− exp
(
−β · IN ·Suscq
)
(contagious),
1− exp
−β ·
(1−ε)·I+ε·η·
∑di=1 0.01i·d−1 ·Ii∑d
i=1 0.01
i·d−1 +θ

N ·Suscq
 (opportunistic).
(1)
β(strain) is the transmission rate of that pathogen strain. For
environmental strains, the infection probabilities only depend
on the respective transmission rates. I(strain) = I(strain)S +
I
(strain)
C (see Figure II.1) is the number of quarters (in lactating
cows) already infected with a specific pathogen strain at the
beginning of the current time step t0. A higher number of
infected quarters I(strain), increases the infection probability for
contagious and opportunistic strains. I(strain)i is the number
of quarters that were infected with a strain at the end of time
step t0 − i. It is taken into account in the environmental part of
opportunistic transmission, where the pathogen strain decays in
the environment for d(strain) days until 1% of the initial bacteria
remain and then disappear. The environmental share is given by
ε(strain), while η(strain) is an additional scaling factor for the
infectiousness of the strain’s environmental part compared to its
contagious part. θ(strain), representing a purely environmental
factor (e.g., introduction by humans), allows (re)infection with a
strain that is not present in the cows nor the environment of the
herd. All parameter values can be found in Table II.1.
The probabilities p(strain)q of the active pathogens are com-
bined by
p
(total)
q = 1−
∏
(1− p
(strain)
q ), (2)
and each previously uninfected quarter gets infected with this
probability. The infecting pathogens are then drawn according to
their relative risk. Infected quarters are allocated to I(strain)S or
I
(strain)
C depending on the probability P
(strain)
c (Table II.1).
At each new time step, previously subclinically infected quar-
ters in IS have the chance to flare up or spontaneously recover
(Figure II.1) with a certain pathogen-specific probability (Table
II.1). The clinically infected quarters are subjected to a three day
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Parameter Description Pathogen Value Reference
Transmission
rate (β)
Rate for susceptible
animals entering
subclinical or clinical
state
S. aureus 0.0179* Zadoks et al. (2002)
S. agalactiae 0.0068 Leelahapongsathon et al. (2016)
S. uberis (contagious) 0.0155* Zadoks et al. (2001a)
S. uberis (environmental) 0.0155* Zadoks et al. (2001a)
E. coli 0.0001* Barkema et al. (1998)
Probability of
clinical state
(Pc)
Probability of
entering clinical state
when infected
S. aureus 0.17 Swinkels et al. (2005a)
S. agalactiae 0.01* **
S. uberis (contagious) 0.32 Zadoks et al. (2003)
S. uberis (environmental) 0.32 Zadoks et al. (2003)
E. coli 0.85 Hogan and Smith (2003)
Flare up
probability
Probability of
subclinical animals
going to clinical state
S. aureus 0.0081* Swinkels et al. (2005a)
S. agalactiae 0.0005* **
S. uberis (contagious) 0.0068* Swinkels et al. (2005b)
S. uberis (environmental) 0.0068* Swinkels et al. (2005b)
E. coli 0.0035* Döpfer et al. (1999)
Spontaneous
recovery
probability
Base probability of
spontaneous cure for
subclinical animals
S. aureus 0.0064* van den Borne et al. (2010b)
S. agalactiae 0.0023* Leelahapongsathon et al. (2016)
S. uberis (contagious) 0.0143* van den Borne et al. (2010b)
S. uberis (environmental) 0.0143* van den Borne et al. (2010b)
E. coli 0.0221* van den Borne et al. (2010b)
Recovery
probability
Probability of
recovery for clinical
animals that are
treated
S. aureus 0.4 Steeneveld et al. (2011)
S. agalactiae 0.7 Steeneveld et al. (2011)***
S. uberis (contagious) 0.7 Steeneveld et al. (2011)
S. uberis (environmental) 0.7 Steeneveld et al. (2011)
E. coli 0.8 Steeneveld et al. (2011)
ε Environmental share
in opportunistic
transmission
S. agalactiae 0.1 arbitrary
η Scaling factor for in-
fectiousness of envi-
ronmental part in op-
portunistic transmis-
sion
S. agalactiae 1 arbitrary
θ Purely environmen-
tal factor in oppor-
tunistic transmission
S. agalactiae 0 arbitrary
d Number of days the
bacteria survive in
the environment
S. agalactiae 40 arbitrary, more than four weeks
(Jørgensen et al., 2016)
* rounded values
** S. aureus values were adjusted by the factor by which incidence is different in Barkema et al. (1998).
*** used value of Streptococcus dysgalactiae or uberisTable II.1: Rates and probabilities used in the transmission framework
for lactating cows (Figure II.1). All parameters are imple-
mented in daily time steps, for all quarters.
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Parameter Description Pathogen Value Reference
Transmission
rate (βdry)
Rate for susceptible
animals entering
subclinical or clinical
state
S. aureus 0.0179* **
S. agalactiae 0.0011* ***
S. uberis (contagious) 0.0011* Halasa et al. (2010, 2009c)
S. uberis (environmental) 0.0011* Halasa et al. (2010, 2009c)
E. coli 0.0001* **
Transmission
rate (β(dct)dry )
Rate for susceptible
animals with dry
cow treatment
entering subclinical
or clinical state
S. aureus 0.0005* Halasa et al. (2010, 2009c)
S. agalactiae 0.0003* ***
S. uberis (contagious) 0.0003* Halasa et al. (2010, 2009c)
S. uberis (environmental) 0.0003* Halasa et al. (2010, 2009c)
E. coli 0.0001* **
Probability of
clinical state
(Pc)
Probability of
entering clinical state
when infected
S. aureus 0.1 Halasa et al. (2010)
S. agalactiae 0.1 ***
S. uberis (contagious) 0.1 Halasa et al. (2010)
S. uberis (environmental) 0.1 Halasa et al. (2010)
E. coli 0.1 Halasa et al. (2010)
Flare up
probability
Probability of
subclinical animals
going to clinical state
S. aureus 0.006* Halasa et al. (2010)
S. agalactiae 0.0005* **
S. uberis (contagious) 0.004* Halasa et al. (2010)
S. uberis (environmental) 0.004* Halasa et al. (2010)
E. coli 0.0035* **
Spontaneous
recovery
probability
Probability of
spontaneous cure for
subclinical animals
S. aureus 0.0079* Halasa et al. (2010)
S. agalactiae 0.0086* ***
S. uberis (contagious) 0.0086* Halasa et al. (2010)
S. uberis (environmental) 0.0086* Halasa et al. (2010)
E. coli 0.0221* **
Recovery
probability
Probability of
recovery for clinical
animals with dry
cow treatment
S. aureus 0.77 Halasa et al. (2010, 2009b)
S. agalactiae 0.89 ***
S. uberis (contagious) 0.89 Halasa et al. (2010, 2009b)
S. uberis (environmental) 0.89 Halasa et al. (2010, 2009b)
E. coli 0.9 Halasa et al. (2010, 2009b)
* rounded values
** same value as during lactation
*** value of Streptococcus spp.Table II.2: Rates and probabilities used in the transmission framework
for dry cows (Figure II.1), probability of clinical state, flare
up and spontaneous recovery were taken from Halasa et al.
(2010), who recalculated them from Bradley and Green (2004)
and Green et al. (2005). All parameters are implemented in
daily time steps, for all quarters.
treatment (default) with antibiotics, they will thereafter either
recover or persist as subclinical cases (remission) (Figure II.1).
The probability for recovery depends on the causative pathogen
and is cow-specific, according to Steeneveld et al. (2011) (Table
II.1 shows the base probability).
The model includes the possibility to scale transmission rate,
flare up probability, and spontaneous recovery probability by
any factor, and to replace the probability P(pathogen)c that a new
infection will be clinical by another value.
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Dry cows
For dry cows, IMI will generally be or stay subclinical, except in
the first or last week of the dry period, where clinical IMI can
also occur.
New infections in dry cows can occur for every active strain.
Contagious strains are considered active, if at least one quarter
of one cow in the herd is infected with that particular strain.
Similarly, opportunistic strains are considered active, if they are
still present in the herd or if they have a non-zero purely environ-
mental element θ(strain). This is important, as the probability of
infection is calculated according to
p(strain) = 1− exp
(
−β
(dct,strain)
dry
)
(3)
for every active pathogen strain, where β(dry,strain)dry is depend-
ing on both the pathogen and whether the cow was treated with
dry cow therapy or not (Table II.2). Note that the infection prob-
ability in the dry period is the same for all quarters and not
cow-specific. The probabilities of the active pathogens are com-
bined by (2). Each previously uninfected quarter gets infected
with this probability. The infecting pathogens are then drawn
according to their relative risk. Infected quarters are allocated
to I(strain)S or, if the cow is in the first or last week of the dry
period, to I(strain)S or I
(strain)
C depending on the probability
P
(strain)
c,dry (Table II.2).
Similar to lactating cows, subclinically infected quarters in dry
cows can flare up or spontaneously recover (Table II.2), however
flare up can only happen in the first or last week of the dry
period.
Additionally, a cow with a flared up quarter in the first week
after dry off will receive dry cow treatment. Dry cow quarters
change their status from IC to IS or S after the same number
of days as for clinical cases in lactating cows. Here, dry cow
treatment influences the probability of recovery for the clinical
quarter (Table II.2). For clinical quarters in the last week of the
dry period, the probability for recovery is calculated similarly
as for lactating cows, only without regarding somatic cell count
(SCC) and days in milk.
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As for lactating cows, transmission rate, flare up probability,
and spontaneous recovery probability can be scaled and the
probability P(strain)c,dry that a new infection will be clinical can be
replaced.
Heifers
Currently, there is no dynamic pathogen transmission in heifers,
i.e. cows prior to their first calving. Instead, each pathogen
strain has a certain probability to infect heifers (Table II.2). These
probabilities are added up for the active pathogens to a total
probability for heifers to be assigned to IS one day before calving.
The pathogens are then drawn depending on their part of the
total probability.
ii.2.3 Production effects and economy
Feeding
Cows are often fed roughage as basic feed plus concentrate to
facilitate a higher milk production. To our knowledge, no studies
have explicitly estimated the decrease in feed due to IMI. In
this model, the feed usage per lactating cow is a function of the
energy-corrected milk (ECM) produced, corresponding to €0.1852
per ECM (following Kirkeby et al., 2016). Therefore, cows with
subclinical and clinical IMI automatically have a decreased feed
intake because their milk production is decreased, as described
below in sections II.2.3 and II.2.3. The model also includes an
additional option to simulate a farmer who feeds only roughage
without concentrate to cows that have their milk withdrawn due
to antibiotic treatment, as described in Halasa et al. (2009a). For
those cases, a proportion of the feed costs is subtracted to account
for lower concentrate usage. By default, however, this option is
disabled.
Milking
The daily milk yield is calculated for lactating cows (Kirkeby et al.,
2016). However, differing from the iCull model, the income from
milk is now dependent on the fat and protein content. Using the
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data set described in Kirkeby et al. (2016), we estimated the daily
mean protein percentage for all cows, depending on days in milk
(DIM) and parity (1, 2 and 3+), and fitted a three parameter Wood
curve to each cow and parity in the data set (see Græsbøll et al.,
2016). Based on the same data set, we estimated distributions for
the fat to protein ratio per parity. In the simulation model, each
cow is assigned three parameters for the Wood curve to describe
the protein percentage and, for each simulated day, the protein
content is calculated based on the cow’s DIM. A fat to protein
ratio is then drawn from the respective distribution for each cow
and used to calculate the daily fat yield based on the milk yield
and protein percentage.
The income from milk is given by summing the income from
fat and protein, withdrawing a milk handling fee based on the
daily kg milk yield and multiplying with a penalty or bonus
factor, depending on the bulk tank SCC (Table II.3).
Parameter Value Description Reference
Antibiotic treatment
period
3 Number of days in antibiotic
treatment, milk from treated
cows is discarded.
Steeneveld et al. (2011)
Milk withdrawal pe-
riod
6 Number of days after antibiotic
treatment where the milk from
treated cows is discarded.
van den Borne et al. (2010a),
Michael Farre pers. comm.
Acute mastitis proba-
bility
0.01 Probability for a cow to get
acute mastitis, when it gets clin-
ical mastitis.
Michael Farre pers. comm.
Antibiotic treatment
cost
€33.3 Cost for antibiotic treatment of
one cow, not including vet visit
or farmer labor.
Michael Farre pers. comm.
Dry cow therapy cost €9.6 Cost for dry cow therapy for
one cow, which includes teat
sealants in 20% of the cases.
Michael Farre pers. comm.
Opportunity costs €20 Opportunity costs for treatment
of one cow with clinical masti-
tis.
Halasa et al., 2009a, Michael
Farre pers. comm.
Protein price €5.8132 Price for 1kg protein www.arla.dk, September 2017
Fat price €4.1519 Price for 1kg protein www.arla.dk, September 2017
Milk handling fee €0.0001343 Fee for handling 1kg milk www.arla.dk, September 2017
Culling costs ca. €500 Costs for culling one cow (price
of a new heifer minus slaughter
value)
Huijps et al. (2008)
Table II.3: Model parameters related to IMI treatment, culling, and
milk price.
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Subclinical IMI
Subclinically infected animals are subject to an increased SCC.
For every subclinical quarter, an increase in the SCC is added
to the generic simulated SCC, according to Schepers et al. (1997,
Table 1) and Wilson et al. (1997, Table 2, used for scaling missing
pathogens). If more than one quarter of a cow is subclinically
infected, the maximum increase is added; however, the SCC is
cut off at a maximum of 10, 000, 000 as higher SCC values are
rarely observed and for numeric stabilization. The increased SCC
in these subclinically infected animals also leads to a higher bulk
tank SCC, which is calculated as the weighted mean SCC in the
total daily amount of milk produced. The milk price, in turn,
is dependent on the bulk tank SCC, as a bulk tank SCC up to
200, 000 will result in a 4% bonus, while a bulk tank SCC above
500, 000 will result in the maximal penalty of 10% (see Kirkeby
et al., 2016).
Linked to an increased SCC in subclinically infected cows is
milk loss, and as the SCC varies daily for each cow, so does the
milk loss. We used the estimates given in Hortet et al. (1999) to
reduce the milk yield of each cow with at least one subclinical
quarter according to SCC, DIM (except for primiparous cows)
and parity (primiparous or multiparous, where we used the esti-
mates for parity 1 or 3+ cows, respectively), see supplementary
Figure II.S7. The milk loss per cow is restricted to 2kg, which
corresponds to the maximal loss in parity 3+ within the limits of
Hortet et al. (1999).
Clinical IMI
Clinical mastitis can reduce a cow’s milk production even after
the cow is not clinical anymore (Gröhn et al., 2004). We used
Gröhn et al. (2004) estimates for milk loss following clinical
infection to fit logarithmic functions to the amount of milk lost
for each pathogen type and for primiparous and multiparous
cows. As a logarithmic function did not seem to be a suitable fit
for primiparous cows with clinical IMI caused by Streptococcus
spp., we fitted in this case a linear function truncated at zero
(Figure II.S9). The respective milk loss is added throughout the
whole lactation to the cow’s produced milk, starting on the first
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day of clinical infection. An example of the milk loss is given in
Figure II.S8.
When a cow gets a clinical IMI, it is treated. In the model,
the default option comprises three days of antibiotic treatment,
during which and for six days afterwards the cow’s milk is with-
drawn and discarded (Table II.3). Treatment costs are based on
expert opinion on Danish herds (see Table II.3) and are compa-
rable to the numbers given in Halasa et al. (2009a). They are
divided into the costs of the antibiotics (€33.3) and opportunity
costs (€20), which include the time the farmer has to spend on
cows with clinical IMI (Table II.3).
Dry cow therapy
Dry cow therapy is the treatment of cows with long lasting
antibiotics at dry off. In the model, the default option applies
antibiotic treatment only to cows that get a clinical IMI during
the first week of dry off to study the dynamics of IMI without the
influence of specific dry cow management. Other options include
different selection strategies for selective dry cow therapy: cows
with a history of clinical IMI, cows with a high SCC at the last
monthly milk yield recording, cows with either of those options,
and blanket dry cow therapy.
Culling
In the model, culling happens on a weekly basis. If there are
more than 200 lactating cows, the farmer will cull the excess
number of cows. About half of the culled cows are chosen
randomly, those are the cases that have to be culled e.g. because
of lameness. The others are chosen by the farmer from a culling
list, where (s)he prioritizes the animals for culling, e.g. cows with
production in the bottom 20%, with insemination difficulties, or
with a high SCC at the last monthly milk yield recording, by
applying weights for every unfavorable circumstance to each
cow (Kirkeby et al., 2016). For every high SCC (> 200, 000) at
subsequent monthly milk yield recordings, the respective cows
will be increasingly prioritized, with a low SCC resetting this
prioritization. After 12 months with a continuously high SCC,
cows will be culled at the first possibility, though the default
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value of 12 months can be easily changed to reflect different
management strategies.
As subclinical IMI causes an increase in the SCC, cows with
subclinical IMI have a higher probability to be prioritized for
culling because of a high SCC. Cows with previous clinical IMI
also have a higher probability of being chosen for culling than
their herd mates. Bar et al. (2008a) found that the odds ratios for
primiparous cows being culled were 7.46, 16.12 and 20.08, if they
had 1, 2 or> 3 clinical mastitis cases, respectively (exponentiating
values of Table 4 in Bar et al., 2008a); for multiparous cows the
respective odds ratios were 3.74, 5.00 and 6.36. We used these
values to apply weights to the culling decision made by the
farmer, with multiparous cows with one previous clinical IMI
receiving a weight of 1 and the other mentioned cases receiving
weights scaled to reflect the ratios found in Bar et al. (2008a).
Furthermore, it can happen, that a cow gets flagged for an acute
IMI when it becomes clinical (Table II.3). These cows will be put
on top of the culling list, from which the farmer chooses in the
weekly culling.
Prioritization for culling is therefore: involuntary cases, cows
with acute IMI, cows with a continuously high SCC, cows with
the highest weight for culling.
The costs of culled animals are calculated as the costs for
raising a replacement heifer for each cow that is culled (to two
years of age, €510), minus the slaughter value the farmer gets for
the culled cow (€51).
Model outputs
The epidemiological model output consists of daily cow level
prevalences, as well as the total number of flare ups, remissions,
subclinical, and clinical IMI for each simulation. Furthermore,
it includes the total number of culled cows due to acute IMI,
subclinical IMI and a history of clinical IMI. Culling due to sub-
clinical IMI includes all culled cows with at least one subclinically
infected quarter that were prioritized for culling because of a high
SCC. To avoid counting a culled cow several times, culling due
to the cow having a history of clinical IMI includes only cases in
which the cow did not have a high SCC at the last monthly milk
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yield recording. Cows culled because of acute IMI are counted
separately.
The economical model output includes the total milk loss in kg
due to subclinical or clinical IMI (both milk loss and withdrawal),
as well as the total income from milk and the mean milk price
penalty percentage (see sections II.2.3, II.2.3, and II.2.3). As the
fat and protein percentages for lost milk are not calculated, a
mean milk price of around €0.4099 per kg is used to calculate
costs for milk loss (mean Arla milk price in September 2017). The
mean milk price penalty value together with the total income
from milk is used to calculate the possible penalty paid due to a
high bulk tank SCC. Further economic output includes expenses
for treatment of clinical IMI as described above (II.2.3), as well as
costs for dry cow therapy (Table II.3).
ii.2.4 Model validation
Several methods for internal validation were used on the model
(Sargent, 2003). Rationalism, including operational graphics: various
scenarios were compared to check consistency and credibility
of model outputs. Traces: single cows were traced over time
to check for consistency. Face validity: model assumptions and
outputs were evaluated by mastitis experts. External validation
was conducted by comparing model predictions to the literature,
as data to validate such a complicated model is not available.
Model convergence
We tested model convergence on two parameters by simulat-
ing 1000 iterations. In a scenario without any IMI causing
pathogens, we tested convergence of the energy corrected milk
yield (ECM), and in a scenario with three pathogens (using de-
fault parameters taken from literature, see Table II.1), we tested
convergence on the number of clinical cases. In both cases visual
inspection showed that 500 iterations were sufficient to obtain
stable results (Figure II.S6). Further visual inspections showed
that after five simulated years herd, population, and transmis-
sion dynamics were always stable, warranting a five year burn-in
period.
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Sensitivity analysis and model runs
We performed sensitivity analysis on a herd with 200 cows, using
500 simulations of 5 years, with a burn-in time of an additional 5
years. All scenarios were initiated with a 20% starting prevalence
for all pathogen strains, with the exception of environmental
strains in multiple pathogen scenarios, where the starting preva-
lence was set to 10%. These values are arbitrary and were chosen
only for presentation of the model.
Sensitivity analyses were carried out on the transmission rate
(β), the spontaneous recovery probability, the probability that
a newly infected animal becomes a clinical IMI case (Pc), the
flare up probabilities, the environmental part of the opportunis-
tic pathogen (ε), and the number of days the opportunistic
pathogen can survive in the environment (d). For the trans-
mission rate parameter, various scaling factors (all < 1, except
for E. coli where factors > 1 were considered) were considered
in the sensitivity analysis; selected values are presented in Table
II.4. Sensitivity analysis for the spontaneous recovery probabil-
ity consisted of several scaling factors between 0.25 and 2. For
the other parameters, sensitivity analyses focused on the actual
value instead of the scaling factor: Pc and flare up probability
were varied between 0.01 and 0.85 and between 0.0002 and 0.02,
respectively. The parameter ε in opportunistic transmission was
varied between 0 and 1, while d was reduced down to 10 days in
increments of 5 days.
To obtain insight into how the model would simulate the
dynamics of pathogen spread, a great number of scenarios were
run in the sensitivity analyses, of which only a few with different
transmission rates were selected and presented here. In the
supplementary material, more scenarios were included.
ii.3 results
The methods used for internal validation showed valid and con-
sistent outcomes of the model in all scenarios. As an illustration,
nine scenarios were selected. These include four one pathogen
scenarios for different pathogens, four two pathogen scenarios
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Scenario Pathogens
Transmission rate
scaling factor Transmission rate
Transmission rate
(dry cows)
7 S. aureus 0.2 0.003,6 0.003,6
9 S. aureus 0.1 0.001,8 0.001,8
14 S. agalactiae 0.55 0.003,7 0.000,6
21 S. uberis (contagious) 0.8 0.012,4 0.000,9
49 S. aureus 0.25 0.004,5 0.004,5
S. agalactiae 0.5 0.003,4 0.000,6
56 S. aureus 0.25 0.004,5 0.004,5
S. uberis (contagious) 0.5 0.007,8 0.000,6
68 S. agalactiae 0.5 0.003,4 0.000,6
S. uberis (contagious) 0.5 0.007,8 0.000,6
88 S. uberis (contagious) 0.5 0.007,8 0.000,6
S. uberis (environmental) 0.01 0.000,2 0.000,01
98 S. aureus 0.25 0.004,5 0.004,5
S. agalactiae 0.5 0.003,4 0.000,6
S. uberis (contagious) 0.5 0.007,8 0.000,6
S. uberis (environmental) 0.01 0.000,2 0.000,01
E. coli 1 0.000,1 0.000,1Table II.4: Selected scenarios. All pathogens start with a 20% preva-
lence, except in the five pathogen scenario (98), where the
environmental strains start with a 10% prevalence. Trans-
mission rates are rounded.
with different pathogen combinations, and one five pathogen
scenario with all pathogens (Table II.4). Scenarios where exact
literature values were used as transmission parameters, led to
high prevalences in our setting (results not shown). Therefore,
the selected scenarios used adjusted transmission rates, leading
to more realistic prevalence estimates (Figures II.2, II.3, and II.4).
Figure II.2 shows selected scenarios with one active pathogen.
The starting prevalence is set to 20%, and during the burn-in
period it fluctuates depending on the pathogen strain (i.e. the
combination of all transmission parameters, see scenarios 7, 14,
and 21, Figure II.2), or changes depending on the transmission
rate (scenarios 9 and 7, Figure II.2). After the burn-in period, the
prevalence has reached a mostly stable level.
The model also allows coexistence of multiple pathogens or
strains, regardless of their transmission mode, on different
prevalence levels, depending on the scaling of the transmission
parameters (Figures II.3 and II.4). Scenario 49 and 56 show two
pathogen scenarios, where the active pathogen strains are S. au-
reus and S. agalactiae or a contagious S. uberis, respectively. The
transmission rate for S. aureus is the same in both scenarios, how-
ever the mean daily prevalence is higher in scenario 56, where
the second active pathogen is present at a low level. In scenario
68, S. agalactiae and the contagious S. uberis strain are coexisting
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Figure II.2: Cow level prevalences in one pathogen scenarios 7, 9, 14,
and 21, see Table II.4. Every scenario shows smoothed daily
prevalences for each of 500 iterations over 5 years with a 5
year burn-in period (with one random iteration displayed
in gray), as well as the mean daily prevalence (bold, black).
The bottom lines show the daily prevalences of clinical IMI,
with the mean displayed as a dashed line.
Figure II.3: Cow level prevalences in two pathogen scenarios 49, 56, 68,
and 88, see Table II.4. Every scenario shows smoothed daily
prevalences for each of 500 iterations over 5 years after a 5
year burn-in period (with one random iteration displayed
in gray), as well as the mean daily prevalence (bold, black).
The bottom lines show the daily prevalences of clinical IMI,
with the mean displayed as a dashed line.
at similar levels to scenario 49 and 56, respectively. Scenario 88
(Figure II.3) shows another scenario with two active pathogen
strains, in this case a contagious and an environmental strain of
S. uberis. Both strains are present at a similar prevalence, with a
higher variation for the contagious strain.
Scenario 98 shows a five pathogen, which also includes both a
contagious and an environmental strain of S. uberis together with
contagious S. aureus, environmental E. coli, and opportunistic
S. agalactiae (Figure II.4). The contagious strains have the same
transmission rate as in the two pathogen scenarios and are at
similar daily prevalence levels. The opportunistic S. agalactiae
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Figure II.4: Cow level prevalences in the five pathogen scenario see
Table II.4, scenario 98. It shows the smoothed daily preva-
lences for each of 500 iterations over 5 years after a 5 year
burn-in period (with one random iteration displayed in
gray), as well as the mean daily prevalence (bold, black).
The bottom lines show the daily prevalences of clinical IMI,
with the mean displayed as a dashed line.
Scenario Flare up Remission subclinical IMI clinical IMI
7 120 (101, 140) 113 (95, 134) 258 (228, 293) 134 (113, 157)
9 44 (36, 53) 40 (32, 48) 98 (84, 112) 47 (38, 57)
14 7 (4, 10) 4 (2, 6) 77 (51, 107) 8 (5, 12)
21 78 (57, 114) 72 (49, 110) 244 (174, 363) 149 (105, 225)
49 172 (147, 200) 164 (138, 192) 436 (385, 498) 196 (167, 227)
56 221 (197, 257) 209 (186, 247) 482 (437, 551) 264 (237, 306)
68 33 (27, 40) 22 (17, 28) 139 (112, 171) 46 (38, 56)
88 58 (50, 67) 45 (37, 53) 136 (120, 156) 94 (82, 108)
98 261 (232, 294) 250 (221, 284) 693 (640, 752) 370 (333, 410)Table II.5: Epidemiological output in median number (with 5% and
95% percentiles) of quarter cases per year (mean over 5 years)
of the scenarios in Table II.4. Numbers are rounded.
strain also has the same transmission rate as in the two pathogen
scenarios, but the prevalence level has increased.
The epidemiological output in Table II.5 shows the number of
quarter cases per year (median over 500 iterations and mean over
5 years simulation period); in the multiple pathogen scenarios,
numbers are summed over all pathogens. The number of subclin-
ical IMI includes all remission cases, while the number of clinical
IMI includes all flare up cases. Also, one cow may be counted
more than one time for the same infection, e.g. if a clinical quar-
ter went into remission and flared up again afterwards. For S.
agalactiae, most clinical IMI are flared up subclinical cases and
there are few clinical IMI, if the prevalence is at moderate levels
(scenario 14). In contrast, the contagious S. uberis strain leads to
many more clinical cases, both flared up and directly infected
(scenario 21).
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Scenario high SCC acute IMI history of IMI
7 22 (18, 26) 1 (0, 2) 3 (2, 4)
9 13 (10, 16) 0 (0, 1) 2 (1, 3)
14 24 (19, 29) 0 (0, 0) 0 (0, 1)
21 15 (10, 20) 1 (0, 2) 4 (3, 6)
49 48 (41, 55) 1 (1, 2) 2 (1, 3)
56 35 (30, 39) 2 (1, 3) 3 (2, 4)
68 27 (21, 33) 0 (0, 1) 2 (1, 3)
88 10 (7, 13) 1 (0, 1) 5 (3, 6)
98 68 (60, 76) 2 (1, 3) 2 (1, 4)Table II.6: Median number (with 5% and 95% percentiles) of culled
cases per year (mean over 5 years) of the scenarios in Table
II.4, see section II.2.3 for culling categories. Numbers are
rounded.
Table II.6 shows the number of culled cows per year (median
over 500 iterations and mean over 5 years simulation period);
acutely culled cows, subclinical cows that were culled with a
noticeable high SCC, and culled cows with a history of clinical
IMI. Most cows that are culled because of IMI related reasons are
connected to a high SCC, though the number and proportion of
cows culled with subclinical IMI or a history of clinical IMI also
depends on the causative pathogen.
The costs associated with subclinical and clinical IMI can be
found in the supplementary Tables II.S1, II.S2, and II.S3.
Further sensitivity analyses showed that the probability of
spontaneous recovery for subclinical cases is similarly influential
on the prevalence as the transmission rate (Figure II.S1): with
a higher probability of spontaneous recovery, the prevalence
decreases.
Sensitivity analysis for the probability for a newly infected
quarter to be clinical (Pc, Table II.1) showed that for S. agalactiae
and the contagious strain of S. uberis an increased proportion of
clinical cases leads to a decreased prevalence, while this effect
was less observable in the environmental pathogens and S. aureus
(Figure II.S2). Similarly, the higher the flare up probability is, the
lower the prevalence becomes (Figure II.S3).
If the environmental part ε in the opportunistic infection is
increased, the prevalence increases, too, ranging from a mean of
17.8% with pure contagious infection (ε = 0) to a mean of 30.3
without any contagious part (ε = 1) after 10 years. This effect is
not visible, if the prevalence is low (< 5%, Figure II.S4).
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Reducing the number of days d the opportunistic pathogen
can survive in the environment showed marginal effects on
model outcome, which is expected due to how the bacterial
survival is weighted.
ii.4 discussion
The described model simulates a dairy cattle herd on daily ba-
sis, including the spread of IMI causing pathogens within the
herd. It also includes various treatment variants for IMI, that will
be investigated for cost-effectiveness in following studies. The
aim of this study was to describe the model, including a new
opportunistic transmission mode. With the historical view of
purely contagious and purely environmental pathogens being
questioned (e.g., Jørgensen et al., 2016; Zadoks et al., 2001a), we
think that this feature is an important step in modelling IMI
spread, representing both the possibility of strain specific trans-
mission properties and recent suggestions of S. agalactiae’s po-
tential opportunistic behaviour. The opportunistic transmission
mode combines both contagious (via milking) and environmental
transmission in one strain, as indicated by Jørgensen et al. (2016).
The contagious part of this new feature was transferred from pre-
viously already implemented contagious transmission (Halasa
et al., 2009a). The environmental part represents the decay of
the pathogen in the environment over time. Using an exponen-
tial function to represent the decay of infectious agents in the
environment is not unusual, although slope of decline may differ
for different pathogens (e.g., Halasa et al., 2016; Whiting et al.,
1996). Still, implementing it for S. agalactiae should be acceptable.
The infection probability depends on three main elements, in
addition to the basic transmission rate; the contribution of the
environment, the slope of decay, and the duration of pathogen
survival in the environment. The latter has been approximated
based on literature (Jørgensen et al., 2016), but the two other
elements are lacking actual data from the field. We speculate that
the impact of the environmental part is strain-specific, meaning
that some strains are mainly found in the environment, persisting
there for some time and causing new infections, while others
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mainly spread via the contagious route. The weight of each mech-
anism is unknown, which warrants further research to assess the
influence of the environment on the spread of this pathogen. Our
model allows weighting of the contagious and environmental
parts of pathogen spread, depending on, e.g., the strain type.
Our current parameterization (ε = 0.1) would represent a mainly
contagious spread of the pathogen with occasional transmission
of IMI through the environment. This was done as an illustration
of opportunistic spread in the model. In the future, the effect
of the different parameters must be examined properly, when
simulating the impact of control strategies against IMI caused by
S. agalactiae.
Default values for all transmission parameters were taken
from literature (Tables II.1 and II.2), which led to unrealistically
high prevalences (Figures II.2, II.3, and II.4). This is not sur-
prising, as studies are usually conducted in herds with large
problems or even outbreaks with the specific pathogens. In those
herds, pathogen spread, and thereby the calculated transmission
rates, are high. On top of that, our additional susceptibility factor
Suscq, used to re-scale the transmission rates to include cow-
specific infection, leads to higher infection probabilities in the
model. The estimated transmission rates from the literature do
not consider quarter factors, but instead they are average values
for all quarters. For instance, it is known that the risk of infection
is higher for quarters with previous IMI (Zadoks et al., 2001b).
In order to consider the effect of these factors in the estimation
of infection probability, the transmission rates are multiplied by
the relative risks of quarter factors (the susceptibility factor), and
hence the probability becomes artificially higher than normal. To
represent a realistic situation, it therefore becomes important to
rescale the transmission rates, as the quarter factors should be
taken into account at the same time. Future studies estimating
transmission rates should consider the effects of quarter and cow
factors on the transmission rate, if possible, in order to be able to
accurately model spread dynamics of IMI causing pathogens.
Our results show sensitivity of the prevalence to changes in
transmission rate and other transmission parameters (see Figures
II.S1–II.S4), making the use of the right parameters important. It
is therefore worrisome that estimates of transmission rates are
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scarce and limited to few studies from few herds (e.g., Barlow
et al., 2013; Leelahapongsathon et al., 2016; Zadoks et al., 2001a,
2003). Nevertheless, we decided to include a susceptibility factor
and thereby cow-specific transmission in the model and adjust
transmission, as studies have shown that relevant risk factors
exist (e.g., Zadoks et al., 2001b). As these factors may be pertinent
for management decisions regarding IMI, not including them
would prevent investigating cow-specific management strategies
in the future. Furthermore, as IMI causing pathogens are thought
to be transmitted, among other things, during the milking pro-
cess (Harmon, 1994) or through reservoirs in the environment
(Blowey and Edmondson, 2010; Zadoks et al., 2001a), transmis-
sion rates are dependent on herd related factors. Considering
that there are only few studies estimating these rates, and condi-
tions are prone to change over the years, transmission rates, in
the absence of proper data, will have to be adjusted in some way
to model different IMI situations representing different herds or
management systems. Hopefully, future research can close these
gaps.
Another point regarding transmission is the assumption in
the model that the same transmission rate can be used for trans-
mission to quarters of the same cow or of other cows. When
transmission happens through the milking equipment, for in-
stance, fluctuations in the milking vacuum could, depending
on the milking machine’s claw, lead to a reflux of milk from an
infected quarter into uninfectedbteats (Besier et al., 2016). IMI
can also be transmitted by flies (Owens et al., 1998). A fly would
probably land on a quarter of the same cow before flying away,
possibly leading to a higher risk of within cow spread. Given the
absence of proper data to parameterize this process, the made
assumption seems inevitable. Should this knowledge gap be
closed in the future, different transmission probabilities could be
used for within cow and between cow transmission.
Our results showed expected behavior when parameters were
changed in sensitivity analyses. Different scenarios showed dif-
ferent prevalence patterns, e.g., in scenarios 49 and 56 (Figure
II.3), where the prevalence of S. aureus was higher when the sec-
ond pathogen’s prevalence was lower. In scenario 98 (Figure II.4),
S. agalactiae reached a higher prevalence level than in scenarios
80 Manuscript II
49 or 68 (Figure II.3), even though the transmission rate was
the same, showing a different behavior of opportunistic trans-
mission depending on the prevalence of other IMI pathogens.
An increased total prevalence leads to more quarters having a
higher risk of contracting an IMI, as history of IMI is modelled
as a risk factor for new IMI. This, combined with the fact that S.
agalactiae can build up and persist in the environment, leads to
its increased incidence. The model can thus simulate different
transmission behaviors of pathogens and different herds, which
is necessary to investigate, e.g., how effective a treatment regi-
men is under different circumstances. The economic part of the
model yields comparable results to other models. For instance,
Steeneveld et al. (2007) found an average per case cost of €109 for
subclinical IMI, while our scenario 9 resulted in a median cost of
about €100 per subclinical IMI case II.S1. In the same scenario,
the median cost for a clinical IMI case was around €226, which
is similar to other studies by e.g. Halasa et al. (2009a) (€101 to
€328), Huijps et al. (2008) (€164 to €235), and Bar et al. (2008b)
(€179 on average). As a substantial part of the costs for IMI
arises from culling (Tables II.S1 and II.S2), and farmers behave
differently in terms of culling (e.g., Fetrow et al., 2006), modelling
herd-specific scenarios instead of average herds is also important
for cost-effectiveness analyses.
Altogether, our model is able to simulate strain-, cow-, and
herd-specific transmission of IMI causing pathogens on quarter
level and with a daily time step. It also includes the possibil-
ity to consider different farmer priorities concerning culling by
changing culling weights, or to include a prediction of the future
value of a cow relative to its herd mates (Græsbøll et al., 2017) in
the culling decision of the farmer, allowing a potentially more
economic choice of cows to be culled. Moreover, the necessary
features to study several treatment strategies for clinical IMI and
selection strategies for dry cow therapy are already implemented
in the model, and further strategies or pathogen strains can be
easily added. This makes it possible to simulate specific herds
and investigate the cost-effectiveness of various changes to man-
agement/prevention or treatment/control strategies, both short
term (operational decision making) and long term (strategic de-
cision making), that can also be strain- and cow-specific. As
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different changes may be more cost-effective depending on the
herd, and selective treatment decisions may be more effective
when selecting the right cows to treat, it is important to include
strain-, cow-, and herd-specifics in a model investigating cost-
effective strategies. Simulating specific instead of average herds
also means simulating diverse herd-specific disease situations,
that are represented by different combinations of pathogens at
different (stable) prevalence levels, which is possible with this
model as shown in Figures II.3 and II.4.
Other bio-economic models simulating mastitis and mastitis
control already exist, but to our knowledge none of the exist-
ing models combine all features presented in this model. The
model by Halasa et al. (2009a, 2010) used the same transmis-
sion framework on cow instead of quarter level, but without
including cow-specific infection and recovery. By simulating on
quarter level, we allow multiple infections per cow, as this hap-
pens in reality, though one quarter can still only be infected by
one pathogen or strain in our model. With this, our model also
differs from e.g. the SIMMAST model (Allore et al., 1998), which
also simulates on cow level, though it does not include cow-
specific recovery, and only allows infection with one pathogen at
a time. The SimHerd model (Østergaard et al., 2005) allows sev-
eral pathogens per cow and is cow- and herd-specific, however,
cow-specific factors are only considered for infection. SimHerd’s
mastitis framework is based on weekly time steps and infection
through a baseline risk function for all mastitis pathogens. While
this is a valid approach in the setting Østergaard et al. (2005)
investigated, our model can explore both constant spread and
infection over time, as well as transitions between the two. In
addition, modelling on quarter level is closer to the underlying
biology, as IMI occurs on quarter level. By modelling the actual
biological unit, IMI management can also be modelled on quarter
level, e.g. drying off chronically infected quarters.
While previous models may distinguish between contagious
and environmental spread, our model explicitly allows both
contagious and environmental strains of the same pathogen,
exemplified by S. uberis, and also introduces a new third oppor-
tunistic transmission type with both contagious and environmen-
tal properties, as discussed above. Furthermore, while we only
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included S. uberis with an environmental and a contagious strain
to illustrate the possibility of having two strains with different
transmission modes, this option should be kept in mind regard-
ing other pathogens like e.g. S. aureus, as the model allows easy
addition of other pathogens or pathogen strains. The question
of which type of transmission is the right one for a particular
pathogen strain cannot be answered by models, but our model
allows the user to choose between the three mentioned transmis-
sion types and compare e.g. management strategies, depending
on what kind of transmission is assumed for a strain. This al-
lows investigations into cost-effectiveness of various strain-, cow-,
and herd-specific IMI prevention and control measures, while
including a farmer’s current strategies, thereby hopefully mak-
ing it easier to convince farmers to adopt proposed cost-effective
changes in the future.
ii.5 conclusions
We developed a strain-, cow-, and herd-specific bio-economic
simulation model of IMI and introduced a new opportunistic
transmission mode. The model is sensitive to parameter changes
in the transmission framework, but it can be fitted to simulate
various pathogen scenarios, representing different herd situations.
However, we found that available parameter estimations for IMI
transmission or cure may be becoming outdated and we therefore
suggest future studies to investigate new parameter estimations.
The economic output allows cost estimations of both subclinical
and clinical IMI, which lie within the ranges found in earlier
studies. This makes it possible to use the model in future studies
to investigate cost-effective prevention and control measures
against IMI that are tailored to a specific herd, hopefully making
it easier to convince the farmer to adopt proposed changes.
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Scenario Milk loss Milk penalty Culling Total Per case
7 9,955 (8823, 11087) 2,310 (1369, 3447) 10,006 (8170, 11842) 22,329 (19574, 24987) 86 (78, 94)
9 3,990 (3478, 4521) −163 (-474, 152) 5,967 (4682, 7160) 9,799 (8153, 11293) 100 (86, 114)
14 12,357 (9070, 15927) 4,981 (2448, 7094) 10,832 (8537, 13316) 28,288 (20922, 34761) 369 (309, 442)
21 9,734 (7530, 12709) 3,206 (1537, 5405) 6,701 (4769, 9272) 19,761 (14264, 26978) 80 (69, 91)
49 24,551 (21767, 27476) 4,714 (3355, 6429) 21,940 (18911, 25061) 51,245 (45749, 57194) 118 (106, 131)
56 19,086 (17464, 20846) 4,750 (3377, 6448) 15,973 (13674, 18085) 39,758 (36308, 43533) 82 (75, 89)
68 16,015 (13306, 19175) 5,702 (3890, 7602) 12,301 (9639, 15055) 34,177 (28262, 40161) 244 (215, 277)
88 8,026 (7317, 8736) 1,992 (1263, 3068) 4,498 (3397, 5875) 14,533 (12699, 16760) 106 (96, 118)
98 38,592 (35651, 41668) 4,324 (3003, 5788) 31,212 (27627, 34976) 74,380 (68313, 80102) 107 (96, 118)Table II.S1: Median costs (with 5% and 95% percentiles) in relation to subclinical IMI in € per year (mean over 5 years). Negative
costs are benefits. Numbers are rounded.
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Scenario Milk loss Treatment Culling Dry cow treatment Total Per case
7 26,675 (18495, 37650) 6,867 (5713, 8016) 1,561 (1010, 2295) 58 (42, 75) 35,246 (27353, 46007) 267 (197, 356)
9 7,336 (4968, 10983) 2,412 (1908, 2878) 1,010 (551, 1561) 27 (15, 40) 10,779 (8285, 14629) 226 (173, 315)
14 389 (218, 678) 388 (213, 576) 184 (0, 367) 6 (0, 12) 949 (612, 1345) 121 (88, 185)
21 15,688 (8383, 28681) 7,843 (5488, 11890) 2,387 (1740, 3213) 18 (10, 31) 26,399 (18730, 39455) 175 (116, 281)
49 42,628 (30829, 58239) 10,120 (8485, 11673) 1,377 (826, 1928) 77 (56, 98) 54,005 (42375, 70358) 278 (209, 365)
56 63,613 (47700, 83022) 13,720 (12152, 15809) 2,111 (1469, 2938) 86 (65, 108) 79,662 (63689, 98681) 298 (236, 381)
68 4,614 (3021, 7418) 2,408 (1961, 2932) 1,102 (551, 1652) 13 (6, 21) 8,179 (6293, 11095) 175 (134, 244)
88 11,796 (8491, 16472) 4,950 (4317, 5673) 2,479 (1740, 3305) 10 (4, 17) 19,264 (15701, 24005) 206 (167, 263)
98 108,477 (89610, 127337) 19,278 (17373, 21260) 2,111 (1377, 2938) 88 (67, 113) 129,832 (111124, 148422) 351 (293, 411)Table II.S2: Median costs (with 5% and 95% percentiles) in relation to clinical IMI in € per year (mean over 5 years). Numbers
are rounded.
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Scenario Total
7 57,346 (48622, 69180)
9 20,506 (17160, 24920)
14 29,295 (21675, 36026)
21 46,855 (34468, 63306)
49 105,616 (92116, 122999)
56 119,855 (102215, 139999)
68 42,555 (36345, 49014)
88 34,092 (29815, 39639)
98 203,787 (184474, 224119)Table II.S3: Median total costs of IMI (with 5% and 95% percentiles) in
€ per year (mean over 5 years), see Tables II.S1 and II.S2.
Numbers are rounded.
Figure II.S1: Sensitivity analysis for the spontaneous recovery proba-
bility. First row: cow level prevalences in one pathogen
scenarios, see Table II.4 and Figure II.2. Second row:
cow level prevalences in corresponding scenarios with
doubled spontaneous recovery probability.
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Figure II.S2: Sensitivity analysis for P(pathogen)c . Shown are cow level
prevalences in one pathogen scenarios corresponding to
scenarios 7, 14, 21, and 33 (see Table II.4 and Figure II.2)
with a changed proportion of clinical cases. First row:
P
(pathogen)
c = 0.01. Second row: P
(pathogen)
c = 0.85.
Figure II.S3: Sensitivity analysis for the flare up probability. Shown
are cow level prevalences in one pathogen scenarios corre-
sponding to scenarios 7, 14, 21, and 33 (see Table II.4 and
Figure II.2) with scaled flare up probabilities. First row:
flare up probabilities 0.0002 (S. aureus) or 0.0005. Second
row: flare up probabilities 0.0163 (S. aureus), 0.0125 (S.
agalactiae), or 0.0137 (S. uberis). Values are rounded.
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Figure II.S4: Sensitivity analysis of ε (0, 0.1, 0.5, 1) at two different trans-
mission rates (first row: 0.0017, second row: 0.0037).
Figure II.S5: Influence of ε on pathogen dynamics in a two pathogen
scenario. First row: scenarios 71 and 73, second row:
scenarios corresponding to 71 and 73 with ε = 0.9.
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Figure II.S6: Model convergence. Upper row shows the variance in
total clinical cases resulting from different numbers of iter-
ations with single pathogen runs of S. aureus, S. agalactiae,
S. uberis (environmental). Lower row shows the variance
of clinical cases for the combined pathogens, and the
variance in energy corrected milk yield (ECM).
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Figure II.S7: The functions for the reduction in the daily milk yield
(RMY) in kg due to subclinical infection for individual
cows based on the estimates from Hortet et al., 1999. In
parity 1 the RMY is not dependent on DIM, which is the
case for multiparous cows. Milk loss is cut at 2 kg.
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Figure II.S8: Examples of the milk loss following infection with three
pathogen types in parity 1 or higher. The blue lines show
a normal daily milk yield without daily variation. All
examples are clinically infected at day 50 (dotted lines).
The orange lines (starting at the dotted lines) show the
milk yield after clinical infection and subsequent recov-
ery towards the normal milk yield. The milk loss was
estimated based on Gröhn et al., 2004
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Figure II.S9: Fit of the milk loss functions used in the model based on
data from Gröhn et al., 2004. Logarithmic functions were
used for all pathogens except Streptococcus spp. in parity
1 where a linear function truncated at zero was used. The
horizontal lines show zero milk loss.
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abstract
The overall aim of this study was to compare different interven-
tion strategies against clinical intramammary infections (IMI). We
conducted a simulation study representing a Danish dairy cattle
herd and ten different intervention strategies against clinical IMI.
As standard intervention, a 3-day intramammary treatment for
all clinical cases was taken. Two strategies reflected the use of
more antibiotics, six strategies reflected cow-specific treatment or
culling decisions, and one strategy reflected a herd with better
hygiene. For these strategies, we investigated costs and effec-
tiveness of culling as an IMI intervention and the influence of
the transmission level on the net income. Our results showed
that nearly all strategies could reduce the number of IMI cases
compared to the standard intervention. This happened either at
the cost of an increased antibiotic usage or an increased number
of cows culled in relation to IMI. However, substantial economic
benefits could only be seen if the transmission level was reduced,
i.e. in the herd with better hygiene. In this case, both antibiotic
treatments and number of culled cows were reduced. The po-
tential economic gain from a reduced transmission level could
be used to improve hygiene without resulting in an overall loss.
Therefore, it should be recommended to reduce IMI transmis-
sion in a dairy herd to a low level through hygiene measures,
maybe in combination with a cow-specific clinical intervention
approach.
key words: dairy cattle, clinical mastitis, treatment, culling
introduction
Mastitis, or intramammary infection (IMI), is frequently found on
dairy farms and causes considerable economic losses (e.g., Halasa
et al., 2007) as well as impairs animal welfare (Broom, 1991; von
Keyserlingk et al., 2009). IMI also contribute a major part to the
use of antibiotics in dairy cattle in Denmark (DANMAP, 2016, p.
24; EMA and EFSA, 2017, p. 29).
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Costs for clinical IMI can be divided into costs associated with
treatment, costs from increased mortality through culling, i.e. for
replacement of culled animals, and indirect costs from production
losses (e.g., Halasa et al., 2007), and were previously investigated
in various studies (e.g., Bar et al., 2008). These studies rely on a
modelling approach, where a farm with IMI is simulated and the
arising costs are calculated. Some focus on modelling occurrence
or transmission of IMI causing pathogens (e.g., Allore et al., 1998;
Hagnestam-Nielsen and Østergaard, 2009; Halasa et al., 2009a;
Østergaard et al., 2005). Others investigate intervention (e.g.,
Halasa, 2012; Steeneveld et al., 2011) or replacement strategies
(e.g., Cha et al., 2014). Many of these studies also consider the
IMI causing pathogen and are thus pathogen-specific (e.g., Allore
et al., 1998; Halasa et al., 2009a; Østergaard et al., 2005), as the
effects of an IMI, e.g. milk production losses, may depend on the
causative pathogen (Gröhn et al., 2004; Hertl et al., 2014).
Usually, investigated intervention strategies for clinical cases
consist of antibiotic treatment, mostly intramammary. However,
in the light of rising consumer awareness regarding antibiotic
usage in food animals and its connection with antimicrobial re-
sistance (Ruegg, 2003), it may be sensible to search for alternative
intervention strategies. For instance, culling cows with clinical
mastitis could be a valid alternative. In contrast to antibiotic
treatment, however, culling of infected animals is rarely consid-
ered as an intervention strategy for IMI, but rather as a possible
consequence of clinical IMI (Halasa and Hogeveen, 2018). It has
previously been studied in the context of optimal replacement
decisions (e.g., Cha et al., 2014; Heikkilä et al., 2012), leading
to only slightly earlier optimal replacement time for cows with
clinical IMI and thus recommending treatment over culling in
most cases. These studies evaluated optimal replacement time
in terms of economics, comparing the results for cows with and
without IMI. Yet, specific culling strategies for clinical IMI have
to our knowledge not been the focus of a study.
Besides antibiotic treatment or culling of cows with clinical
mastitis, it may also be economically beneficial to lower transmis-
sion of IMI causing pathogens, for instance by improving hygiene
or biosecurity. However, if pathogen transmission is contagious,
the number of new cases depends on the number of infected
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animals (Halasa et al., 2009a). Lowering the transmission of IMI
causing pathogens may therefore lead to a long-term indirect
cost reduction due to a decrease in the number of new cases
(Steeneveld et al., 2011). Consequently, the long-term effects of
lowering transmission have to be evaluated with a model that
includes transmission dynamics as in Halasa’s study (2012).
The aim of the current study was to evaluate different IMI
intervention strategies, using three distinct approaches (using
more antibiotics, reactive culling, and reducing the transmission
rate by, e.g., improving herd hygiene or increasing biosecurity).
For this purpose, cow- and pathogen-specific transmission of IMI
was modelled for a Danish dairy cattle herd with 200 dairy cows
at different transmission levels. Subsequently, strategies with
cow-specific antibiotic treatment of clinical cases, cow-specific
culling of cows with clinical IMI, and improving hygiene at the
farm were compared for farm economics and epidemiological
parameters, including the number of clinical IMI cases, culled
cows, and antibiotic doses (treatment days).
materials and methods
Herd and Transmission Model
herd model. The model used in this study is the MiCull
(Mastitis-iCull) model, Version 2.0. The original MiCull model
Version 1.0 (Gussmann et al., 2018b) was used in Kirkeby et al.
(2017) and differs only in the possible interventions for clinical
IMI, which are new in Version 2.0, as explained below. The model
and all simulations were programmed and run in the statistical
computing software R version 3.2.2 “Fire Safety” (R Core Team,
2016). Figures were made using the packages ggplot2 (Wickham,
2009).
In the model, a dairy herd with 200 dairy cows is simulated
in single-day time steps (Kirkeby et al., 2016). The cows are
distributed in five compartments (calves, heifers, lactating cows,
dry cows, calving area). After a stochastic number of days, each
cow moves on to the next compartment if it was not culled.
Feeding depends on which compartment a cow is in and, for
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lactating cows, takes the produced milk into account. Lactation
(milk, protein, and fat) and somatic cell count (SCC) curves are
cow-specific (Græsbøll et al., 2016) and adjusted for IMI effects,
i.e. increased SCC (Schepers et al., 1997; Wilson et al., 1997) and
decreased milk yield (Gröhn et al., 2004; Hortet et al., 1999). Milk
from clinical cows is withdrawn during antibiotic treatment and
for six days afterwards. Once a month, milk yield and SCC are
recorded. The future average milk production (FAP) of a cow
was estimated (Græsbøll et al., 2017).
transmission framework. The model currently includes
five pathogen strains that can cause IMI, a contagious Staphylococ-
cus aureus, environmental Escherichia coli, both a contagious and
an environmental Streptococcus uberis, and Streptococcus agalactiae
with both contagious and environmental elements combined. The
IMI transmission module was adapted and extended from Halasa
et al. (2009a, 2010). Heifers are modelled separately from the lac-
tating herd until they calve, where they have a certain probability
to enter their first lactation infected. For new infections in lactat-
ing cows, the infection probability for every non-infected quarter
is calculated. This probability depends on the active pathogen
strains, on the number of infected quarters for contagious strains,
and on the cow’s susceptibility. The susceptibility of a cow takes
risk factors as parity and previous IMI into account (Zadoks et al.,
2001) and adjusts susceptibility relative to previously uninfected
primiparous cows. Every new infection has a pathogen-specific
probability to immediately appear as a clinical case, otherwise it
will be subclinical (Halasa et al., 2009a). Furthermore, previously
infected quarters have a certain pathogen-specific probability for
spontaneous recovery from the subclinical state or for flare up
from subclinical to clinical. Clinical quarters are treated with a
3-day antibiotic intramammary treatment, after which the clinical
quarter will return to either susceptible or subclinical, depending
on the cow-specific recovery probability (Steeneveld et al., 2011).
If a cow had a clinical IMI during the lactation or a high SCC
(200,000 or higher) at one of the last three monthly recordings,
a pooled milk sample will be sent for testing by polymerase
chain reaction (PCR, sensitivity and specificity are given in Table
III.1) before dry off. Cows with a positive PCR test result receive
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Parameter Description Value Reference
Transmission rate Rate for susceptible quarters to enter
infected state
0.0009 Fitted values
Probability of clinical
state
Probability for a quarter to enter
clinical state upon infection
0.17 See Table III.S1
Flare up probability Probability for a subclinical quarter
to become clinical
0.0081 See Table III.S1
Spontaneous
recovery probability
Probability for a subclinical quarter
to become susceptible (without
treatment)
0.0064 See Table III.S1
Recovery probability Probability for a clinical quarter to
become susceptible after treatment
0.4 See Table III.S1
Test sensitivity Test sensitivity for PCR (used at dry
off)
0.908 Mahmmod et al. (2013)
Test specificity Test specificity for PCR (used at dry
off)
0.988 Mahmmod et al. (2013)
Probability to
identify pathogen
Probability to identify causative
pathogen by PCR
0.85 Taponen et al. (2009)
Table III.1: Model parameters for the main causative pathogens S. au-
reus during lactation
antibiotic dry cow treatment, while cows with a negative result
will be dried off without dry cow treatment. New infections
can occur during the first and last week of the dry period, but
infection probabilities do not depend on the number of infected
quarters and are lower for cows that received dry cow treatment
(Halasa et al., 2009b). Similarly, subclinical cases can only flare
up to clinical cases in the first and last week of the dry period
and only for cows without dry cow treatment. Cows that become
clinical in the first week, will also receive dry cow treatment.
Spontaneous recovery can occur during the whole dry period
(Halasa et al., 2010).
culling. Once a week, if the number of lactating and dry
cows exceeds the target count of 200 dairy animals, cows are
evaluated for culling (Kirkeby et al., 2016). All cows get weighted
flags for low milk yield, parity, reproduction status, high SCC,
and previous cases of clinical IMI, and the cows with the highest
weights are culled. There is also a certain probability that some
cows have to be culled for other reasons, e.g., lameness (Kirkeby
et al., 2016). This involuntary culling takes precedence over
voluntary culling. Costs for culling are around €1,000 (price of a
new heifer), not including the income from slaughter. However,
for every culled cow, the mean slaughter value is deducted,
resulting in less than €1,000 cost for every culled cow.
104 Manuscript III
Intervention Strategies for Clinical IMI
A Danish dairy cattle herd with a default yearly median cumula-
tive clinical incidence of about 21% on cow level, mostly caused
by S. aureus, was simulated for this study.
indifferent treatment for all cows (basic3, basic5).
The default intervention in the model for clinical IMI is a 3-day
intramammary treatment (Basic3). A second strategy consists
of an extended intramammary treatment for five days (Basic5).
In all following strategies, treatment will always be 3-day intra-
mammary treatment, unless specified otherwise.
longer treatment for high producing cows (longer).
As described above, the FAP was used to determine cows in the
top 25% of expected future milk production. In this strategy,
these cows are treated for five instead of the usual three days.
culling of repeated clinical imi cases (repeated). For
this strategy, cows showing a clinical IMI for the second time in
their current lactation are culled instead of treated. Testing Before
Treatment (Before50 and Before75). Here, clinical cases are not
immediately treated. Instead, a milk sample of the new clinical
quarters will be sent for testing by PCR with 85% probability
to identify the causative pathogen, as described by Taponen
et al. (2009). Test results will return one day later, and are
used to calculate the expected recovery probability, based on the
causative pathogen, history of IMI, parity, days in milk (DIM) of
the cow, and SCC at the last monthly milk recording (Steeneveld
et al., 2011). If the pathogen could not be identified, a mean base
cure probability is used instead of the cure probability for the
actual causative pathogen. The estimated recovery probability is
used to decide whether a cow will be culled (recovery probability
below 50% (Before50) or 75% (Before75)) or treated.
culling with exceptions (notculltop and notcullpreg-nant).
With the Before75 strategy, the farmer may also decide not to cull
a certain group of cows, e.g., cows in the top 25% according to
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the FAP (notCullTop), or cows that are more than approximately
4 months pregnant (notCullPregnant). These cows are always
treated without sending a milk sample for testing.
testing after treatment (after). Similarly to testing be-
fore treatment, in this strategy quarters are tested by bacterial
culture seven days after treatment ended. Test sensitivity and
specificity are respectively 0.523 and 0.895 (Mahmmod et al.,
2013). If the test result is positive when it returns one day later,
the cow will be culled.
better hygiene (hygiene). Strictly spoken, this strategy did
not represent a clinical IMI intervention, but rather a similar herd
with a better hygiene. This was simulated by using a lower
transmission rate, due to better milking and general hygiene,
resulting in a low cumulative clinical incidence of about 8%
(Hygiene). Clinical IMI intervention in this herd consisted of
3-day intramammary treatment.
Simulations and Model Output
For each of the ten described strategies, we ran 500 iterations of a
five year period with an additional five years of burn-in time, to
insure stable results describing the effect of the strategies rather
than the initial parameter values (transmission parameters are
given in Table III.1).
Model output was collected in the simulated five year period
and included economics in the form of income from milk (which
is calculated from fat and protein price, a milk handling fee,
and a penalty or bonus depending on the bulk tank SCC), costs
related to IMI (testing, treatment including opportunity costs,
culling, dry cow treatment), and other costs (culling with a
high SCC or history of IMI, feed), with prices given in Table
III.2. The mentioned costs were subtracted from the income
from milk to calculate a mean (over five years) yearly income for
the farm, from which additional expenses (e.g., costs for other
diseases, or running costs) have yet to be deducted. The output
also included epidemiological parameters, e.g., the number of
clinical cases (quarters entering clinical state from susceptible
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Price Reference
1kg protein 5.8132 www.arla.dk, September 2017
1kg fat 4.1519 www.arla.dk, September 2017
Handling of 1kg milk −0.01343 www.arla.dk, September 2017
Slaughter value per cow 483 Kudahl et al. (2007)
Feeding
Per calf per day −0.0026 Kirkeby et al. (2016)
Per heifer/dry cow per day −0.9311 Kirkeby et al. (2016)
Per energy corrected milk −0.1947 Kirkeby et al. (2016)
Treatment (per day) −11.10 Michael Farre (SEGES, Aarhus, Denmark, personal
communication)
Opportunity cost (per case
per day)
−6.66 Halasa et al. (2009a); Michael Farre (SEGES, Aarhus,
Denmark, personal communication)
Dry cow treatment −9.60 Michael Farre (SEGES, Aarhus, Denmark, personal
communication)
Bacterial culture −12 Michael Farre (SEGES, Aarhus, Denmark, personal
communication)
PCR −13.3 Michael Farre (SEGES, Aarhus, Denmark, personal
communication)Table III.2: Prices in EUR used in the model to calculate income (posi-
tive values) and costs (negative values)
or subclinical state), the number of subclinical cases (quarters
entering subclinical state from susceptible or clinical state), the
number of culled cows (due to IMI intervention, or with a high
SCC or history of IMI) and the number of treatment days (a
3-day treatment of a clinical quarter equals three treatment days)
over the simulated five year period. The numbers are rounded to
integers, or in the case of percentages to one decimal.
Sensitivity analyses
Sensitivity analyses were performed for test characteristics, i.e.
probability to identify the pathogen according to Taponen et al.
(2009), or test sensitivity and specificity according to Cederlöf
et al. (2012); base cure probability after treatment; fat and pro-
tein prices for 2017 in Denmark (www.arla.dk/om-arla/ejere/
arlapris/2017); prices for culling; as well as transmission rates
and causative pathogens, reflecting different herds (Table III.3).
results
All results for the mentioned strategies can be found in Table
III.4. The numbers presented are rounded median values (with
the 5th and 95th percentiles) of the annual average over the five
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Sensitivity analysis Values
Test characteristics
Sensitivity / specificity of bacterial culture 0.52/0.9∗ 0.78/0.97 0.83/0.97 0.88/0.94 0.94/0.9
Probability to identify a pathogen by PCR 0.9 0.85∗ 0.8 0.75 0.5
Base cure probability 0.2 0.4∗ 0.6 0.7
Milk price
Price for 1kg protein / 1kg fat in EUR 5.25/3.75 5.51/3.94 5.66/4.04 5.81/4.15∗ 5.92/4.23
Additional costs for culling in EUR 0* 250 500 1,000
Transmission rates per quarter per day
Low incidence herd
emphS. aureus 0.00004
emphS. uberis (contagious) 0.0002∗
emphS. uberis (environmental) 0.000002∗
High incidence herd (S. aureus) 0.0018
Medium incidence herd (contagious S. uberis) 0.0047
Medium incidence herd (environmental S. uberis) 0.00009Table III.3: Values used in the sensitivity analyses, default values (Table
III.1 and III.2) are marked by *
simulated years. Clinical and subclinical cases are always quarter
cases.
In the basic strategy (Basic3), there were 42 clinical cases per
year in median, ranging from 33 to 51 cases for the 5th and 95th
percentiles, respectively (Table III.4). These cases led to a median
123 treatment days per year. There were 136 subclinical cases in
median, and in median 16 cows were culled with a high SCC or
a history of IMI. The median yearly income in the Basic3 strategy
was €187,666 (Table III.4).
Comparable numbers for clinical cases and culled cows could
be observed when the high producing cows were treated for five
days instead of three (Longer), but with a higher median and
variance in treatment days. The median number of subclinical
cases was lower, with a higher variance skewed to the left (Table
III.4). If all cows were treated for five days (Basic5), the median
number of clinical cases and of subclinical cases was lower and
the median number of treatment days increased. The number of
culled cows seemed slightly lower (Table III.4). In these strategies,
the median yearly income remained similar (Table III.4).
In the strategy Repeated, where cows with repeated clinical
IMI cases were culled, the number of clinical cases resembled the
number of clinical cases in Basic5, though with less treatment
days and more culled cows, which also included cows culled
as IMI intervention (Table III.4). In all other strategies that in-
cluded reactive culling, there were less clinical cases, with the
smallest median of 29 cases in strategy Before75. The numbers
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Strategy
N
et
incom
e
C
linicalIM
I
cases
SubclinicalIM
I
cases
Treatm
ent
days
C
ulled
cow
s
Basic3
187,666
(173,363;202,147)
42
(33;51)
136
(121;161)
123
(95;151)
16
(12;20)
Basic5
190,014
(175,823;205,741)
37
(19;46)
123
(86;145)
179
(93;220)
15
(11;18)
Longer
188,307
(175,953;203,414)
41
(27;51)
133
(109;157)
129
(81;162)
16
(12;19)
R
epeated
191,280
(179,588;205,338)
38
(21;46)
125
(90;145)
86
(53;106)
20
(14;25)
A
fter
191,699
(179,990;207,164)
35
(15;43)
129
(80;147)
101
(46;125)
22
(13;27)
Before50
196,995
(181,427;211,492)
30
(15;38)
111
(75;130)
47
(36;64)
24
(10;29)
Before75
197,576
(184,745;213,907)
29
(13;35)
106
(71;120)
7
(4;11)
32
(18;38)
notC
ullTop
196,704
(182,197;213,318)
32
(14;39)
113
(72;127)
32
(12;43)
29
(16;34)
notC
ullPregnant
195,600
(184,007;210,633)
31
(14;37)
112
(74;123)
24
(12;32)
30
(17;35)
H
ygiene
205,326
(193,513;217,172)
16
(13;24)
80
(72;102)
47
(37;71)
11
(8;14)
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Figure III.1: Results of the sensitivity analysis for the base cure rates
in selected strategies (increasing cure rates from left to
right, Table III.3). Box plots show yearly income (income
from milk minus costs for IMI intervention, dry cow treat-
ment, feed, and culling) and yearly cumulative clinical
IMI incidence for 500 iterations. Gray boxes show results
with default values. For each iteration, means over the
simulated five year period were taken.
of subclinical cases in strategies Repeated and After were higher
than in Basic5, though lower than in Basic3 and Longer. All
other strategies including culling showed fewer subclinical cases,
with the smallest median of 106 in strategy Before75. All culling
strategies had a larger number of culled cows than the strategies
without culling as an intervention, up to a median of 32 cows
culled per year in strategy Before75. In return, the median num-
ber of treatment days was lower, with a minimum of 7 treatment
days in median in strategy Before75. Generally, the numbers of
culled cows and treatment days were reversed: more treatment
days corresponded to less culled cows. An exception was the
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Figure III.2: Results of the sensitivity analysis for transmission rate
(light gray, left: low transmission rates, right: high trans-
mission rate S. aureus, Table III.3) and main causative
pathogens (white, left: contagious S. uberis, right: environ-
mental S. uberis, Table III.3). Box plots show yearly income
(income from milk minus costs for IMI intervention, dry
cow treatment, feed, and culling) and yearly cumulative
clinical IMI incidence for 500 iterations. Dark gray boxes
show results with default values (Table III.1). The leftmost
box for strategy Basic3 is equivalent to strategy Hygiene.
For each iteration, means over the simulated five year
period were taken.
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strategy After, which had both more treatment days and more
culled cows than the strategy Repeated (Table III.4). The median
yearly income in the strategies Repeated and After was around
€191,500. In the strategies Before50, Before75, notCullPregnant,
and notCullTop it varied from €195,600 (notCullPregnant) to
€197,576 (Before75).
The low transmission herd (Hygiene) yielded a higher median
yearly income than any intervention strategy and the lowest
median number of clinical cases, subclinical cases and culled
cows. The number of treatment days was comparable to Before50,
with half the number of cows culled in relation to IMI.
Sensitivity analysis (see Table III.3 for input values) on test
characteristics showed that varying the probability to identify the
pathogen by PCR before treatment did not lead to large changes
in the results. When increasing sensitivity (and thus decreasing
specificity) for bacterial culture in strategy After, the income did
not change much, while the number of clinical IMI cases and
treatment days per year decreased (Figure III.S1).
An increased base cure probability after treatment led to in-
creased income and decreased number of clinical IMI, treatment
days and culled cows in all strategies, though the effect was
less visible in strategies where cows are tested and culled before
treatment. In strategy Before50, the number of clinical IMI and
treatment days increased with increasing base cure probability
(Figure III.1). With low transmission rates (Hygiene), the outcome
was not sensitive to the base cure probability.
Sensitivity analysis for the fat and protein prices according to
Danish prices in 2017 showed that the yearly income is highly de-
pendent on the milk price, with medians ranging from
€120,597 to €200,096 in the Basic3 strategy. The other strate-
gies showed a similar pattern in the relation between milk price
and yearly income (Figure III.S2).
When culling was more expensive, the yearly income was
lower. In strategies with more culled cows, this effect was more
pronounced (Figure III.S3). This led to greater discrepancies in
the yearly income among the different intervention strategies.
Sensitivity analyses for transmission rates led to varying cu-
mulative clinical incidences. When a herd with a default me-
dian cumulative clinical incidence of around 19% was modelled,
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where most cases were caused by an environmental S. uberis
strain, results were mostly similar (Figure III.2). If most cases
where caused by a contagious S. uberis strain, differences were
more noticeable (Figure III.2). For one, the variation in the re-
sults was higher. In the strategies Before75 (results not shown),
notCullPregnant, and notCullTop, the median number of clinical
cases and culled cows was lower, though the range of results was
comparable. Similar to the environmental strain, the contagious
S. uberis strain led to a higher number of clinical cases and a
lower median yearly income in the strategy Before50. In the
other strategies, the median yearly income was higher for both S.
uberis strains.
Results for other strategies than 3-day intramammary treat-
ment in a herd with a lower (8%) median cumulative clinical
incidence can be seen in Figure III.2. In a herd with a low
number of clinical cases, the yearly income was higher and the
differences between the different intervention strategies seemed
smaller. Contrarily, in a herd with a higher (35%) median cu-
mulative clinical incidence, where most cases were caused by
S. aureus, the income was lower and the differences between
strategies were bigger. There, the cumulative clinical incidence
could be reduced down to a median of 22% through intervention
strategy Before75 (results not shown), which also decreased the
number of treatment days drastically. However, 23% of the cows
were culled with reasons related to IMI (results not shown).
discussion
The objective of this study was to evaluate different intervention
strategies against clinical IMI. In the study, ten strategies were
presented. In the default strategy (Basic3), there was no reactive
culling and all clinical cases were treated intramammary for
three days. Two strategies reflected interventions with increased
antibiotics usage (Basic5, Longer). Six interventions explicitly
included culling as an intervention against IMI, where a cow-
specific decision to cull or treat a cow with clinical IMI was taken.
Reactive culling could happen instead of treatment (Before50,
Before75, notCullTop, notCullPregnant, Repeated) or for not
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cured cows (After). The last strategy reflected a herd with better
hygiene (Hygiene).
Although various previous studies have investigated IMI in-
tervention and culling in relation to clinical IMI (e.g., Cha et al.,
2014; Halasa, 2012; Heikkilä et al., 2012), culling as a strategy
against clinical IMI, as presented in the current study, has rarely
been considered as a reactive measure (Halasa and Hogeveen,
2018). Furthermore, in other IMI intervention studies, IMI trans-
mission was seldom taken into account. In the present study,
we modelled both IMI transmission and interventions, allowing
an evaluation of different intervention strategies’ long-term ef-
fects. Another new aspect of the current study was that both
economics and epidemiological consequences are presented as
output. Farmers are not solely interested in farm economics, but
also in other perceived benefits (Jansen and Lam, 2012; Valeeva
et al., 2007). Clinical IMI cases are perceived as both cost and
time intensive (Jansen et al., 2009), thus presenting the number of
clinical cases in addition to the economics could provide farmers
different incentives to adopt a new strategy. The number of treat-
ment days and cows culled in relation to IMI are also shown to
give an estimate for respectively antibiotic usage and longevity,
which may also affect the choice of an intervention strategy.
Our results showed that economically, i.e. in their yearly in-
come, all strategies seemed more successful than indifferent 3-day
intramammary treatment for all clinical cases (Basic3). Using
more antibiotics (Basic5, Longer) led to only a small increase
in yearly income, while the increase was higher in intervention
strategies with reactive culling. Here, testing newly clinical quar-
ters and subsequent cow-specific treatment or culling decisions
(Before50, Before75, notCullTop, notCullPregnant) led to a higher
income than testing a week after treatment (After) or culling cows
with repeated cases (Repeated). These results are not consistent
with an earlier study that found cow-specific treatment not to be
economically beneficial (Steeneveld et al., 2011). Nevertheless,
this study did not model IMI transmission. By including trans-
mission, the reduced number of IMI cases due to an intervention
strategy could be taken into account, which in turn can explain
the higher yearly income, consistent with the findings of Halasa
(2012).
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Increasing the sensitivity of bacterial culture resulted in fewer
cases (Figure III.S1). This result is concordant with van den
Borne et al. (2010a), who showed that test sensitivity to detect
subclinical IMI had substantial impact on the cost-effectiveness of
control strategies for subclinical IMI. The results were also sensi-
tive to the cure (Figure III.1) and transmission rates (Figure III.2),
which is consistent with studies by Halasa (2012) and Down et al.
(2013). Unfortunately, there exist only a small number of studies
estimating the transmission rates of few IMI causing pathogens.
Further studies are needed, also with focus on assessing the
impact of control strategies on the transmission of IMI causing
pathogens. This would allow a more precise assessment of the
cost-effectiveness of IMI control in dairy herds.
Sensitivity analysis for the cost of culling showed that with
increasing culling costs, the income decreased (Figure III.S3). The
opposite was the case for increased milk prices (Figure III.S2).
Increased culling costs or reduced milk prices may therefore have
a substantial effect on the cost-effectiveness of an intervention
strategy. Hence, these factors must be taken into account when
deciding on which intervention strategy to adopt, especially if
reactive culling is being considered. It is important to mention
that we had fixed prices over time. We acknowledge that this is
unrealistic, but it is not only difficult to predict changes in prices;
fixing a price also removes extra noise that would make it more
difficult to compare different strategies.
Together, our results showed that compared to an indifferent
3-day intramammary treatment for all clinical quarters, there
were three possibilities to improve a herd’s IMI situation, i.e. to
reduce the number of not only clinical but also subclinical quar-
ter cases. The first was to increase the usage of antimicrobials
for treatment of clinical IMI cases (Basic5). If this is not desired,
an alternative was to cull reactively (After, Repeated, Before50,
Before75, notCullTop, notCullPregnant). In this case, antibiotic
treatment could be greatly reduced, but the number of cows
culled in relation to IMI increased. A decision between these two
options could be seen as a decision between an increased risk for
antimicrobial resistance (more antibiotics) or decreased longevity
(more culling). From an economic point of view, culling seemed
to be the better choice in the studied herd with a medium cumu-
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lative clinical incidence. However, for a high cumulative clinical
incidence, this distinction was not as clear and depended on the
individual culling strategies (Figure III.2), while it was nearly
indiscernible when the cumulative clinical incidence was low
(Figure III.2). The third option, reducing the transmission level
in the herd (Hygiene), was the only possibility to decrease IMI
cases, antibiotic treatment, and IMI related culling at the same
time. In fact, the strategy Hygiene and the sensitivity analysis
on the transmission rate of the main causative pathogen showed
that solely adopting an intervention strategy for clinical IMI was
not enough to reach a stable low incidence in a herd that was
comparable with a low transmission due to good hygiene. Unfor-
tunately, there are only very few studies investigating the effect
of hygienic measures. Lam et al. (1996) investigated the effect
of postmilking teat disinfection and found that it reduced the
transmission rate noticeably. Huijps et al. (2010) estimated the
costs and effects of various separate hygienic measures, however,
not in terms of transmission rates. Due to the lack of studies
investigating the effect of a comprehensive hygienic strategy on
the transmission rate of IMI pathogens within a herd, we did not
include the costs arising from such a comprehensive hygienic
strategy in this study. This makes it difficult to properly assess
the cost-effectiveness of the strategy Hygiene. Nevertheless, there
was a considerable profit in reducing the transmission rate in
Hygiene, though it remains to be shown if the economic gain
would be enough to improve herd hygiene enough to reach the
assumed lower transmission rate. Even so, from an epidemiolog-
ical point of view, improving hygiene led to better results than
a higher use of antibiotics or more culling. However, the choice
of which approach to take should also depend on the specific
herd and situation, as different intervention strategies may be
preferable depending on the main causative pathogen strain. The
decision has to be taken by the farmer, who has to decide which
option fits best to his/her beliefs or ideas for the respective herd.
In this study, we do not consider non-antibiotic treatment for
IMI. To investigate this possibility, the model would also have to
include a distinction between mild, moderate, or severe clinical
IMI cases, as non-antibiotic treatments are mainly considered for
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mild or moderate clinical IMI (e.g., McDougall et al., 2016, 2009).
This could be considered in future studies.
Also, some of the strategies presented in this paper involved
strict culling rules, that farmers may not want to adhere to.
For that reason, we considered strategies where groups of an-
imals were excluded from culling, e.g., cows that were more
than about four months pregnant (notCullPregnant) or high-
producing cows (notCullTop). The latter strategy particularly
considers an earlier study on determinants for antimicrobial
treatment, where in some Danish herds, high producing cows
were more likely to be treated (Gussmann et al., 2018a). We
also simulated other strategies, e.g., higher chances for heifers
to be treated. However, results showed to be quite similar, so
they were not presented here. Nevertheless, Vaarst et al. (2006)
found that there were farmers willing to adopt a culling strategy
that matched their goal for the herd, so including some form of
reactive culling in IMI intervention strategies is not unreason-
able. Still, this kind of culling affects the usual culling procedure,
especially considering that we modelled a closed herd, where
replacement heifers had to be available on-herd. This may lead to
problems when a larger number of animals have to be culled due
to other, non-voluntary reasons, e.g., other diseases. However,
in this study we concentrated on IMI interventions and their
economic and epidemiological effects, leaving future studies to
further investigate culling dynamics as a whole.
conclusions
We showed that cow-specific intervention strategies against IMI
including reactive culling can be economically beneficial in the
long term, even more so than a strategy with increased antibiotic
treatment. The increased income from milk together with the
reduced number of IMI cases compensated for the extra inter-
vention costs, though economic benefits also depended on the
transmission level in the herd. All strategies except one could
also reduce the number of clinical cases compared to indifferent
3-day intramammary treatment. This happened either at the cost
of an increased antibiotic usage, or at the cost of the number
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of cows culled in relation to IMI. Therefore, the farmer has to
choose the right balance between treatment and culling for a
specific herd, given his/her goals for antimicrobial usage and
longevity, as well as the main causative pathogen in the herd.
With this study, we have shown that cow-specific treatment or
culling decisions will in most cases reduce the incidence of clin-
ical IMI, while increasing the farm’s income in the long term.
However, the best option to reach a stable low number of IMI
cases would be to reduce IMI transmission. Unfortunately, data
is missing to assess cost-effectiveness of this strategy.
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Figure III.S1: Results of the sensitivity analysis for sensitivity and speci-
ficity of bacterial culture (After; increasing sensitivity
from left to right, Table III.3) and probability to identify
the causative pathogen (Before50, Before75, notCullTop,
notCullPregnant; increasing probability from left to right,
Table III.3) in selected strategies. Box plots show yearly
income (income from milk minus costs for IMI interven-
tion, dry cow treatment, feed, and culling) and yearly
cumulative clinical IMI incidence for 500 iterations. Gray
boxes show results with default values. For each iter-
ation, means over the simulated five year period were
taken.
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Figure III.S2: Results of the sensitivity analysis for milk prices (increas-
ing price from left to right, Table III.3). Box plots show
yearly income (income from milk minus costs for IMI
intervention, dry cow treatment, feed, and culling) and
yearly cumulative clinical IMI incidence for 500 iterations.
Gray boxes show results with default values. For each
iteration, means over the simulated five year period were
taken.
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Figure III.S3: Results of the sensitivity analysis for culling costs (in-
creasing price from left to right, Table III.3). Box plots
show yearly income (income from milk minus costs for
IMI intervention, dry cow treatment, feed, and culling)
and yearly cumulative clinical IMI incidence for 500 iter-
ations. Gray boxes show results with default values. For
each iteration, means over the simulated five year period
were taken.
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Parameter Description Value Value Reference (value lactation)
(lactation) (dry period)
Transmission rate Rate for susceptible quarters to enter infected state
S. aureus 0.00004 0.0009 Fitted value
S. agalactiae 0.0007 0.0001 Fitted value
S. uberis (contagious) 0.0002 0.00001 Fitted value
S. uberis (environmental) 0.000002 0.0000001 Fitted value
E. coli 0.000001 0.000001 Barkema et al. (1998)
Probability of clinical
state
Probability for a quarter to enter clinical
state upon infection
S. aureus 0.17 0.1 Swinkels et al. (2005a)
S. agalactiae 0.01 0.1 Barkema et al. (1998) and Swinkels et al. (2005a)
S. uberis (contagious) 0.32 0.1 Zadoks et al. (2003)
S. uberis (environmental) 0.32 0.1 Zadoks et al. (2003)
E. coli 0.85 0.1 Hogan and Smith (2003)
Flare up probability Probability for a subclinical quarter to become clinical
S. aureus 0.0081 0.006 Swinkels et al. (2005a)
S. agalactiae 0.0005 0.0005 Barkema et al. (1998) and Swinkels et al. (2005a)
S. uberis (contagious) 0.0068 0.004 Swinkels et al. (2005b)
S. uberis (environmental) 0.0068 0.004 Swinkels et al. (2005b)
E. coli 0.0035 0.0035 Döpfer et al. (1999)
Spontaneous recov-
ery probability
Probability for a subclinical quarter to be-
come susceptible (without treatment)
S. aureus 0.0064 0.0079 van den Borne et al. (2010b)
S. agalactiae 0.0023 0.0086 Leelahapongsathon et al. (2016)
S. uberis (contagious) 0.0143 0.0086 van den Borne et al. (2010b)
S. uberis (environmental) 0.0143 0.0086 van den Borne et al. (2010b)
E. coli 0.0221 0.0221 van den Borne et al. (2010b)
Recovery probability Probability for a clinical quarter to be-
come susceptible after treatment or dry
cow treatment
S. aureus 0.4 0.77 Steeneveld et al. (2011)
S. agalactiae 0.7 0.89 Steeneveld et al. (2011)
S. uberis (contagious) 0.7 0.89 Steeneveld et al. (2011)
S. uberis (environmental) 0.7 0.89 Steeneveld et al. (2011)
E. coli 0.8 0.9 Steeneveld et al. (2011)Table III.S1: Model parameters for all secondary pathogens during lactation and dry off, references are given for values during
lactation. Dry period values are taken from Halasa et al. (2010).
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abstract
The objective of this study was to evaluate and compare different
combinations of intervention strategies against contagious or
opportunistic subclinical and clinical intramammary infections
(IMI). We simulated two different Danish dairy cattle herds with
ten different interventions strategies, including three baseline
strategies without subclinical interventions. In one herd, the
main causative pathogen of IMI was Staphylococcus (S.) aureus.
In the other herd, Streptococcus (St.) agalactiae was the main
causative agent. For both herds, we investigated costs and effec-
tiveness of all ten intervention strategies. Intervention strategies
consisted of measures against clinical and subclinical IMI, with
baselines given by purely clinical intervention strategies. Our
results showed that strategies including subclinical interventions
were more cost-effective than the respective baseline strategies.
Increase in income and reduction of IMI cases came at the cost of
an increased antibiotic usage and an increased culling rate in re-
lation to IMI. However, there were differences between the herds.
In the St. agalactiae herd, the clinical intervention strategy did
not seem to have a big impact on income and number of cases.
However, intervention strategies which included cow-specific
clinical interventions led to a higher income and lower number
of cases in the S. aureus herd. The results show that intervention
strategies including interventions against contagious or oppor-
tunistic clinical and subclinical IMI can be highly cost-effective,
but should be herd-specific.
key words: dairy cattle, mastitis, control, simulation model
introduction
Mastitis, or intramammary infection (IMI), causes considerable
economic losses for many dairy cattle farms (e.g., Halasa et al.,
2007). Costs for IMI arise from both treatment of cases and
replacement of prematurely culled animals, as well as, indirectly,
from production losses (e.g., Halasa et al., 2007). Production
losses occur as a response to the inflammation, for both clinical
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(Gröhn et al., 2004; Hertl et al., 2014) and subclinical mastitis
(Halasa et al., 2009a; Hortet et al., 1999).
Consequently, there is a multitude of studies investigating the
economic effects of clinical (e.g., Bar et al., 2008; Hagnestam-
Nielsen and Østergaard, 2009) and subclinical IMI (e.g., Halasa
et al., 2009b; Huijps et al., 2008). However, only few studies
explicitly investigated the economic effects of intervention against
clinical (Halasa, 2012) or subclinical IMI (e.g., van den Borne et
al., 2010a; Steeneveld et al., 2007; Swinkels et al., 2005a), mainly
focusing on treatment with antibiotics. Moreover, interventions
against IMI are typically investigated separately for clinical or
subclinical cases, albeit that clinical and subclinical IMI are a joint
problem. Reducing the number of infected quarters through, e.g.,
treatment of subclinical cases should also lead to less flared up
clinical cases (see, e.g., van den Borne et al., 2010a). In the case
of contagious transmission, a good intervention strategy against
clinical IMI can be expected to decrease IMI transmission (e.g.,
Steeneveld et al., 2011), thereby also leading to less subclinical
cases. It is therefore not immediately visible how intervention
strategies against subclinical or clinical IMI may interact. To
our knowledge, there are no previous studies investigating the
economic effects of interventions against subclinical and clinical
IMI combined. Furthermore, the usual investigated intervention
strategies are antibiotic treatments. Although culling could also
be considered as an intervention against IMI, it is commonly only
regarded as a consequence of IMI (Halasa and Hogeveen, 2018)
and studied in the context of optimal replacement times (e.g.,
Cha et al., 2014; Heikkilä et al., 2012).
Consumer awareness regarding antimicrobial resistance and its
connection with antibiotic usage in food animals is rising (Ruegg,
2003). Thus, while antibiotics are important to control and pre-
vent IMI, prudent use of antibiotics is essential. A combined
cow-specific approach of culling or treating animals with subclin-
ical IMI may therefore be sensible. For instance, low producing
cows could be culled instead of treated if they are diagnosed
with contagious subclinical IMI. This would minimize the risk
of pathogen spread to healthy herd mates and reduce additional
antibiotics usage, while still improving herd health. Still, the
economic effects of such a strategy must be investigated.
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The aim of this study was to evaluate intervention strate-
gies against subclinical IMI, combined with different interven-
tion strategies against clinical IMI, caused by contagious or op-
portunistic (both contagious and environmental) IMI causing
pathogens. For this purpose, two different Danish dairy herds
with 200 cows including cow- and strain-specific IMI transmis-
sion were modelled. In one herd, IMI cases were mainly caused
by contagious Staphylococcus (S.) aureus, while they were mainly
caused by opportunistic Streptococcus (St.) agalactiae in the other
herd. These pathogens were chosen as they are of major concern
in Denmark. For these herds, several subclinical and clinical inter-
vention strategies were combined and farm economics, antibiotic
usage, culling, and epidemiological parameters were compared.
materials and methods
Herd and Transmission Model
The MiCull (Mastitis-iCull) model version 3.0 was used in this
study. The original MiCull version 1.0 was described in detail in
Gussmann et al. (2018b), MiCull version 2.0 includes different
intervention strategies against clinical IMI (Gussmann et al., un-
published data). The current version 3.0 additionally includes
intervention strategies against subclinical IMI, as described below.
The model was programmed and all simulations were run in the
statistical computing software R version 3.2.2 “Fire Safety” (R
Core Team, 2016). Figures were made using the package ggplot2
(Wickham, 2009).
herd model. The model is a stochastic mechanistic popula-
tion model that simulates a Danish dairy herd with 200 cows in
daily time steps (Gussmann et al., 2018b). All animals belong
to one of five compartments (calves, heifers, lactating cows, dry
cows, calving area), and move on to the next compartment after
a stochastically determined number of days. Lactation (milk,
protein, and fat) and somatic cell count (SCC) curves are esti-
mated for all cows based on Græsbøll et al. (2016) and adjusted
for IMI, i.e. increased SCC (Schepers et al., 1997; Wilson et al.,
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1997) and decreased milk yield (Gröhn et al., 2004; Hortet et al.,
1999). Once a month, milk yield and SCC are recorded, and the
expected future average production (FAP) of a cow is estimated
as described by Græsbøll et al. (2017). If a cow is treated with an-
tibiotics, the milk is withdrawn and discarded during treatment
and for six days afterwards. Feeding of lactating cows depends
on the produced milk.
transmission framework. The model simulates IMI spread
in a dairy herd on quarter level (Gussmann et al., 2018b). It cur-
rently includes five pathogen strains: a contagious S. aureus,
both a contagious and an environmental St. uberis, St. agalactiae
with contagious and environmental elements at the same time
(opportunistic), and environmental Escherichia coli. Heifers are
exempt from dynamic transmission and have a probability to
already be infected at calving. For lactating cows, the infection
probability for every non-infected quarter is calculated every
day. This probability depends on the active pathogen strains,
the susceptibility, and, for contagious pathogens, on the number
of infected quarters. Transmission of St. agalactiae has an envi-
ronmental and a contagious part (Gussmann et al., 2018b). The
susceptibility is relative to previously uninfected primiparous
cows and is determined by risk factors such as parity or previous
IMI (Zadoks et al., 2001). A newly infected quarter can appear as
either a subclinical or a clinical case, depending on a pathogen-
specific probability (Halasa et al., 2009b). Clinical quarters are
treated with a 3-day intramammary treatment. After treatment
ended, the quarter will either recover to susceptible with a cow-
specific probability, or return to subclinical (Steeneveld et al.,
2011). Subclinical quarters have daily pathogen-specific probabil-
ities for spontaneous recovery (return to susceptible) or for flare
up (become clinical).
Before a cow with a clinical IMI during lactation or a high SCC
(200,000 or higher) at one of the last three monthly recordings
is dried off, a test of a pooled milk sample by polymerase chain
reaction (PCR) will be simulated (sensitivity and specificity are
given in Table IV.1). If the test result is positive, the cow receives
dry cow treatment, otherwise it will be dried off without dry cow
treatment. New IMI and spontaneous recovery can occur during
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Parameter Description Value Reference
Herd 1 Herd 2
Transmission rate Rate for susceptible quarters to
enter infected state
0.0009 0.003 Fitted values
Probability of
clinical state
Probability for a quarter to enter
clinical state upon infection
0.17 0.01 See Table IV.S1
Flare up probability Probability for a subclinical
quarter to become clinical
0.0081 0.0005 See Table IV.S1
Spontaneous
recovery probability
Probability for a subclinical
quarter to become susceptible
(without treatment)
0.0064 0.0022 See Table IV.S1
Recovery
probability
Probability for a clinical quarter
to become susceptible after
treatment
0.4 0.7 See Table IV.S1
Test sensitivity Test sensitivity for PCR (used at
dry off)
0.908 Mahmmod et al. (2013)
Test specificity Test specificity for PCR (used at
dry off)
0.988 Mahmmod et al. (2013)
Probability to
identify pathogen
Probability to identify causative
pathogen by PCR
0.85 Taponen et al. (2009)
Table IV.1: Model parameters for the main causative pathogens (S.
aureus in Herd 1 or St. agalactiae in Herd 2) during lactation
the whole dry period (Halasa et al., 2010). However, infection
probabilities are simulated to be lower for cows with dry cow
treatment, and they are independent of the number of infected
quarters (Halasa et al., 2009c). Clinical cases (flared up and newly
infected) can only occur in the first or last week of the dry period.
If a cow becomes clinical in the first week, it will receive dry cow
treatment.
culling. Cows are assessed for culling once a week, if the total
number of cows in the herd exceeds the target count of 200 dairy
animals (Gussmann et al., 2018b; Kirkeby et al., 2016). Parity,
reproduction status, low milk yield, high SCC, and previous
cases of clinical IMI are weighted, and the cows with the highest
weights are culled. Involuntary culling, i.e. culling for other
reasons such as, e.g., lameness, happens with a certain probability
and is prioritized over voluntary culling (Kirkeby et al., 2016).
Culling costs include the market value of a new heifer and the
slaughter value of the culled cow (see Table IV.2).
Intervention Strategies for IMI
For this study, two different Danish dairy cattle herds were
simulated. In both herds, the primary pathogen contained a
contagious element, however, the transmission mode and param-
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Price Reference
1kg protein 5.8132 www.arla.dk, September 2017
1kg fat 4.1519 www.arla.dk, September 2017
Handling of 1kg milk −0.01343 www.arla.dk, September 2017
Costs of a heifer 1000 Assumed market value
Slaughter value per cow 483 Kudahl et al. (2007)
Feeding
Per calf per day −0.0026 Kirkeby et al. (2016)
Per heifer/dry cow per day −0.9311 Kirkeby et al. (2016)
Per energy corrected milk −0.1947 Kirkeby et al. (2016)
Treatment (per day) −11.10 Michael Farre (SEGES, Aarhus, Denmark, personal
communication)
Opportunity cost (per case
per day)
−6.66 Halasa et al. (2009b); Michael Farre (SEGES, Aarhus,
Denmark, personal communication)
Dry cow treatment −9.60 Michael Farre (SEGES, Aarhus, Denmark, personal
communication)
Bacterial culture −12 Michael Farre (SEGES, Aarhus, Denmark, personal
communication)
PCR −13.3 Michael Farre (SEGES, Aarhus, Denmark, personal
communication)Table IV.2: Prices in EUR used in the model to calculate income (posi-
tive values) and costs (negative values)
eters differed. In one herd, the majority of IMI cases were caused
by purely contagious S. aureus (Herd 1), while opportunistic St.
agalactiae (Herd 2) caused most subclinical cases in the second
herd. Intervention measures included treatment, testing, and
culling, and they were aimed at both clinical and subclinical
cases. For the strategies, clinical and subclinical intervention
measures were combined, with three baseline strategies (only
clinical intervention measures). Results for subclinical interven-
tion TestTreatCull (see below) are only shown in combination
with clinical intervention Basic3.
clinical imi: indifferent treatment for all cases (ba-sic3). In the default intervention, all clinical cases receive a
3-day intramammary treatment.
clinical imi: testing before treatment (before50). A
milk sample of every new clinical quarter is sent for testing by
PCR. After one day, test results return and are used to calculate
an expected recovery probability, which depends on the causative
pathogen (85% probability for correct identification, see Table
IV.1), history of IMI, parity, days in milk (DIM), and SCC at the
last milk recording (Steeneveld et al., 2011). For unidentified
pathogens, recovery probability is a mean base cure probability
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(see Table IV.1). Cows with a recovery probability below 50% are
culled, all other cases are treated.
clinical imi: culling with exceptions (notculltop). Sim-
ilarly to the Before50 strategy, cows with a recovery probability
below 75% are culled. However, as described above, the FAP is
calculated for all cows and those in the top 25% according to
FAP are always treated (i.e., these cows are not culled).
subclinical imi: test, treat and cull (testtreatcull).
In this strategy, cows with a high SCC (>200,000) in two con-
secutive milk recordings are tested by PCR. Test results return
after one day and positive quarters receive 3-day intramammary
treatment. After one month, quarters are re-tested and cows are
culled, if the test is positive. Intervention against clinical IMI is
Basic3.
subclinical imi: treatment with exceptions (cullbot-tom).
Cows with a high SCC in two consecutive milk recordings are
tested by PCR and test results return after one day. Positively
tested cows are culled if they are in the bottom 25% according to
FAP, otherwise the respective quarter is treated intramammary
for three days. This strategy is combined with each of the in-
tervention strategies against clinical IMI (CullBottom & Basic3,
CullBottom & Before50, CullBottom & notCullTop).
subclinical imi: cow-specific treatment (treattoplonger).
Similarly to CullBottom, cows with a high SCC in two consec-
utive milk recordings are tested by PCR and test results return
after one day. Positively tested cows are culled if they are in the
bottom 25% according to FAP, otherwise the respective quarter
is treated intramammary. Treatment lasts for five days, if the
cow is in the top 25% according to FAP, or three days otherwise.
This strategy is combined with each of the intervention strategies
against clinical IMI (TreatTopLonger & Basic3, TreatTopLonger &
Before50, TreatTopLonger & notCullTop).
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Simulations and Model Output
We simulated the presented strategies for five years with a pre-
ceding five year burn-in period. The three clinical intervention
strategies without added subclinical intervention serve as base-
line strategies. 500 iterations per strategy insured stable results
that described the effects of the strategies rather than the initial
parameter values.
In the simulated five year period, the economic and epidemi-
ological model outputs were collected: income from milk (de-
pending on fat and protein prices, a fee for milk handling, and
a bonus or penalty for the bulk tank SCC), IMI related costs
(testing, lactational and dry cow treatment, opportunity costs,
culling), other costs (feed, culling with a high SCC or history of
IMI), number of subclinical cases (susceptible or clinical quarters
entering subclinical state, including infected quarters of heifers
at first calving), number of clinical cases (susceptible or subclin-
ical quarters entering clinical state), number of treatment days
(e.g., three treatment days for a 3-day treatment), and number
of culled cows (culling as IMI intervention or with a high SCC
or history of IMI). The gross income for the farm was calculated
by subtracting the mentioned costs from the income from milk,
while additional expenses (e.g., costs for other diseases, other
costs related to cattle, buildings, and machinery) were not con-
sidered. Model output is presented as rounded median values of
the annual arithmetic mean over five simulated years (including
the 5th and 95th percentiles). IMI cases are counted on quarter
level. Prices are given in Table IV.2.
Sensitivity analyses
Sensitivity analyses were performed for base cure probability
after lactational treatment; fat and protein prices in Denmark in
2017 (www.arla.dk/om-arla/ejere/arlapris/2017); and culling
costs (Table IV.3). For St. agalactiae (Herd 2), an additional sen-
sitivity analysis for the environmental part in transmission was
conducted (Table IV.3).
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Sensitivity analysis Values
Base cure probability (Herd 1) 0.2 0.4∗ 0.6
Base cure probability (Herd 2) 0.5 0.7∗ 0.8
Environmental part in St. agalactiae trans-
mission
0.1 0.25 0.5 0.75 0,9
Milk price
Price for 1kg protein / 1kg fat in EUR 5.25/3.75 5.51/3.94 5.66/4.04 5.81/4.15∗ 5.92/4.23
Additional costs for culling in EUR 0* 250 500 1,000Table IV.3: Values used in the sensitivity analyses, default values (Table
III.1 and III.2) are marked by *
results
An overview of all results can be found in Table IV.4, with input
values for sensitivity analyses in Table IV.3.
In Herd 1, where the main problem was S. aureus IMI, the
baseline strategy Basic3 yielded a median yearly income of
€187,666, with a median of 42 clinical and of 136 subclinical
cases per year. There were 123 treatment days per year and 16
cows per year culled in relation to IMI (median values). The other
two baseline strategies Before50 and notCullTop led to a higher
median yearly income (about €197,000) and lower median yearly
number of cases (clinical and subclinical), with substantially less
treatment days and more cows culled in relation to IMI (Table
IV.4). All strategies with intervention against subclinical IMI
could further improve the median yearly income and reduce the
number of cases.
Combined with Basic3, the strategies TestTreatCull, CullBot-
tom, and TreatTopLonger led to comparable yearly numbers of
clinical (27 in median) and subclinical (120–122 in median) cases.
Among these three strategies, TestTreatCull yielded the lowest
median yearly income (€198,418) with the other two strategies
yielding about €2,000 (CullBottom) and €2,500 (TreatTopLonger)
more per year (median values). The median yearly numbers of
treatment days were higher than in the baseline strategies, rang-
ing from 149 (CullBottom) to 193 treatment days (TestTreatCull).
The median yearly number of culled cows was 23 with strat-
egy TestTreatCull and 45 and 43 with strategies CullBottom and
TreatTopLonger, respectively.
When the strategies CullBottom and TreatTopLonger were
combined with one of the other two baseline strategies Before50
and notCullTop, the median yearly income was between €204,000
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Figure IV.1: Results of the sensitivity analysis for the base cure proba-
bilities in Herd 1 (S. aureus). The box plots show the mean
annual income (income from milk minus costs for feed,
culling, dry cow treatment, and IMI intervention), mean
annual number of clinical IMI cases, and of subclinical IMI
cases. Results with default values are marked in gray.
and €206,000. Median yearly numbers of clinical cases ranged
from 14 to 16 and from 83 to 87 for subclinical cases. There were
more treatment days (around 40) than in the respective baseline
strategies (median yearly numbers), but less than with Basic3.
The median yearly number of cows culled in relation to IMI was
higher than that in the baseline strategies, but lower than in the
CullBottom and TreatTopLonger strategies when combined with
Basic3.
In Herd 2, where St. agalactiae IMI was the main problem, the
median yearly income with the baseline strategies was much
lower than in Herd 1 (€155,170 with Basic3). The median yearly
number of clinical cases was 20 (notCullTop) or 21, and the
median yearly number of subclinical cases was between 121 and
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Figure IV.2: Results of the sensitivity analysis for the base cure proba-
bilities in Herd 2 (St. agalactiae). The box plots show the
mean annual income (income from milk minus costs for
feed, culling, dry cow treatment, and IMI intervention),
mean annual number of clinical IMI cases, and of subclini-
cal IMI cases. Results with default values are marked in
gray.
130. There were 62 treatment days with Basic3 and 18 treatment
days with notCullTop (median yearly values). Conversely, a
median number of 22 (Basic3) and 31 (notCullTop) cows were
culled per year in relation to IMI.
With all other strategies, the median yearly income was around
€200,000, there were a median of 13 clinical cases and of 94 to
97 subclinical cases per year. The median yearly number of
treatment days was higher than in the baseline strategies, ranging
from 149 (TestTreatCull) down to 82 (CullBottom & notCullTop).
Similarly, more cows were culled in relation to IMI (between 38
and 42 in median), with the exception of strategy TestTreatCull,
where the number was reduced to 17.
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Figure IV.3: Results of the sensitivity analysis for culling prices in Herd
1. The box plots show the mean annual income (income
from milk minus costs for feed, culling, dry cow treatment,
and IMI intervention). Results with default values are
marked in gray.
Sensitivity analysis for the base cure probability after lacta-
tional treatment showed that the yearly income increased and
the number of cases decreased (both clinical and subclinical)
with increasing cure probability. In Herd 1 (S. aureus), this trend
was most visible when the clinical intervention was Basic3 and
least visible when it was Before50 (Figure IV.1). In Herd 2 (St.
agalactiae), the trend was less visible, but more dependent on the
subclinical than the clinical intervention (Figure IV.2).
An increase of the environmental part of St. agalactiae trans-
mission led to a slight decrease in income and increase in the
number of subclinical cases (results not shown).
Sensitivity analysis on the fat and protein prices showed a
high dependency of the yearly income on the milk price for
all strategies, with median values ranging from €109,000 to
€187,000 for baseline strategy Basic3 in Herd 1. Differences
between strategies were similar, independent of the milk price
(results not shown).
Variation of culling costs showed a decrease in income for
increased costs. Reduction in the yearly income was higher in
strategies where more cows were culled (Figure IV.3).
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discussion
The objective of this study was to evaluate different combina-
tions of intervention strategies against clinical and subclinical
IMI of contagious or opportunistic origin, as these are of major
concern in Danish dairy cattle herds. For that purpose, three
clinical and three subclinical strategies were combined. Alto-
gether, ten different strategies were presented for two different
herds, one with an S. aureus problem (Herd 1) and another with
a St. agalactiae problem (Herd 2). Three of those were baseline
strategies, i.e. strategies without intervention against subclinical
IMI. In all strategies, clinical cases were treated with intramam-
mary antibiotic injections for three days or culled, though there
was no reactive culling in the baseline strategy Basic3. Inter-
ventions against subclinical mastitis consisted of testing, 3-day
intramammary treatment, and reactive culling of persistently
infected cows (TestTreatCull). The other subclinical strategies
reflected cow-specific control measures. Low producing cows
could be subjected to reactive culling instead of treatment (3 Cull-
Bottom and 3 TreatTopLonger strategies), and high producing
cows could be treated for five instead of three days, if tested
positive for subclinical IMI (all TreatTopLonger strategies).
Model results showed that adding intervention measures
against subclinical IMI to a clinical intervention strategy led
to a higher yearly income and both less clinical and less sub-
clinical cases (Table IV.4). The increase in yearly income was
especially noticeable in Herd 2, where most subclinical cases
were caused by St. agalactiae. This is not surprising, as St. agalac-
tiae is mostly associated with subclinical IMI (Keefe, 1997), so
intervention against subclinical IMI could be expected to be more
effective than intervention against clinical IMI. These findings
are in general consistent with earlier studies that have shown
that interventions against contagious subclinical IMI could be
cost-effective (e.g., van den Borne et al., 2010a). However, our
results suggest additionally, that altering clinical intervention
on top of adding subclinical interventions could in some cases
lead to an even higher yearly income, while further reducing the
number of IMI cases (Herd 1, Table IV.4). If clinical cases are rare,
as in Herd 2, the clinical intervention strategy does not seem to
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be important, if an intervention strategy against subclinical IMI is
in place (Herd 2, Table IV.4). This illustrates, that it is important
to make herd-specific decisions, taking the clinical manifestation
of the causative pathogen into account when choosing an inter-
vention strategy in the herd. Schukken et al. (2012) also pointed
out that herd-specific decisions are important for control and
prevention of IMI.
Although intervention against subclinical IMI lost a bit in
effectiveness when the environmental part of transmission of
opportunistic St. agalactiae was higher in sensitivity analysis, the
differences between Herd 1 and 2 were more pronounced. The
difference between the two herds was also visible in the sensitiv-
ity analysis on the base cure probability. In Herd 1, sensitivity
to the cure probability seemed to be more dependent on the
clinical part of the intervention strategy (Figure IV.1). Contrarily,
changing the subclinical part of the intervention strategy had a
greater influence on results in Herd 2 (Figure IV.2). This further
emphasizes the importance of herd-specific decisions.
In both herds, the most cost-effective strategies included inter-
vention measures against subclinical IMI and there were several
strategies that seemed similarly cost-effective in terms of yearly
income and number of IMI cases. The difference between these
strategies could be seen in the number of treatment days and
culled cows. Generally, changing the clinical intervention could
reduce antibiotic usage at the cost of an increased number of
culled cows (compare, e.g., CullBottom & Before50 and CullBot-
tom & notCullTop, Table IV.4). The same trend could be seen
when comparing strategy TestTreatCull with one of the other
subclinical strategies. Changing subclinical intervention from
CullBottom to TreatTopLonger did not seem to affect the number
of culled cows, but slightly increased treatment days. Strategies
including TreatTopLonger may therefore not be ideal. Neverthe-
less, the results show that cost-effective strategies still come with
a certain price: increased antibiotics usage or reduced longevity.
The farmer will have to decide which kind of costs he or she
can best justify for their farm. A possibility to partly avoid this
particular dilemma could be to reduce IMI transmission rates in
the herd through rigorous hygienic or biosecurity measures (Lam
et al., 1996). This would lead to a reduced IMI incidence, while
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also reducing both treatment days and the number of cows culled
in relation to IMI (results not shown). However, there are few
studies investigating cost-effectiveness of hygienic measures (e.g.,
Huijps et al., 2010), so it remains unclear if the increase in income
from milk would compensate for the costs of implementing a
comprehensive hygiene strategy.
In this study, we did not change prices over time. That may
be unrealistic, but it simplifies comparison of different interven-
tion strategies, as extra noise is removed. Sensitivity analysis
of culling costs and milk prices showed that both have a sub-
stantial influence on the yearly income (Figure IV.3). However,
the implications differ; while an increased milk price led to a
higher income in all strategies, the extent to which higher culling
costs lowered the yearly income depended on the intervention
strategy. Therefore, culling costs should be taken into account
upon choosing an intervention strategy, too.
The presented strategies included strict culling rules and led
to a high number of culled cows. However, the culling rules for
subclinical IMI concentrated on removing persistently infected or
low producing cows. As a previous study showed that in some
Danish herds a high milk production could be a determinant
for antimicrobial treatment (Gussmann et al., 2018a), it does not
seem so farfetched that farmers may be willing to consider culling
low producing cows. This would also conform to a study by
Vaarst et al. (2006), where farmers were willing to adopt culling
strategies that fit into their goal for the herd. The strict culling
rules also affect the usual culling procedure in the model, as
we simulated a closed herd where replacement heifers had to
be reared on-herd. In a real herd, where other, non-voluntary
culling occurs, e.g. due to other diseases, a strict culling strategy
in relation to IMI may be challenging to implement. Furthermore,
there is an ethical aspect to consider: strict culling rules may
reduce longevity and thus impede animal welfare (Bruijnis et al.,
2013). In this study, however, we focussed on the economic and
epidemiological effects of IMI interventions, and we leave it to
future studies to investigate how general culling dynamics are
influenced by strict culling rules for IMI.
It should be kept in mind, that this study used a modelling
approach to investigate different intervention strategies. The
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results depend on the model parameters, e.g., transmission and
cure rates, and on the modelled herd structures. These are likely
to differ to a certain degree in real herds. However, while a
field study to validate the results would be ideal, it would also
be costly and the trends found in the results are clear. The
differences in cost-efficiency could be explained and were far
from marginal, allowing the strong belief that the results of the
model are trustworthy.
conclusions
We investigated different combinations of cow-specific interven-
tion strategies against contagious or opportunistic clinical IMI
and subclinical IMI in two situations; in a herd with S. aureus
as the main causative pathogen, and in another herd with St.
agalactiae as the main causative pathogen. Intervention mea-
sures generally led to an increased number of culled animals or
higher intake of antibiotics. We demonstrated that intervention
strategies against both subclinical and clinical IMI, including
cow-specific treatment and culling decisions, could reduce IMI
incidence and thereby increase the farm’s yearly income in the
long term. In addition, the optimal intervention strategy was
dependent on the main causative pathogen within the herd, il-
lustrating that control of IMI must be herd-specific.
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Parameter Description Value Value Reference (value lactation)
(lactation) (dry period)
Transmission rate Rate for susceptible quarters to enter infected state
S. aureus 0.00004 0.0009 Fitted value
S. agalactiae 0.0007 0.0001 Fitted value
S. uberis (contagious) 0.0002 0.00001 Fitted value
S. uberis (environmental) 0.000002 0.0000001 Fitted value
E. coli 0.000001 0.000001 Barkema et al. (1998)
Probability of clinical
state
Probability for a quarter to enter clinical
state upon infection
S. aureus 0.17 0.1 Swinkels et al. (2005a)
S. agalactiae 0.01 0.1 Barkema et al. (1998) and Swinkels et al. (2005a)
S. uberis (contagious) 0.32 0.1 Zadoks et al. (2003)
S. uberis (environmental) 0.32 0.1 Zadoks et al. (2003)
E. coli 0.85 0.1 Hogan and Smith (2003)
Flare up probability Probability for a subclinical quarter to become clinical
S. aureus 0.0081 0.006 Swinkels et al. (2005a)
S. agalactiae 0.0005 0.0005 Barkema et al. (1998) and Swinkels et al. (2005a)
S. uberis (contagious) 0.0068 0.004 Swinkels et al. (2005b)
S. uberis (environmental) 0.0068 0.004 Swinkels et al. (2005b)
E. coli 0.0035 0.0035 Döpfer et al. (1999)
Spontaneous recov-
ery probability
Probability for a subclinical quarter to be-
come susceptible (without treatment)
S. aureus 0.0064 0.0079 van den Borne et al. (2010b)
S. agalactiae 0.0023 0.0086 Leelahapongsathon et al. (2016)
S. uberis (contagious) 0.0143 0.0086 van den Borne et al. (2010b)
S. uberis (environmental) 0.0143 0.0086 van den Borne et al. (2010b)
E. coli 0.0221 0.0221 van den Borne et al. (2010b)
Recovery probability Probability for a clinical quarter to be-
come susceptible after treatment or dry
cow treatment
S. aureus 0.4 0.77 Steeneveld et al. (2011)
S. agalactiae 0.7 0.89 Steeneveld et al. (2011)
S. uberis (contagious) 0.7 0.89 Steeneveld et al. (2011)
S. uberis (environmental) 0.7 0.89 Steeneveld et al. (2011)
E. coli 0.8 0.9 Steeneveld et al. (2011)Table IV.S1: Model parameters for all secondary pathogens during lactation and dry off, references are given for values during
lactation. Dry period values are taken from Halasa et al. (2010).
5 GENERAL D ISCUSS ION
5.1 data analysis
In the first manuscript (Section 3.2), we showed that data from
the Danish Cattle Database can be used to categorise herds into
different groups regarding use of antibiotic treatment for udder
health. Prominent determinants for treatment were, e.g., health
indicators (including diagnostics), age, or milk production.
In addition to the investigated factors, other non-investigated
factors could predict treatment, maybe even better than in our
analysis. For instance, Jansen et al. (2009) found that farmer
attitudes such as a perceived lack of control of mastitis could
explain a large part of the variation within subclinical or clinical
mastitis incidence. Therefore, it does not seem farfetched that
farmer attitudes might also influence antibiotic treatment. In
Denmark, antibiotic treatment must be prescribed by a veterin-
arian. Considering that, another influential factor for antibiotic
treatment could be the herd veterinarian or the existence of a
herd health programme (Lind et al., 2012). In contrast to farmer
attitudes, which are not registered in a database, records of the
responsible herd veterinarinan should exist and could therefore,
theoretically, be considered in the analysis without too much
effort. However, in the data made available to us, information
about the veterinarian was not included.
In general, the disease recording data for clinical mastitis seem
to be of good quality in Denmark (Wolff et al., 2012). However,
the Danish Cattle Database is not complete, especially where it
concerns non-mandatory data, e.g., dry off dates. These have
to be considered as a possible source of bias, when analyses
are conducted with this data. If herds have to be excluded
from analyses because their data are incomplete, results may
not be applicable for the whole target population. It is therefore
important to realise which population the study population can
155
156 general discussion
be assumed to sufficiently represent. Within a herd, incomplete
data are harder to recognise and deal with. If registrations are
systematically missing, wrong, or unavailable, results are likely
falsified. Randomly missing data on the other hand should
still produce usable results. Unfortunately, this can rarely be
determined from the database alone, so a certain trust in the
register data is required.
On top of missing data, registration errors can occur and lead
to inconsistent data and further bias. An example of inconsistent
data was a clinical registration for a cow 8236 days (around 22.5
years) after calving. This was most likely caused by a registration
error for the date or the cow identity. Registration errors can in
many cases be detected, although they cannot be easily corrected
without further information. Dealing with these kinds of error is
part of data curation.
However, inconsistency can also be caused by subjective as-
sessment. Disease recording allows registration of cases as
“Yverbetændelse, subklinisk” (subclinical inflammation of the ud-
der), “Yverbetændelse” (inflammation of the udder), or
“Yverbetændelse, akut” (acute inflammation of the udder), but
also of mastitis pathogens. Different persons may have different
habits or opinions about when a case classifies as acute, or when
to register the causative pathogen instead of a subclinical case.
This is one of the reasons why we did not differentiate between
registrations in Manuscript I.
Despite errors and potential bias, register data are a valuable
source of information, as they are recorded on a regular basis and
include a large quantity of registrations covering a substantial
proportion of the population. Obtaining this information via
field studies would most likely be a logistically demanding and
very costly challenge. The value of register data should therefore
not be underestimated. Instead, the data should be constantly
assessed, understood, curated, and improved. Most importantly,
results of analyses based on register data should be interpreted
with caution, bearing the potential bias in mind.
5.2 modelling 157
5.2 modelling
5.2.1 Implications across manuscripts
In Manuscript II (Section 4.3), the model was introduced and
discussed. One of the results was that lower prevalences generally
led to higher per-case costs (Section 4.2). This means that an
individual IMI case was of less economic consequence if there
were more cases in total. Since the goal is identification of cost-
effective intervention measures, it may be better to look at the
total income and costs, instead of comparing costs on a per-case
basis.
Therefore, the economic output was presented as a net income
in the following Manuscripts III (Section 4.4) and IV (Section 4.5).
In these manuscripts, different intervention strategies against
mastitis were investigated and compared. The investigated in-
terventions took determinants for antimicrobial treatment (or
aspects thereof) into account based on information found in Ma-
nuscript I (see above and Section 3.2): testing before treatment
(diagnostics), considering milk production, or adjusting decision
making for primiparous cows (age). Results for the latter were
not presented, as there were no conspicuous changes compared
to strategies where decisions were not adjusted.
However, while milk production was identified as a determ-
inant for antimicrobial treatment in Manuscript I, use of milk
yield as a determining factor in a treatment strategy was not
specifically cost-effective (see strategy “Longer” in Manuscript
III). When used as a determining factor for reactive culling in
an intervention strategy, on the other hand, it could improve
cost-effectiveness (strategy “notCullTop” in Manuscript III and
“CullBottom” in Manuscript IV). For farmers who already use
milk yield as a determinant for treatment, it may not be such a big
step to switch to one of these strategies, provided that they are
willing to consider strategies with reactive culling. Other farmers
may be willing to consider these strategies because they believe
in IMI diagnostics, or if their preferred mastitis management
strategy can also be incorporated. Consequently, intervention
strategies and their communication should be customised for the
respective farmer (Jansen and Lam, 2012; Ritter et al., 2017).
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5.2.2 Modelling IMI and IMI interventions
While the model is sensitive to changes in all transmission para-
meters, changes in the transmission rate seemed to be most
effective and consistent in altering pathogen occurrence. The
transmission framework, including opportunistic transmission,
and the need for accurate estimates of transmission parameters
were discussed in Manuscript II (Section 4.3). In the following
two Manuscripts III (Section 4.4) and IV (Section 4.5), intervention
strategies against clinical and subclinical IMI were investigated.
We found that nearly every intervention strategy was more cost-
effective than the standard three day treatment and that adding
subclinical intervention to a clinical intervention strategy could
further improve cost-efficiency. Depending on the main causat-
ive pathogen, a different combination of clinical and subclinical
interventions was the preferable option.
Cow-specific interventions and reactive culling led to cost-
effective strategies at the cost of increased antibiotics usage or
culling. Increased use of antimicrobials may hamper societal
acceptance of a strategy, as consumers are increasingly aware of
antibiotics usage in food production and antimicrobial resistance
(Ruegg, 2003). Similarly, increased culling may create negative
impressions about the dairy industry, as longevity is linked to
animal welfare (Bruijnis et al., 2013). Thus, ethics of targeted
culling must be considered in practice. Decreasing mastitis in-
cidence by improving hygiene would circumvent these problems
(see Section 4.4). However, seeing that farmers consider extra
labour as one of the most disturbing aspects of mastitis (Kuiper
et al., 2005), they may not be eager to dedicate more time to a
more thorough and rigorous daily hygiene regimen.
Another important point regarding hygiene was raised in Ma-
nuscript III: a comprehensive hygiene strategy would probably
be most effective from an epidemiological point of view, but
the cost-effectiveness of such a strategy is unclear. Why is hy-
giene different from the other intervention strategies, where cost-
effectiveness was investigated by the modelling approach? Cull-
ing of infected animals is not directly connected to the transmis-
sion framework, but antibiotic treatment of IMI causes changes
in the framework by increasing the cure rates (see Section 2.1.2).
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Studies providing information about cure after treatment are
therefore necessary (e.g., Steeneveld et al., 2011). Hygiene simil-
arly intervenes directly in the transmission framework by redu-
cing the transmission rate (see Section 2.1.2). Hence, parameter
estimates regarding hygiene are needed for implementation in
the model. While some studies about costs and efficacy of hy-
gienic measures exist (e.g., Huijps et al., 2010), little is known
about how different hygienic measures complement each other.
Is their efficacy additive or are some measures more or less ef-
ficient than one would expect when combined? We could have
compared single hygiene measures against different intervention
strategies in Manuscript III. However, the focus of the manuscript
was on intervention against clinical IMI in general, so we decided
to emulate a comprehensive hygiene strategy by reducing the
transmission rate and only compare effectiveness in this case.
Besides the intervention strategies introduced in Chapter 4,
we also tested other strategies. These were not shown, be-
cause their results were not better than those of the presented
strategies. There are also further additions that could have been
considered in the model regarding the implemented options for
intervention, e.g., selection strategies for dry cow treatment. At
the moment, the model includes three options for selective DCT;
cows can be selected for testing if they fulfill one or both of the
following conditions: if they had an elevated SCC in the current,
last, or second to last month; or if they had a clinical IMI during
the lactation. Further options could also take the elevation level
of the SCC or cow factors into account.
It is important to note that, regarding both clinical and sub-
clinical intervention strategies, we focused on pathogens with
contagious transmission (S. aureus) or transmission with conta-
gious elements (S. agalactiae). The reason for this choice was
that these pathogens depend on the number of infected quarters.
Controlling this number by intervention measures was expected
to inhibit spread of infection to healthy herd mates. Our results
showed that taking action to clear infection could prevent new
cases and milk loss. In environmental transmission, such a clear
effect would not be expected. For a similar reason, S. agalactiae
was only investigated in Manuscript IV, as it causes foremost
subclinical IMI.
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5.2.3 Model choice
The MiCull model is a mechanistic, stochastic model. That
means that the assumed inner mechanisms of a dairy herd and
IMI transmission and intervention are modelled in a stochastic
manner. In that sense, models including IMI transmission are
always mechanistic. Another type of model often used for mast-
itis are dynamic programming models. Dynamic programming
models describe the modelled system, in this case a dairy cow,
as a set of possibly hierarchical state variables with a discrete
number of states (Bellman, 1957). At any time step, the states
can change, depending on the assumed transition probabilities.
The goal is to optimise a given objective function (net present
value of a cow, Bar et al., 2008b; Cha et al., 2014). Considering
their structure, these kinds of models are particularly suited for
optimisation problems (Cha et al., 2014) or to investigate costs
per case or cow (Bar et al., 2008b). As we were not only interested
in herd economics, but also epidemiological effects, we chose the
mechanistic approach.
This allowed us to test and compare different intervention
strategies against clinical and subclinical IMI without conduct-
ing field studies. The limitations of this approach lie in the
need to understand the underlying structures and their proper
parameterisation. In the absence of Danish parameter estimates,
literature values from studies conducted in other countries had to
be used. If parameter estimates are not available at all as, e.g., for
a comprehensive hygiene strategy, cost-effectiveness cannot be
investigated. Missing quantitative knowledge is also the reason
why not all known risk factors could be included in the model.
Milk production level has for example been identified as a risk
factor (e.g., Koeck et al., 2014), but for modelling purposes, a
quantification is necessary. Similarly, to properly represent strain-
specific characteristics for all strains, e.g., cure after treatment
(van den Borne et al., 2010b), strain-specific parameter estimates
are required. In the MiCull model, two strains of S. uberis are
included. However, they differ only in their transmission modes
and not in the other parameters, as the necessary parameter
estimates are missing. They were added regardless to showcase
strain-specificity of the model.
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Nevertheless, as described in Chapter 4, the MiCull model
complies with the requirements given in Section 2.3 (see also Fig-
ure 3), given that parameter estimates are available. Compared
to the other models introduced in Section 2.2.2, it models IMI
on quarter level and thus allows up to four different pathogens
per cow. Transmission is strain-specific and allows one of three
different transmission modes per strain. Pathogen-specific effects
on production are modelled for both clinical and subclinical IMI.
The model includes cow-specific infection and cure of clinical
IMI. Furthermore, IMI is also modelled during the dry period.
Finally, different options for DCT and intervention strategies
against clinical and subclinical IMI are available, including cow-
specific intervention and reactive culling. The model is therefore
strain-, cow-, and herd-specific.
Finally, it should be remembered that at this stage, the model
is still a scientific decision support tool. That is, the results
obtained by the model should be seen as indications for possible
cost-effective intervention strategies. Models are only as good
as their input allows. In Manuscripts III and IV, a rigorous use
of diagnostics and monthly monitoring of SCC were assumed.
Farmers may, for one reason or another, not always strictly adhere
to the strategy. This or other, unforeseen factors might influence
the outcome in reality, so field testing of the suggested strategies
to validate the model results would be ideal. According to Ritter
et al. (2017), practical evidence would also help with motivating
farmers to adopt management changes.

6 CONCLUS IONS
This thesis used a modelling approach to investigate costs and
efficacy of different intervention strategies against IMI. The res-
ults showed that control of mastitis can be improved in cost-
effectiveness by cow- and herd-specific strategies that include
reactive culling and measures against subclinical IMI. Based on
the research questions in Section 2.3, the following conclusions
could be reached.
rq1a Data from the Danish Cattle Database could be used to
find determinants for antimicrobial treatment for udder health.
Based on how much each factor contributes, herds could be
classified into three different groups. These groups represented
herds with resembling treatment practices.
rq1b For lactational treatments, the three groups were char-
acterised by age and diagnostics based treatment, production
based treatment, and treatment in connection with culling. For
DCT, age and diagnostic based treatment were separate groups
with production based treatment as the third group.
rq2 The developed model was sensitive to changes in all
transmission parameters. However, changes in the transmis-
sion rate seemed to be most influential and consistent in altering
pathogen occurence, followed by spontaneous recovery probabil-
ity.
rq3 Nearly every proposed intervention strategy resulted in
a lower IMI incidence than a default three day intramammary
treatment for all clinical cases without causing economic losses.
Cow-specific intervention strategies that included testing and
reactive culling led to better results.
163
164 conclusions
rq4 Adding any subclinical intervention measure could fur-
ther improve an intervention strategy by another reduction of
IMI incidence and increase in income. Additional subclinical
intervention measures led to an increase in antibiotic usage and
culling.
rq5 There was not a unique best intervention strategy against
IMI. Choice of strategy rather depended on the herd and the
present causative pathogens. The optimal strategy would also
change depending on the concessions the farmer is willing to
make regarding costs in the form of antibiotic usage and culling
of cows. However, the optimal intervention strategy in terms of
pure cost-effectiveness always involved testing and cow-specific
treatment or reactive culling decisions for both clinical and sub-
clinical IMI.
7 PERSPECT IVES
The methods used for data analysis in Chapter 3 and the model
presented in Chapter 4 can be used or expanded in the future.
Determinants for antibiotic treatment may change over time
and so rerunning the analysis once in a while would help with
monitoring changes in treatment behaviour. It may, in particular,
be interesting so see if the determinants changed after the milk
quota system was abolished in 2015. As mentioned in the discus-
sion in Chapter 5, the herd veterinarian could also be included
in future analyses. Furthermore, a similar analysis could be run
to find determinants for culling.
Regarding the model, there are various possibilities for future
studies. In Chapter 5, investigating effects of different hygiene
measures or different selection strategies for dry cow treatment
were discussed. As the results in this thesis have shown that
intervention strategies should be herd-specific and herd sizes
in Denmark are increasing, it may also be interesting to invest-
igate how cost-effectiveness of intervention strategies changes
with herd size. A less rigorous use of diagnostics and delayed
treatment or culling decisions could be investigated to account
for a more erratic component in human behaviour. It could also
be interesting to consider and compare different SCC thresholds
when selecting cows for testing for subclinical IMI.
Moreover, there are several factors that were not addressed
in this thesis that could be included in the model in the future,
for instance, drying off of single quarters, cow-specific cure after
treatment of subclinical cases, or shedding patterns. The current
model only includes a rudimentary implementation of heifer
mastitis, this could also be expanded. Finally, a field study to
validate some of the model results could be conducted.
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APPEND IX
Parameter Description Pathogen Value Reference
Infection
probability
Probability that a heifer
will be infected with the
pathogen at first calving
S. aureus 0.0171 De Vliegher et al. (2012)
S. agalactiae 0.0188 De Vliegher et al. (2012)
S. uberis (contagious) 0.0747 De Vliegher et al. (2012)
S. uberis (environmental) 0.0747 De Vliegher et al. (2012)
E. coli 0.0747 De Vliegher et al. (2012)Table 2: Missing values from Table II.2. Values are means of the values
for quarter level samples reported in Table 1 (De Vliegher
et al., 2012).
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